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ABSTRACT
Radioimmunoassays were developed for measurement of insulin, glucose-dependent 
insulinotropic polypeptide (GIF) and glucagon-like peptide-1 (GLP-1) in rat salivary 
gland extracts and human saliva. Insulin and GIP were found in rat salivary 
submandibular glands (SSG), and human saliva. Insulin was also found in rat salivary 
parotid glands (SPG), but GLP-1 was not detected in rat SSG or SPG or human saliva.
Chronic whole black tea consumption in rats increased GIP levels in the duodenum 
and reduced plasma glucose levels, these effects were primarily attributable to 
caffeine. However red wine polyphenols appeared to be responsible for increased 
duodenal GLP-1 concentrations in rats.
Insulin levels in human saliva rose following a swallowed meal but not following a 
sham fed meal, GIP levels in saliva decreased following both swallowed and sham fed 
meals. Acute red vdne consumption increased salivary a-amylase activity in 
volunteers, whole black tea consumption modulated circulating GIP and GLP-1 
levels.
This is the first known report of GIP in human saliva. On the basis of time-course 
studies and integration of data from rats and volunteers it is concluded that insulin in 
saliva is derived from circulating insulin, whereas GIP in saliva is probably secreted 
by the SSG. It is suggested that GIP is involved in the inhibition of gastric acid 
secretion via the somatostatin-gastrin pathway. Further work is necessary to verify 
this hypothesis.
The modulation of circulating GIP and GLP-1 can be explained by the consumption 
of black tea and red wine increasing gut transit time. Consumption of black tea and 
red wine does not modulate the endocrine activity of the salivary glands. Relative 
dietary physiological doses of black tea and red wine were used in all experiments to 
determine the effects that would be seen in the consumer. Therefore, although this 
research found relatively little effects of black tea or red wine consumption on the 
hormonal and metabolic response to a meal or the endocrine activity of the salivary 
glands, it is representative of the effects seen in the consumer.
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1.1 INTRODUCTION
The salivary glands and saliva have been relatively ignored in terms of research but are 
known to secrete a number of well-known peptide hormones (Barka, 1980). The peptide 
hormone insulin was first determined in extracts from rat and mouse salivary glands in the 
1970's. Since then many workers have used a wide range of techniques to verify both the 
presence of insulin-like immunoreactivity (ILI) in extracts from the salivary glands and that 
it is identical to pancreatic insulin. Little is known of the possible functions of the insulin 
present within the salivary glands and human saliva. Other endocrine peptides, glucose- 
dependent insulinotropic polypeptide (GIP) and glucagon-like immunoreactivity, have been 
found in the salivary gland (Tseng et a l, 1995; Lawrence et a l, 1977). The main functions 
of pancreatic insulin are to stimulate the storage of carbohydrate, protein and fat. GIP and 
glucagon-like peptide-1 (GLP-1) act to potentiate insulin secretion via the enteroinsular 
axis (EIA). These hormones play an important role in carbohydrate metabolism, the 
corresponding salivary hormones may play a systemic endocrine or a local role.
Black tea and red wine are both widely consumed in the UK diet, and provide two of the 
major sources of dietary tannins and polyphenols in the UK. Consumption of dietary 
tannins is known to cause hypertrophy of the salivary parotid gland (SPG) in rodents and 
also to elicit the secretion of a family of proline-rich proteins. Metabolites of red wine and 
black tea are detectable in plasma following consumption of these beverages. The 
consumption of black tea and red wine with a meal has some effects on postprandial 
glucose metabolism. It is therefore possible that the consumption of red wine and black tea 
with a meal may have other effects on the postprandial metabolism of food.
Assuming that insulin, GIP and GLP-1 were present in salivary glands, then it would be 
feasible that the consumption of dietary tannins and phenols may modulate the secretion of 
the peptide hormones insulin, GIP and GLP-1 from the salivary glands and into saliva. If 
the secretion of these peptide hormones were modulated in any way by dietary tannins and 
phenols, then any subsequent endocrine-mediated effects would be independent of the 
absorption or metabolism of the dietary tannins and phenols.
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1.1.1 EUROPEAN UNION PROJECT
The European Union (EU) funded this project, which formed part of the EU project entitled 
"Understanding the biological effects of dietary complex phenols and tannins and their 
implications for the consumer health and well being". The University of Surrey was one of 
eleven contractors involved. The work, which forms this thesis, was undertaken at the 
Centre for Nutrition and Food Safety within the University of Surrey.
The aims of the EU project were to determine whether complex phenols and tannins 
influence nutritional adequacy or bioavailability. It was also to determine whether complex 
phenols and tannins are associated with the incidence of chronic disease and whether 
variations in the consumption of complex phenols and tannins influence these phenomena.
Across the EU there are many variations in diet resulting in differences in the quantities of 
complex phenols and tannins consumed. A diversity of diets will provide varying types of 
complex phenols and tannins in varying proportions. Therefore, any effects on salivary 
endocrine activity discovered could give an insight into the various effects of the complex 
phenols and tannins found in European diets.
The following review of literature is aimed to familiarise the reader with the biology, 
biochemistry and function of the peptide hormones GIP, GLP-1 and insulin. The functions 
and relevant research associated with the salivary glands are also reviewed. The 
introduction also seeks to review the main health effects of dietary complex phenols and 
tannins.
1.2 INSULIN
Insulin is a two-chain polypeptide hormone linked by disulphide bridges, with a molecular 
weight of 5808 Daltons (see figure 1.1). The A-chain consists of 21 amino acids and the B- 
chain consists of 30 amino acids. Insulin is mainly synthesised by the endoplasmic 
reticulum of B-cells in the pancreas where it is stored in membrane bound granules and
CHAPTER 1
secreted by the Golgi apparatus. The precursor of insulin is preproinsulin, which is broken 
down to proinsulin as it enters the endoplasmic reticulum. Proinsulin is cleaved by 
proteolytic action to insulin and its connecting peptide (C-peptide) before secretion. Insulin 
and C-peptide are produced in equimolar amounts.
A chain
Gly-Ile-Val-Glu-Gln-Cys-Cys-Thr-Ser-IIe-Cys-Ser-Leu-Tyr-Gln-Leu-Glu-Asn-Try-Cys-Dsn 
B chain I /
Phe-Val-Asn-Gln-His-Leu-Cys-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cys-Gly-Glu-Arg-Gly-Phe-
Phe-Tyr-Thr-Pro-Lys-Thr
Denotes disulphide bond 
Figure 1.1 Amino acid sequence of human insulin
Insulin is not bound to a carrier protein and circulates free in the blood. The half-life of free 
insulin in the circulation is about five minutes; it is extracted from portal blood by the liver. 
Eighty percent of secreted insulin is degraded in the liver and kidneys.
1.2.1 FUNCTIONS OF INSULIN
The principal actions of insulin are to stimulate the storage of carbohydrate, protein and fat 
by, for example, the stimulation of glycogen synthesis in both muscle and liver, and 
acceleration of glycolysis in the liver. The hormone also acts to stimulate the synthesis of 
proteins in a variety of ways and to inhibit protein degradation. The main functions of 
insulin are characterised in table 1.1.
Insulin acts to facilitate glucose transport into muscle and adipose tissue by increasing the 
number of insulin-sensitive glucose transporters within the cell membrane. Glucose does
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not enter cells by diffusion across the cell membrane, it requires facilitated diffusion 
(carrier mediated diffusion) by specific glucose transporters. These transporters allow 
passive diffusion of glucose into cells down a concentration gradient. Five different glucose 
transporters, named GLUT 1 through to GLUT 5, have been characterised and these are 
tissue specific (Gould & Holman, 1993). In muscles and adipose tissue the glucose 
transporter is GLUT 4, which is insulin sensitive (Manchester & Lawrence, 1996). Insulin 
acts on GLUT 4 by stimulating the transporter molecules to move from the cytoplasm, 
where they are maintained in a pool, to the cell membrane. Once exposure to insulin is 
removed the GLUT 4 molecules return to the cell cytoplasm (Frayn, 1996).
Table 1.1 The effects of insulin on various tissues 
Tissue Action
Adipose tissue Increased glucose entry, fatty acid synthesis, glycerolphosphate
synthesis, triglyceride deposition and uptake.
Activation of lipoprotein lipase 
Inhibition of hormone sensitive lipase 
Muscle Increased glucose entry, glycogen synthesis, amino acid uptake, protein
synthesis in ribosomes, ketone uptake and uptake 
Decreased protein catabolism and release of gluconeogenic amino 
acids
Liver Increased protein, glycogen and lipid synthesis
Decreased ketogenisis and gluconeogenisis 
General Increased cell growth
Insulin acts to stimulate glycogen synthesis in both muscle and liver. Insulin regulates the 
enzymes involved in glycogen synthesis by activating the rate-controlling enzyme of 
glycogen synthesis (glycogen synthase) and by inhibiting the enzyme controlling glycogen 
breakdown (glycogen phosphorylase) (Manchester & Lawrence, 1996). After insulin binds 
to receptors in the cell wall, it acts to stimulate changes in the phosphorylation of the 
enzyme (Rosen, 1987). Therefore glycogen synthesis is increased and glycogen breakdown
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is decreased, which leads to net glycogen storage.
Insulin suppresses the activity of the enzyme hormone-sensitive lipase in adipose tissue 
(Rosen, 1987). This enzyme catalyses the breakdown of stored triacylglycerides (TAG) into 
glycerol and non-esterified fatty acids (NEFA). The concentration of NEFA in plasma 
reflects their rate of release from adipose tissue and therefore plasma levels of NEFA have 
an inverse relationship with plasma concentrations of insulin and also glucose. After the 
absorption of nutrients, the increasing plasma glucose and insulin concentrations lead to an 
increase in glucose uptake and glycolysis by adipose tissue (Frayn, 1996). This leads to 
increased production of glycerol-3-phosphate and the re-esterification of fatty acids within 
adipose tissue. Following nutrient absorption there is an increased insulin/glucagon ratio, 
which alters liver metabolism, causing a reduction in the rate of ketone body formation and 
secretion.
Dietary fat is absorbed into mucosal cells of the intestinal brush border membrane by 
simple diffusion in the form of free fatty acids. Within enterocytes, fatty acids are then 
esterified to form new TAG molecules. TAG are non-polar, hydrophobic compounds, 
which are carried in plasma bound to lipoproteins. Peak postprandial levels of plasma TAG 
occur three to five hours following a mixed meal (Elliott et ah, 1993). TAG bound to its 
carrier are hydrolysed at adipose tissue by lipoprotein lipase (LPL) and absorbed into 
adipocytes. LPL is insulin sensitive and therefore activity of this enzyme is stimulated after 
a meal when insulin levels are high (Frayn, 1996). The process of TAG storage within 
adipocytes is facilitated by the suppression of the enzyme hormone-sensitive lipase by 
insulin (Rosen, 1987).
Insulin acts in an anabolic function to stimulate net protein synthesis in the body and also to 
prevent protein breakdown. In insulin-dependent diabetes, patients suffer a loss of protein 
from the body, which is reversed by the treatment with insulin (Linn et a l, 1996).
Insulin binds to specific receptors on insulin sensitive tissues, which consist of four 
subunits, two a  and two ^-chains, embedded within cell membranes. The a-subunits bind
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insulin and are extracellular, whilst the p-subunits span the cell membrane. After insulin 
binds to the a-subunits the insulin-receptor complex becomes internalised into the cell. The 
binding of insulin to its receptor triggers the tyrosine kinase activity of the intracellular 
ends of the p-subunits (Rosen, 1987). This produces autophosphorylation of the tyrosine 
residues of the p-subunit, which is necessary for insulin to exert its biological effects.
Insulin sensitive tissues are located in many sites around the body, a major site is the liver 
where insulin acts to stimulate glycogen synthesis. Muscle cells also contain insulin 
receptors, where insulin binding facilitates diffusion of glucose into the cell. mRNA for 
insulin receptors are also found in the brain, adipose tissue, pancreas and many other target 
tissues throughout the body (Tsujimoto et a l, 1995; Campion et a l, 1997).
1.2.2 INSULIN SECRETION
Insulin secretion occurs mainly in response to changes in plasma glucose levels. An 
increase in plasma glucose concentration above 5 mmol/1 (basal levels) causes increased 
glucose metabolism by B-cells in the pancreas, which leads to ATP production. Insulin is 
stored in granules within the Golgi apparatus of the pancreatic B-cells, the granules fuse 
with the cell membrane and the contents of the granule, i.e. insulin, are discharged into the 
intracellular space. This response also stimulates new insulin synthesis, and if elevated 
plasma glucose levels continue, then insulin secretion will continue and circulating insulin 
levels increase. Insulin secretion also occurs in response to the absorption of amino acids, 
notably arginine and leucine, leading to a net increase in protein synthesis following 
consumption of a meal containing protein (Milner, 1969).
Insulin secretion is also modulated by the afferent nervous system, secretion is stimulated 
in the pancreas by a-adrenergic and inhibited by the p-adrenergic nerves. Parasympathetic 
innervation of pancreatic islets mediates the 'cephalic phase' insulin secretion in response to 
the sight, smell and taste of food. In a cephalic phase response circulating insulin levels rise 
from basal, prior to the ingestion of nutrients, within two minutes following the stimulus, 
peaking within four minutes and returning to basal within ten minutes (Karhunen, 1997;
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Teff et al., 1993). It is believed that cephalic phase responses occur to prepare the body for 
forthcoming nutrients. Postprandial insulin secretion occurs in response to a rise in plasma 
glucose levels and does not occur immediately following food ingestion. Cephalic phase 
insulin responses are approximately 3% of the magnitude of postprandial insulin release 
{ jQ ^e ta l, 1993).
Oral glucose is not absorbed through the stomach; therefore increased plasma glucose 
levels following food ingestion and the subsequent insulin secretion are dependent on 
gastric emptying and the absorption of nutrients from the small intestine. The rate of gastric 
emptying is one determinant of insulin secretion.
1.2.2.1 Insulin and the enteroinsular axis
The term enteroinsular axis (ETA) describes the regulatory control exerted by the 
gastrointestinal tract on the endocrine pancreas, which contributes to enhanced insulin 
secretion following ingestion of a meal. The EIA is comprised of a neural and an endocrine 
component, which act to modulate pancreatic insulin secretion against that determined by 
the circulating glucose concentration (Ebert, 1990). In man, the incretin hormones GIF and 
GLP-1 stimulate insulin release from pancreatic B-cells via specific receptors in a glucose- 
dependent manner (Morgan et al., 1988).
1.3 GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE (GIP)
Glucose-dependent insulinotropic polypeptide (GIP) is a forty-two amino acid residue 
peptide, with a molecular weight of 5105 Daltons (see figure 1.2). GIF is mainly 
synthesised and secreted by the K cells in the mucosa of the duodenum and upper jejunum 
(Morgan et al., 1978). Rat preproGIP is 144 amino acids in length. The main form of GIF 
found in plasma is bioactive GIF (1-42) (Fehmann et a l, 1995b), another form of bioactive 
GIF is the C-terminally truncated form GIF (1-30) (Fehmann & Goke, 1995a). Unless 
otherwise stated the term GIF refers to bioactive GIF (1-42). GIF is structurally related to 
Glucagon-Like Peptide-1 (GLF-1), and both are members of the secretin family of 
hormones (Knapper et al, 1996).
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GIF was initially characterised by its ability to inhibit gastric acid secretion hence the name 
Gastric Inhibitory Polypeptide. The name has since been changed to Glucose-dependent 
Insulinotropic Polypeptide, to reflect the wider physiological functions of this hormone, 
namely to stimulate insulin secretion in the presence of hyperglycemia, but it still has the 
same acronym of GIF.
Tyr-Ala-Glu-Gly-Thr-Fhe-Ile-Ser-Asp-Try-Ser-Ile-Ala-Met-Asp-Lys-Ile-Arg-Gln-Gln-
Asp-Fhe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Ser-Asp-Trp-Lys-His-Asn-Ile-
Thr-Gln
Figure 1.2 Amino acid sequence of human GIF
1.3.1 FUNCTIONS OF GIP
GIF acts both inside and outside the gut and is a potent stimulator of glucose-induced 
insulin secretion via the enteroinsular axis (EIA) (Knapper et a l, 1996) with a powerful 
insulinotropic effect. GIF is an incretin hormone, ie, a gut factor that is released into the 
circulation after nutrient ingestion, which contributes to meal-induced insulin secretion 
owing to its glucose-dependent insulinotropic abilities. This only occurs from the 
pancreatic B-cells when blood glucose levels are higher than fasting levels (greater than 4 
mmol/1). GIF binds to specific receptors on B-cells of the pancreas (Morgan et a l, 1988). 
Stimulation of GIF receptors in pancreatic B-cells causes the cyclic AMP production 
required for insulin release (Moens et a l, 1996). Both GIF (1-42) and the C-terminally 
truncated form GIF (1-30) stimulate cAMF production and proinsulin gene expression 
equipotently (Fehmann & Goke, 1995a). The insulin response to acetylcholine is also 
potentiated by GIF (Verchere et al, 1991). GIF also potentiates Ca2+ dependent glucagon 
secretion in alpha-cells of the rat pancreas (Ding et al, 1997).
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GIF and GIF (1-30) amide inhibit gastric acid secretion via stimulation of endogenous 
somatostatin release. The inhibition of pentagastrin-stimulated gastric-acid secretion by 
GIF and GIF (1-30) amide is reversed by the presence of a somatostatin receptor 
antagonist, which has been shown to inhibit somatostatin-induced inhibition of 
pentagastrin-stimulated gastric acid secretion (Rossowski et a l, 1998). GIF is a stronger 
inhibitor of gastric acid secretion than the C-terminal truncated form GIF (1-30) amide 
(Rossowski et a l, 1992). Gastrin-stimulated gastric-acid secretion is not inhibited by an 
infusion of GIF at physiological levels (1 pmol/kg/min) in normal volunteers (Nauck et al, 
1992). GIF is known to stimulate somatostatin release from the gastric mucosa. GIF (1-42) 
and GIF (1-30) amide inhibits bombesin-stimulated amylase release equipotently 
(Rossowski et a l, 1992).
GIF plays a role in lipid metabolism. The 24 hour pattern of plasma GIF levels in 
volunteers consuming a typical western diet closely parallels that of plasma TAG (Elliott et 
al, 1993). GIF receptors are expressed in adipocytes (Usdin et a l, 1993) and in rats GIF 
acts to lower postprandial plasma TAG levels following a fat load (Ebert et a l, 1991). GIF 
also increases insulin receptor affinity and increases the sensitivity of insulin-stimulated 
glucose transport in adipocytes (Starich et a l, 1985). Physiological levels of GIF 
significantly increased insulin-mediated glucose uptake in the presence of insulin in sheep 
(Rose et a l, 1998). The effects of GIF in adipose tissue are partly linked to the presence of 
insulin.
The GIF receptor is a member of the secretin-vasoactive intestinal polypeptide family of G- 
protein-coupled receptors; expression in tissue culture cells stimulates cAMF production 
and increases intracellular calcium (Usdin et a l, 1993). GIF receptor mRNA has been 
located in the pancreas, gut, adipose tissue, heart, pituitary, inner layers of the adrenal 
cortex and the cerebral cortex, hippocampus, olfactory bulb of the brain, stomach, 
duodenum, proximal small intestine and the submandibular glands (Fehmann et a l, 1995b; 
Usdin et a l, 1993; Tseng et a l, 1993). The fact that there is mRNA for GIF receptors in the 
brain suggests a possible neurotransmitter role for the peptide (Morgan, 1996).
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1.3.2 SECRETION OF GIF
GIF secretion occurs in response to the absorption of nutrients from the intestine, especially 
glucose, and long chain fatty acids (Morgan et al, 1988). In man, fat has been shown to be 
a greater secretagogue of GIF than carbohydrate on an isocaloric basis (Morgan, 1996) 
whilst protein is a poor stimulus for GIF secretion (Knapper et a l, 1996). GIF secretion 
occurs in response to the rate of absorption of nutrients (Ellis et a l, 1995), and its secretion 
is sensitive to both acute and chronic changes in diet.
Nutrient ingestion increases both GIF synthesis and secretion. The postprandial elevation of 
plasma GIF levels is dependent on the size of the meal, carbohydrate and fat content 
(Morgan, 1996). Both glucose and fat administration significantly increase GIF synthesis 
and food deprivation decreases GIF mRNA synthesis (Higashimoto et a l, 1995). There is 
evidence to suggest that GIF is a secretagogue for GLF-1 in rats but not in humans 
(Fehmann 1995b).
1.4 GLUCAGON-LIKE PEPTIDE-1 (7-36) AMIDE, GLP-1
GLF-1 (7-36) amide is released from its precursor preproglucagon in intestinal L-cells (see 
figure 1.3). Freproglucagon is a 180 amino acid prohormone, whose main cleavage 
products in the intestine are glicentin, oxyntomodulin, GLF-1 and GLF-2. GLF-1 (7-36) 
amide is the 30 amino acid biologically active form of the truncated forms of the peptide, 
GLF-1 (7-37) and GLF-1 (9-36) amide (Knapper et a l, 1996). GLF-1 and GLF-2 are 
formed in equimolar amounts.
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PROGLUCAGON
GRRP GLUCAGON IP-1 GLP-1 IP-2 GLP-2
30/33 61/64 69/72 108/111 123/126 158/160
Pancreas alpha cells
GRRP GLUCAGON
30/33 61
MAJOR PROGLUCAGON FRAGMENT
72 158
ntestine (L-cells)
GLICENTINE GLP-1 GLP-2
69 78 107 126 158
OXYNTOMODULINE
33 69
Figure 1.3 Structural organisation of mammalian proglucagon. The numbers refer to amino 
acid sequences in proglucagon. The peptides released by posttranslational processing are 
shown. IP, intervening peptide.
1.4.1 FUNCTIONS OF GLP-1
The main effects of GLP-1 are on insulin secretion and the inhibition of gastric emptying. 
GLP-1 is a potent stimulator of insulin secretion and has been shown to inhibit gastric acid 
secretion in man (O'Halloran et a l, 1990). GLP-1 also inhibits glucagon release (Dalessio 
et a l, 1995).
GLP-1 plays a major role in the enteroinsular axis (EIA) and therefore the modulation of 
insulin secretion in response to the ingestion of nutrients (Wang et a l, 1995). Work 
conducted to compare the insulinotropic effects of GLP-1 and GIP, found that GLP-1 was 
several times more potent than GIP on a molar basis, although, GLP-1 circulates in blood at 
a much lower level than GIP (Elahi et a l, 1994; Siegel et a l, 1992).
It has been suggested that GLP-1 released after meals promotes glucose assimilation by
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both augmenting insulin secretion, and through a separate mechanism, by increasing 
glucose uptake and/or inhibiting glucose output (Dalessio et a l, 1995). GLP-1 (7-36) amide 
is an important incretin hormone, GIP and GLP-1 together account for all of the EIA. After 
ingestion of a mixed meal, plasma levels of the hormone were raised, and remained 
elevated during the day consistent with its role as an incretin, and also with a role in fat 
metabolism (Elliott et a l, 1993).
The incretin effect of GLP-1 has been demonstrated by use of receptor antagonists and 
enzymes, such as dipeptidyl peptidase IV, which degrade GLP-1. GLP-1 (7-36) is degraded 
by the serum enzyme dipeptidyl peptidase IV to biologically inactive form GLP-1 (9-36) 
amide (Kieffer et a l, 1995). Inhibition of this enzyme in rats led to improved glucose 
tolerance and increased insulin secretion in an incretin-mediated response (Pauly et a l, 
1999). The GLP-1 receptor has a specific antagonist exendin (9-39) (Schirra et a l, 1998); 
injection of exendin (9-39) immediately before an enteral glucose infusion in rats reduced 
the total insulin secretory response by 60 % (Kolligs et a l, 1995).
GLP-1 has been linked with satiety in man. An increase in plasma GLP-1 concentration 
was associated with a decrease in appetite (Lavin et a l, 1998). Whilst 
intracerebroventricular (ICV) injection of GLP-1 inhibits feeding in rats, ICV injection of a 
specific GLP-1-receptor antagonist, exendin (9-39) blocked the inhibitory effect of GLP-1 
on food intake (Turton et a l, 1996).
GLP-1 (7-36) amide inhibits gastric acid secretion via stimulation of endogenous 
somatostatin release. The inhibition of pentagastrin-stimulated gastric-acid secretion by 
GLP-1 (7-36) amide is reversed by the presence of a somatostatin receptor antagonist 
which has been shown to inhibit somatostatin-induced inhibition of pentagastrin-stimulated 
gastric acid secretion (Rossowski et a l, 1998). Gastrin-stimulated gastric-acid secretion 
was not inhibited by an infusion of GLP-1 (1 pmol/kg/min) in normal volunteers (Nauck et 
a l, 1992). GLP-1 is reported to be an inhibitor of gastric lipase. When GLP-1 was infused 
intravenously in man, in amounts corresponding to postprandial levels, pentagastrin- 
stimulated gastric lipase secretion was inhibited (Wojdemann et a l, 1998).
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In addition to controlling acid secretion GLP-1 acts to inhibit gastric emptying following 
food ingestion. Both GLP-1 (7-36) amide and GLP-1- (7-37) exhibit a dose dependent 
inhibitory effect on gastric emptying in healthy volunteers, their effect was of a similar 
magnitude (Nauck et a l, 1997).
The GLP-1 receptor is a member of the secretin-vasoactive intestinal polypeptide family of 
G-protein-coupled receptors. Transcripts for GLP-1 receptor mRNA have been found in 
both foetal and adult mouse brain, the small and large intestine, pancreas, liver, lung and 
kidney of the rat (Campos et a l, 1994), GLP-1 and its specific receptors are found in the 
hypothalamus (Turton et a l, 1996). Co-localisation of GLP-1 receptors, glucokinase and 
GLUT-2 in the same area supports the idea that these cells play an important role in 
glucose sensing in the brain (Alvarez et al, 1996), it has also been suggested that GLP-1 is 
a physiological mediator of satiety (Turton et a l, 1996). The hepatic vagus nerve 
specifically recognises an intraportal appearance of truncated GLP-1 in the portal vein 
(Nishizawa et a l, 1996).
1.4.2 SECRETION OF GLP-1
GLP-1 is secreted by intestinal L-cells in the distal part of the small intestine, in response to 
food ingestion. GLP-1 secretion occurs rapidly following nutrient ingestion (Herrmann et 
al, 1995). The normal signal for GLP-1 secretion from the upper small intestine is 
mediated by GIP in rats and by gastrin-releasing peptide in humans (Drucker, 1998). 
Ingestion of glucose is the main stimulus for GLP-1 secretion, but both fat and protein test 
meals induce small but significant increases in plasma GLP-1 levels (Elliott et a l, 1993). 
Higher levels of plasma GLP-1 have been determined following a 100 g oral glucose load 
compared with a 50 g oral glucose load (Schirra et a l, 1996). The magnitude of GLP-1 
secretion depends on the rate of entry of nutrients into the upper small intestine, not their 
absorption. GLP-1 release may also be stimulated by the enteric nervous system or by 
hormones released from cells of the proximal intestine (Herrmann-Rinke et al, 1995).
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Both the amidated form of GLP-1- (7-36) amide and the glycine extended form GLP-1 (7- 
37) are secreted from the human small intestine. Of the GLP-1 secreted 80 % is GLP-1 (7- 
36) amide and 20 % is GLP-1 (7-37) (Orskov et a l, 1994). These workers reported that 
both of these forms of GLP-1 are found in human plasma, although levels of GLP-1 (7-36) 
increase from basal levels of 7 ± 1 pmol/1 to 41 ± 5 following a meal compared with 7 + 1 
increasing to 10 ± 1 with the GLP-1 (7-37).
1.5 SALIVARY GLANDS
The main fimction of the salivary glands is the release of hormones and other 
pharmacologically active compounds, the release of enzymes to aid digestion and the 
production of saliva. Saliva performs several functions including lubrication of the mouth 
and foodstuffs to facilitate the swallowing of food boluses and prevention of 
demineralization of tooth enamel.
In most mammals three pairs of major salivary glands can be distinguished: the 
submandibular (also known as the mandibular or the sub maxillary gland), the parotid and 
the sublingual (see figure 1.4). All the secretory end pieces in salivary glands are drained 
by a branched duct system. The salivary parotid gland (SPG) is a diffiise structure 
extending from behind the ear to the shoulder and clavicle in rats. The salivary 
submandibular glands (SSG) lie on either side of the midline of the jaw, and the sublingual 
lie behind the submandibular glands towards the far sides of the body in both rats and man.
The salivary glands are a rich source of biologically active peptides. It has been known for 
some time that a number of growth factors are synthesised within the sahvary glands and 
secreted into saliva. Epidermal growth factor is secreted from the submandibular glands 
(Boyer et a l, 1991), and transforming growth factor alpha, insulin and IGF-1 mRNAs, 
have been located in the ductal cells of both the parotid and submandibular glands. The 
presence of these factors/hormones has been confirmed in saliva (Humphreysbeher et a l, 
1994; Kerr et a l, 1995). Vasoactive intestinal polypeptide (VIP) is present in SSG and acts 
to stimulate mucin release (Turner, 1993) and increase cyclic AMP production in human
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Parotid gland
Accessory parotid gland
Parotid duct
Sublingual gland
Submandibular gland
Figure 1.4 The location of the salivary glands (Tortora & Grabowski, 1993).
The submandibular gland consists mostly of serous acini cells (serous fluid secreting 
exocrine portion of the gland) and a few mucous acini (mucous secreting exocrine 
portion of the gland). The parotid glands consist of all serous acini.
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production in human SSG (Larsson et al, 1986). Lipoprotein lipase activity has been found 
in day old rat SSG and sublingual glands (Nagato & Masuno, 1993). Esterases have been 
found in SSG and SPG saliva (Lindqvist & Augustinsson, 1975).
The salivary glands contain several proteins involved in glucose homeostasis. Human 
saliva contains a proline-rich polypeptide salivary peptide P-C (Kimura et a l, 1998). 
Peptide P-C potentiates glucose-induced insulin release and inhibits arginine-induced 
glucagon release in rat pancreas (Kimura et a l, 1995; Nakashima et a l, 1995). Salivary 
peptide P-C cells have been located in acinar serous cells located near to secretory ducts of 
the SSG (Kimura et a l, 1998).
Proteins involved in the control of gastric acid secretion have been located within the 
salivary glands. The presence of somatostatin has been reported in the submandibular 
salivary glands and human saliva (Deville de Perrier et a l, 1989). A gastrin-like substance 
has been reported in human salivary glands (Takeuchi er a l, 1970). The gland was not 
specified. It would therefore appear that the functions of the peptides secreted and 
synthesised within the salivary glands are varied and might be involved in areas related to 
postprandial metabolism of food, which include the control of gut secretions and the 
postprandial metabolism of food.
Diabetic animals have been reported to have an altered protein profile in the salivary glands 
compared with non-diabetic animals. Streptozotocin-induced diabetic rats had decreased 
levels (30-60 %) of proline-rich proteins (PRP) and amylase in the secretory granules of 
salivary parotid glands and increased somatostatin levels in SSG compared with non­
diabetic controls. Treatment with insulin led to an increase in a-amylase protein and 
mRNA but no effect on PRP levels (Szczepanski et a l, 1998; Kim et a l, 1990) and a 
reversal of the increased somatostatin levels (Deville de Perrier et a l, 1989). Diabetes 
mellitus and impaired glucose tolerance do not impair salivary gland function in relation to 
subjective responses to questionnaires regarding salivary hypofunction (Cherry-Peppers et 
al, 1992). Higher calcium ion levels were determined from both parotid and submandibular 
saliva from diabetic patients compared with normal controls (Marder et a l, 1975).
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1.5.1 SALIVARY a-AMYLASE
a-Amylase (ptyalin) is present in saliva as well as the pancreas and is secreted from the 
serous cells of the parotid gland. When food is consumed it is first chewed and swallowed 
in a bolus, this mechanical breakdown of food in the mouth allows the food to come into 
contact with saliva, and therefore a-amylase. Within this bolus salivary a-amylase breaks
down starch in the stomach until the pH reduces to a level where the protein is denatured. 
As much as 50 % of dietary starch is broken down by a-amylase in the stomach. In the rat,
a-amylase activity and mRNA were detected in parotid gland saliva but not detected in rat
submandibular saliva, and mRNA for a-amylase was found to decrease with age (Roller
et al, 1992).
1.5.2 INSULIN AND THE SALIVARY GLANDS
Insulin-like immunoreactivity (ILI) has been reported in rat salivary parotid glands (SPG) 
(Smith & Toms, 1986b; Murakami et a l, 1982; Smith et a l, 1986a; Taouis et a l, 1995), 
and salivary submandibular glands (SSG) (Deville de Perrier et a l, 1989; Shubnikova et 
al, 1984; Deville de Perrier et a l, 1992; Deville de Perrier et a l, 1997; Smith & Toms, 
1986b). ILI has also been reported in the SPG and SSG of mice (Kerr et a l, 1995; Patel et 
al, 1986; Shubnikova et a l, 1984), and in SSG of cats, hamsters, bulls and rabbits 
(Shubnikova et a l, 1984) and in human SPG (Murakami et a l, 1982). There have also been 
reports of ILI in saliva from mice (Kerr et a l, 1995) and humans (Fekete et al, 1993).
Different methods have been used to detect ILI in the salivary glands. These include gel 
electrophoresis, PCR, molecular biology techniques, chromatography (Shubnikova et al, 
1984; Kerr et a l, 1995; Cooper & Clarke, 1985; Murakami et a l, 1982; Patel et a l, 1986). 
All of these workers have reported a positive presence of an insulin-like substance, which is 
structurally identical to pancreatic insulin.
Staining techniques have been used to locate the position of the ILI-secreting cells in the 
salivary glands. Immunocytochemistry staining using guinea pig anti-insulin antiserum
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located insulin-like staining within cells of the intercalated ducts of SPG and granular 
convoluted tubule of SSG in rats (Smith & Toms, 1986b; Smith et a l, 1986a) and mice 
(Patel et al, 1986). Immunoflourescent staining indicated the presence of ILI in the striated 
ducts of SSG from cats, rabbit, bull, pig and men, and granular ducts of rat and mouse 
(Shubnikova et a l, 1984). The location of insulin containing cells within the salivary 
glands is consistently reported to be close to ducts. Although this does not provide any 
evidence of synthesis within the salivary glands it does possibly provide evidence of 
secretion from the salivary glands.
1.5.2.1 Possible functions o f ILI in salivary glands
If salivary gland ILI originates from local synthesis then it is possible that ILI in salivary 
glands has paracrine effects within the glands. Levels of ILI in extracts of SSG were two­
fold higher in young adult compared with mature rats (Deville de Perrier et a l, 1996). ILI 
in extracts of SSG and SPG were higher in suckling rats than prepubescent animals and ten­
fold higher than in elderly rats (Carter et a l, 1995). It is therefore possible that salivary 
gland ILI has some function in developing animals that is independent of pancreatic 
insulin.
There is conflicting evidence in the literature for the role of salivary gland insulin in 
diabetic animals. It has been postulated that salivary gland ILI is increased in diabetic 
animals to compensate for the low levels produced in the pancreas. Higher levels of ILI 
were extracted from SSG of dexamethasone-induced diabetic rats compared with controls 
(Deville de Perrier et a l, 1997), and streptozotocin-induced diabetic rats compared with 
controls (Taouis et a l, 1995; Deville de Perrier et a l, 1989). These results contrast with the 
reduced levels of ILI from extracts of SSG after depancreatization and in alloxan-induced 
diabetic rats (Shubnikova et a l, 1984) and in extracts of SPG from diabetic BB rats 
compared with controls (Smith et al, 1986a). Reduced levels of ILI were reported in 
extracts of SSG, SPG and pancreas from diabetic mice compared with non-diabetic control 
mice, although the author noted that the diabetic mice were considerably smaller than non­
diabetic (Patel et a l, 1986). Overall the majority of reports find that ILI is reduced in 
extracts from the salivary glands of diabetic animals compared with non-diabetic animals.
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Other workers have reported that salivary gland ILI concentration is not dependent on 
serum insulin levels (Carter et a l, 1995). This would suggest that secretion of ILI does not 
increase in diabetic animals to compensate for low pancreatic insulin secretion.
Salivary gland extracts of ILI have demonstrated similar biological actions to that of 
insulin.
1. An intramuscular injection of mouse pancreatic insulin and ILI extracted from mouse 
and human SSG caused a decrease in plasma glucose levels compared with controls in 
vivo (Shubnikova et a l, 1984).
2. Addition of extracts from SSG increased lipogenesis and activated p-subunit 
autophosphorylation of the insulin receptor and stimulated amino acid uptake in in vitro 
experiments (Taouis et a l, 1995).
3. Extracts of pancreas, SSG and SPG exhibited dose response relationships with glucose 
oxidation in adipocites (Patel et a l, 1986).
These data combined with the data regarding the chemical characteristics of ILI from 
extracts of the salivary glands suggest that salivary gland ILI is identical to that of 
pancreatic insulin.
1.5.2.2 Insulin and saliva
ILI was detected by radioimmunoassay in mouse saliva (Kerr et a l, 1995) and human 
saliva (Fekete et a l, 1993; Marchetti et a l, 1986; Marchetti et a l, 1988; Vallejo et al, 
1984). There is evidence to suggest that the ILI in saliva although indistinguishable from 
synthetic insulin standards (Marchetti et a l, 1988; Vallejo et a l, 1984), is an ultrafiltrate 
fi*om blood and not from local synthesis in the salivary glands. A positive linear 
relationship has been demonstrated between saliva ILI and plasma insulin in normal and 
obese volunteers (Fekete et a l, 1993; Marchetti et a l, 1986).
1.5.3 GIF AND THE SALIVARY GLANDS
There is at present little knowledge available regarding the presence or function of GIP in 
the salivary glands. To date there are two reports by the same workers concerning GIP in
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rat salivary glands (Tseng et al, 1993; Tseng et a l, 1995). These workers reported GIP 
mRNA in rat SSG (Tseng et al, 1993), GIP mRNA increased following an oral glucose 
load. In a separate experiment GIP-like immunoreactivity (GLI) was determined in extracts 
from rat SSG, levels increased following a glucose load (Tseng et a l, 1995). Levels of GIP 
in the small intestine are higher in fasted animals compared with those sacrificed 
postprandially. Therefore the higher levels of GLI in extracts of SSG from fed animals does 
not correlate with a role for SSG GIP in postprandial metabolism. It is more likely that 
salivary gland GIP has a paracrine role within the salivary glands, or local effects within 
the buccal cavity.
However, the evidence for the presence of immunoreactive GIP in salivary glands is not 
conclusive. Immunocytochemical staining of SSG and salivary parotid glands using rabbit- 
anti GIP antiserum found no immunostaining for GIP in either gland (Smith & Toms, 
1986b). Since Tseng et al found mRNA for GIP in SSG the two sets of data would appear 
to be contradictory. It is possible therefore that the GIP located in the SSG has a different 
chemical configuration/antigenic specificity for GIP antiserum to that of intestinal GIP.
1.5.4 GLP-1 AND THE SALIVARY GLANDS
There are no reports in the literature of GLP-1 in the salivary glands or saliva, but 
glucagon-like immunoreactivity has been reported in rat salivary glands (Lawrence et al, 
1977). A native form of peptidylglycine alpha-amidating monooxygenase (PAM) is 
secreted into saliva (Kato et a l, 1992); this is a regulating enzyme in the synthesis of 
biologically active hormones that have a carboxy-terminal amide, such as GLP-1. A 
discrete population of cells with glucagon-like staining from V-terminal specific antiserum 
was associated with acini from SSG and SPG (Smith & Toms, 1986b). It is therefore likely 
that GLP-1 might be present within the salivary glands.
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1.5.5 PROLINE-RICH PROTEINS (PRP) AND HISTIDINE-RICH PROTEINS 
(HRP)
The salivary glands secrete a family of proline-rich proteins, which bind to dietary 
polyphenols. Many dietary polyphenols are said to be astringent. Astringency causes the 
sensation of a dry mouth and can be described as causing tongue curling and puckering. 
The word astringency comes from the Latin ad stringere meaning 'to bind to', which is 
possibly the chemical process that occurs in the mouth to give rise to this sensation. 
Compounds that have the ability to bind and cross-link proteins are considered to be 
astringents, the most commonly known being tannins (Green, 1993). Many astringent 
molecules are also bitter. It is possible that astringents work by an effect on the lubricating 
capacity of saliva, causing mucoproteins to precipitate out of saliva leaving a less 
lubricating fluid (Green, 1993). If the astringent has bound to or cross-linked with salivary 
proteins then this will lead to a dry mouth sensation.
A protein high in glutamic acid, glycine and proline from rat parotid saliva was 
characterised by (Keller et a l, 1975). The acinar cells of the SPG secrete proline-rich 
proteins (PRP) (Clifford, 1986). PRP constitute about seventy percent of the total salivary 
protein (Carlson, 1993), and contain 25-45% pro line as well as high quantities of glycine, 
glutamic acid or glutamine. PRP can be characterised as either acidic or basic, with 
variation in glycosylation or phosphorylation (Mehansho et a l, 1996; Muenzer et al., 
1996). Basic PRP are detected in the salivary parotid gland and are absent from other 
salivary glands (Ferreira et al., 1992). Basic PRP levels are increased in rats given a low 
protein diet (Johnson et a l, 1995). Acidic PRP are detected in the parotid, submandibular 
and sublingual gland (Ferreira et a l, 1992).
There are many proposed roles for PRP in saliva, one of which involves their interactions 
with dietary tannins and polyphenols. It has been shown that dietary tannins are bound by 
PRP, and these proteins may form the first line of defence against possible adverse effects 
of ingested tannins (Mehansho et a l, 1996). Isoproterenol and dietary tannins both 
stimulate a similar change in gene expression in the rat parotid gland (Mehansho et a l.
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1992) and both lead to hypertrophy of the SPG. Tannins fed to mice and rats caused a net 
loss in body mass in the first days of ingestion, the subsequent gain in body mass correlated 
with induction of PRP synthesis (Mehansho et a l, 1983).
Several low molecular weight histidine-rich peptides are secreted into parotid and 
submandibular gland saliva. Histatins are histidine-rich proteins that are secreted into 
human saliva (Sugiyama, 1993; Turk et a l, 1993). HRP have been shown to have a greater 
affinity for binding to and precipitating tannins than proline rich proteins (Yan & Bennick, 
1995).
1.6 COMPLEX PHENOLS AND TANNINS
Phenols are found in a wide variety of foodstuffs and are naturally occurring constituents of 
many plants, they also enter foods through processes applied to them such as the smoking 
of meats. The term 'phenol' is used to describe structures with a benzene ring and one or 
more hydroxyl groups attached to it, or their functional derivatives such as methyl ethers. 
Phenols are present in foods as simple phenols for example caffeic acid, or in more 
complex conjugated forms such as chlorogenic acids and flavonoids. The term flavonoid 
refers to the structure of compounds, which consist of two phenolic nuclei connected by a 
three-carbon element. If the C3 element is saturated the compound is referred to as a 
flavanol (or flavanone) and if it is unsaturated then it is referred to as a flavpnol (or 
flavone).
Tannins are described as water-soluble phenols with a molecular weight in the range of 
500-3000, which are efficient precipitators of proteins and contain at least two 
unconjugated 1,2-di or 1,2,3-trihydroxyphenyl residues. Tannins can be broadly separated 
into two groups based on their structure, hydrolysable tannins (for instance gallic acid 
esters of glucose) and condensed tannins with a flavanol skeleton. In black tea there are 
many poorly characterised pigments which are termed derived tannins.
Both red wine and black tea are major sources of dietary phenols and tannins in the
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European diet. Black tea is produced by the promotion of enzymatic oxidation of flavanols 
by the enzyme polyphenol oxidase within the tealeaf during fermentation, the reaction is 
allowed to proceed for 90 to 120 minutes and the fermentation product is then heated and 
dried. The production process of black tea leads to the formation of flavonoid derivatives 
such as theaflavin and thearubigin. Black tea also contains catechin, derived tannins, 
epicatechin and epigallocatechin. Red wine contains derived tannins, gallic acid, 
anthocyanins, flavonols and flavonol glycosides and caffeic acid.
1.6.1 SPECIFIC PHYSIOLOGICAL EFFECTS OF RED WINE AND BLACK TEA
The polyphenols from red wine have been implicated in the French paradox, a phenomenon 
in which high fat diets are consumed but there is a low incidence of heart disease. 
Epidemiological studies have indicated that consumption of red wine is negatively 
associated with coronary heart disease (Wald et a l, 1976).
1.6.1.1 Plasma metabolites
Catechin, a flavanol present in black tea, has been detected in human plasma following 
consumption of black tea. Increased plasma catechin levels were observed following 
repeated consumption of green and black tea compared with the consumption of water. The 
addition of milk to the tea had no effect on plasma catechin levels compared with those 
observed following consumption of black tea without milk (van het Hof et a l, 1999). 
Ingestion of a green tea extract capsule equivalent to two cups of green tea gave rise to 
levels of catechin in plasma approximately reflecting the initial composition of green tea 
(Nakagawa et a l, 1999).
Following consumption of red wine at physiological doses (equivalent to one or two 
glasses) plasma metabolites of the flavanoid catechin, caffeic acid and 4-0-methylgallic 
acid have been observed in human plasma (Donovan et a l, 1999; Caccetta et a l, 2000). 
The observation of metabolites from black tea and red wine in plasma following 
consumption of these beverages indicates that the polyphenolic content of red wine and 
black tea is absorbed into the body from the gut, and is therefore possibly metabolised
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following ingestion. Depending on the physiological effects of these metabolites this may 
have beneficial effects for the consumer.
1.6.1.2 Glucose transport
Both black tea and red wine have demonstrated an ability to affect glucose metabolism in 
both man and rats. Tea extract inhibited mucosal uptake of glucose and sodium in rats in 
vivo and inhibited the activity of isolated Na K^- ATPase in vitro (Kreydiyyeh et al, 
1994). Black tea decreased blood glucose and TAG levels in a 75-day feeding experiment 
where rats were fed black tea extract or water, this effect was not dose-dependent (Zeyuan 
et a l, 1998). Red wine has also been associated with altered glucose tolerance. The 
polyphenol content of red wine has been associated with enhanced glucose tolerance. The 
consumption of red wine or tannic acid with a mixed meal by volunteers induced a smaller 
increase in blood glucose levels following the meal than the same meal consumed with an 
equal volume of water or ethanol. This effect was insulin independent (Gin et a l, 1999).
In vivo experiments have indicated that individual tannins inhibit the intestinal transport of 
sugar via interactions with the sodium transporter. Phloridzin, tannic acid and chlorogenic 
acid inhibit transport of D-glucose and other sugars from the jejunum (Rodriguez et al, 
1982; Welsh et a l, 1989). Flavonol glycosides from onions interact with glucose 
transporters from intestinal mucosa in a partially sodium-dependent manner (Gee et al,
1998). Cinnamates are transported into intestinal mucosa by a Na^-dependent pathway 
(Wolffram et a l, 1995). It has been proposed that polyphenols reduce glucose uptake by 
causing dissipation of the Na^ gradient, which drives active glucose transport (Welsh et al, 
1989).
1.6.1.3 Antioxidant activity o f red wine and black tea
Black tea extracts have been shown to protect against lipid peroxidation in plasma in vitro 
(Cherubini et a l, 1999; Vinson et a l, 1999; Hodgson et a l, 1999). Preincubation of plasma 
with green or black tea (with and without milk) enhanced the resistance of LDL to 
oxidation in vitro, dose dependently (van het Hof et a l, 1999; Vinson et a l, 1999; Serafini 
et a l, 1996). These reports suggest possible beneficial effects for the consumer following
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regular consumption of green and black tea, although the data from the in vitro experiments 
would be equivalent to intravenous exposure to black tea and therefore much higher doses 
than would be expected from black tea consumption.
The protective effects of black tea against plasma lipid peroxidation from in vitro 
experiments are not conclusively demonstrated in in vivo studies. Consumption of green 
and black tea (eight cups a day for three days) did not inhibit LDL oxidation ex vivo (van 
het Hof et a l, 1999). Also hamsters fed a diet supplemented with black tea extract for 10 
weeks did not show any increased resistance to oxidation of plasma LDL (Nicolosi et al, 
1999). Conversely, the ingestion of black and green tea by volunteers increased plasma 
antioxidant activity 30 to 50 minutes following ingestion of 300 ml tea in vivo, there was no 
increase in plasma antioxidant activity when the tea was consumed with milk (Serafini et 
al, 1996). These reports suggest that although metabolites of black tea are found in plasma 
following consumption of black tea and from in vitro studies protective effects of black tea 
have been demonstrated against lipid peroxidation, the same beneficial effects may not 
occur in in vivo experiments and therefore consumers of black tea.
Similar antioxidant effects to those of black tea are reported for red wine polyphenols in 
vitro. Red wine extract containing monomeric and oligomeric forms of flavonoids 
protected against oxidation of porcine LDL in vitro (Freemont et a l, 1999). It has been 
demonstrated that the relative antioxidant activity of wine against LDL oxidation in vitro 
correlates with the total phenol content of the wine determined by the Folin-Ciocalteu 
method (Frankel et a l, 1995; Simonetti et a l, 1997). The antioxidant activity of red wine 
has been shown to correspond with its free radical scavenging ability. Red wine has a 
greater free radical scavenging potential then its corresponding grape juice (Sanchez- 
Moreno et a l, 1999). The data from the in vitro experiments would be equivalent to 
intravenous exposure to red wine and therefore much higher doses than would be expected 
from red wine consumption. These reports suggest possible beneficial effects for the 
consumer following regular consumption of red wine. In rabbits that were given a daily 
dose of red wine for 14-months the LDL was found to be less susceptible to oxidation than 
that of the alcohol drinking control group (Wakabayashi, 1999), in contrast the
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consumption of red wine by volunteers led to increased levels of polyphenol metabolites in 
plasma with no effect on ex vivo oxidation in plasma (Caccetta et a l, 2000).
Another mechanism by which red wine has been postulated to protect against coronary 
heart disease is by the inhibition of platelet aggregation. A positive relationship has been 
demonstrated between platelet aggregation and heart disease. A four week intervention 
study where volunteers consumed moderate amounts of red wine and clear alcohol 
indicated that inhibition of platelet aggregation was due to alcohol and not the flavonoid 
content of red wine (Pellegrini et a l, 1996). Conflicting data have been published where 
purple grape juice was found to be a potent inhibitor of platelet aggregation (Keevil et a l, 
2000).
1.6.1.4 Inhibition o f non-haem iron absorption
Dietary inhibitors of non-haem iron absorption have been cited as a cause of iron 
deficiency. Black tea is a known inhibitor of iron absorption in man, the non-haem iron 
absorption after a bread meal was inhibited up to 90 % by black tea extract (Hurrell et a l,
1999). This possibly negative effect of black tea has been proven to be of benefit in 
sufferers with iron overload syndromes such as genetic haemochromatosis or refractory 
anaemia. Regular consumption of black tea with meals by patients suffering from genetic 
haemochromatosis over one year reduced iron stores by one third compared with a non-tea 
drinking control group (Kaltwasser et a l, 1998). An investigation into the effect of wine 
consumption on iron absorption indicates that the phenolic fraction of red wine inhibits 
non-haem iron absorption. The extent of inhibition was found to increase when volunteers 
were given red wine with a reduced alcohol content; white wine did not inhibit non-haem 
iron absorption (Cook et a l, 1995).
1.6.1.5 Other physiological effects
Black tea extracts have been shown to protect against chromosomal damage caused by 
heavy metals in vitro (Mukherjee et al, 1999), and oral administration of black tea has 
been shown to inhibit DNA synthesis in both malignant and non-malignant tumours in mice 
(Conney et a l, 1999). Consumption of a high flavonoid diet containing 6 cups of tea /day
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for 2 weeks reduced oxidative damage to lymphocyte DNA compared with a low flavonoid 
diet (Lean et a l, 1999). Hot water extracts from whole and decaffeinated orange pekoe 
black tea inhibited the in vitro mutagenic activity of heterocyclic aromatic amines (HAA), 
using the Ames test (plate incorporation assay with TA98 salmonella typhimurium) (Stavric 
et a l, 1996). Dietary supplementation of rats with green and black tea extract (30g/kg) for 
14 days reduced D-galactosamine activity, a compound which causes liver injury in rats by 
the inhibition of RNA and protein synthesis (Sugiyama et a l, 1999).
1.7 CAFFEINE (1,3,7-TRIMETHYLXANTHINE)
Caffeine is a naturally occurring constituent of tea leaves, cocoa beans and coffee beans. 
Plants synthesise caffeine from purines; the precursor of caffeine is theobromine. Other 
natural purines include theophylline and theobromine found in cocoa derived products such 
as chocolate.
Tea and coffee provide the greatest source of caffeine for the UK consumer. In the UK an 
average cup of tea will provide 42 mg caffeine and an average cup of coffee 60 mg 
caffeine. Other major sources of caffeine in the UK diet include the cola beverages and 
chocolate confectionery. The amount of caffeine present varies between products for all 
dietary sources. Caffeine can be detected in all body fluids and can pass through all 
biological membranes.
There are three main mechanisms proposed for the physiological actions of caffeine: 
antagonism of adenosine Al and A2 receptors, inhibition of phosphodiesterases and 
mobilisation of intracellular calcium. Adenosine Al receptors are located in the brain, 
heart, trachea, kidney and adipose tissue, and intervene in cellular exchanges of potassium 
and calcium. They have a role in the regulation of cellular polarity, excitability of nerves, 
diuresis and secretion of renin, certain neurotransmitters and hormones. Adenosine A2 
receptors are responsible for the relaxation of smooth muscle. Caffeine is a weak inhibitor 
of phosphodiesterases, which leads to relaxation of the trachea and bronchial tubes. This 
also acts to stimulate cardiac function, and increase blood flow in coronary arteries. The
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mobilisation of intracellular calcium stored in the endoplasmic reticulum causes changes in 
nerve cell function, secretion of neurotransmitters and muscle contraction.
The action of caffeine as a psychological stimulant is well documented and caffeine is 
added to many painkillers.
1.7.1 CAFFEINE AND NUTRIENT METABOLISM
Caffeine has effects on body glucose utilisation in man and rodents. Caffeine (200 mg) has 
been shown to increase levels of plasma glucose two to four hours following ingestion of 
caffeine with an oral glucose load (75 g) in man compared with a non-caffeine control 
(Pizziol et a l, 1998). In rats intraperitoneal injection of caffeine increased plasma glucose 
and insulin concentrations (Leblanc et a l, 1995). Caffeine potentiated glucose-induced 
insulin secretion in mice islet transplants (Shi, 1997) and promoted lysosomal glycogen 
breakdown in new-born rat hepatocytes (Kalamidas et a l, 1994). Caffeine increases 
cerebral glucose utilisation and decreases cerebral blood flow (Nehlig et a l, 1991).
Caffeine has been demonstrated to have effects on non-esterified fatty acids (NEFA) in 
blood. Caffeine ingestion increased fasting NEFA during exercise in man (Powers et a l, 
1983) and intravenous injection of caffeine increased NEFA concentration at rest (Hetzler 
et a l, 1990; Cowan et a l, 1977). In rats, intraperitoneal injection of caffeine increased 
plasma NEFA and insulin concentrations (Leblanc et a l, 1995). This therefore suggests 
that a habitual tea drinker may have an altered glucose homeostasis compared with non­
caffeine consumers.
1.8 AIMS AND OBJECTIVES
This project will seek to answer the question: Do dietary complex phenols and tannins 
modulate the endocrine activity of the salivary glands? If complex phenols and tannins are 
shown to modulate the endocrine activity of the salivary glands, then it may not be 
necessary for the absorption of dietary complex phenols and tannins to occur for there to be
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a systemic effect.
This aim of this work was first to determine whether the gastrointestinal hormones glucose- 
dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and insulin 
were present in the rat salivary submandibular gland (SSG), salivary parotid gland (SPG) 
and in human saliva. If these hormones were found then it was intended to investigate those 
factors involved in their secretion, with particular emphasis on the consumption of the 
complex phenols and tannins (CPT) present in black tea and red wine and to seek a possible 
metabolic role for these hormones in saliva.
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MATERIALS AND METHODS 
AND
METHOD DEVELOPMENT
2.1 MATERIALS
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a-Amylase activity kit
Acetic acid
Acetonitrile
Anti-GIF antisera
Anti-GLP-1 antisera
Anti-insulin antisera
Aprotinin G1157
Bovine serum albumin RIA grade
Brij 35 Solution 30 % w/v
Cannula 1.1 X 28 mm
Chloramine T
Donkey anti-rabbit antisera
Donkey anti-guinea pig antisera
EDTA blood tubes
Flouride oxalate blood tubes
Gamma counter
GIP human
Glucose determination kit 
GLP-1 human
Human serum albumin antisera 
Insulin - pure human 
Lithium heparin blood tubes 
Lyophilised synthetic human GIP 
Lyophilised synthetic human 
GLP-1 
NEFA C kit
Normal guinea pig serum 
Normal rabbit serum 
Plastic disposable 3 ml tubes 
Plastic disposable 7 ml column 
Polyethylene glycol
Randox, Diamond road, Crumlin, Co. Antrim
Fischer Scientific UK Ltd, Loughborough, Leics LEI 1 5GG
Fischer Scientific UK Ltd, Loughborough, Leics LEI 1 5GG
Dr L.M.Morgan University of Surrey, Guildford GU2 5XH
Dr L.M.Morgan University of Surrey, Guildford GU2 5XH
Dr S. Hampton, University of Surrey, Guildford GU2 5XH
Sigma Chemicals, Poole, Dorset BH12 4QH
Sigma Chemicals, Poole, Dorset BH12 4QH
Sigma Chemicals, Poole, Dorset BH12 4QH
Simcare Ltd, Peter Rd, Lancing, W. Sussex BN15 8TJ
Sigma Chemicals, Poole, Dorset BH12 4QH
Dr S. Hampton, University of Surrey, Guildford GU2 5XH
Guildhay, Guildford, Surrey
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Sigma Chemicals, Poole, Dorset BH12 4QH
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Sac-cel anti guinea pig IgG 
Sac-cel anti rabbit IgG 
Saline (sterile) solution 
Scintilation vials 
Sephadex G-15 
Total Protein Biuret Kit 
Triacylglycerol kit 
Triflouroacetic acid
IDS Ltd, Boldon Business Park, Boldon, NE35 9PD 
IDS Ltd, Boldon Business Park, Boldon, NE35 9PD 
Phoenix Pharmaceuticals Ltd, Glouster, England 
Wallac, Crownhill, Milton Keynes, MK8 OAB 
Sigma Chemicals, Poole, Dorset BH12 4QH 
Randox, Diamond road, Crumlin, Co. Antrim 
Roche Diagnostics, Bell Lane, Lewes, E. Sussex BN7 ILG 
Fischer Scientific UK Ltd, Loughborough, Leics LEI 1 5GG
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2.2 ESTABLISHED METHODS
2.2.1 PREPARATION OF BUFFERS
The following is a description of all buffers used in the preparation of reagents for 
radioimmunoassays.
1. 0.04 M phosphate buffer pH 6.5 
O.O4MKH2PO4
0.04 M Na2HP04 in RO water
2. 0.1M bicarbonate buffer pH 9.8 
0.lMNa2CO3
0.1 M Na HCO 3 in RO water
3. 0.4 M phosphate buffer pH 7.4 
23 gNa2HP04
5.97 g NaH2P04 .2H20 in 500 ml RO water
4. 0.04 M phosphate buffer pH 7.4 
23 gNa2HP04
5.97 g NaH2P04 .2H20  in 5 1 RO water
2.2.2 PLASMA GIP RADIOIMMUNOASSAY (RIA)
This assay was first described by Morgan (1978) for the detection of glucose-dependent 
insulinotropic peptide in human plasma. The GIP RIA was carried out over four days, in 
plastic disposable tubes (see 2.1). On the first day the assay diluent, standards and the 
antiserum were prepared, on the second day the affinity-purified I^^^-labelled GIP was 
added, and on the fourth day the bound and free antigen were separated. In this assay 
the bound antigen was counted.
2.2.2.1 Preparation o f assay diluent
The assay diluent was prepared with phosphate buffer 0.04 M pH 6.5 (section 2.2.1),
0.5% w/v human serum albumin (HSA), and aprotinin 50,000 KIU/100 ml were added 
to make the assay diluent. The assay diluent was used throughout the assay for dilution 
of all reagents.
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2.2.2.2 Preparation o f antiserum
GIF antiserum was raised in rabbits against a purified natural porcine GIF. This 
antiserum crossreacted 100% with human GIP. The antiserum did not crossreact with 
GLP-1 (7-36)amide, glucagon, secretin, vasoactive intestinal peptide (VIP) and 
pancreatic peptide (Elliott et a l, 1993). GIF antiserum was used at an initial 
concentration of 1:9000.
2.2.2.3 Preparation o f standards, quality controls and samples
Standards were prepared from vials containing 100 ng lyophilised synthetic human GIP 
(section 2.1) diluted with assay diluent to give a concentration of 16,000 pmol/1. This 
was further diluted to give concentrations of 800, 400, 200, 100, 50 and 25 pmol/1 for 
use in the assay. Standards were added to the assay at 100 pl/tube.
Plasma samples (see section 2.2.14) were defrosted immediately prior to use. Plasma 
samples were centrifuged for 10 minutes at 1852 x g (Beckman J6) to remove any 
fibrinogen clots. Quality control samples containing a low and high concentration of 
GIP were obtained from fasted and 45 min postprandial volunteers respectively. Blood 
was taken and centrifuged (10 minutes at 1852 x g); the plasma was pooled and stored 
in 1 ml tubes at -20 °C until required. These were added to the assay at 100 pl/tube.
Tubes were set up to test non-specific binding (NSB) of samples in the absence of 
antisera (see table 2.1). Data for NSB were required for each series of plasma samples, 
standards and for each quality control.
2.2.2.4 Preparation o f charcoal-stripped plasma
Charcoal-stripped serum (CSS) was prepared using pooled serum taken from overnight- 
fasted volunteers. Agarose-coated charcoal was added to the serum at 20 g/100 ml of 
serum. This was then mixed for 24 h decanted and centrifuged at 3000 x g for 30 min at 
4 °C. Charcoal fines were removed by filtering through a Zeitz filter. CSS was stored in 
10 ml aliqouts at -20 °C until use. CSS was added to all standards at 100 pl/tube.
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2.2.2.5 Preparation o f affinity-purified f^^-lalelled GIP
The procedure for preparation of the labelled GIF is described in section 2.2.5. Aliquots 
of labelled GIP were purified using an affinity column, which contains anti-GIP 
antibodies coupled to glass beads housed in a 7 ml disposable plastic column (section
2.1). The colunrn was stored in 0.1m  bicarbonate buffer pH 9.8 (section 2.2.1) and 
stored at 4 °C. Prior to use the column was washed with 10 ml 0.3 % HCl, and then 20 
ml assay diluent. The I*^^-labelled GIP was reconstituted in 3 ml of assay diluent and 
layered onto the top of the column. The column was placed into a sealed container and 
roller mixed for 30 min.
After 30 min the column was removed from the roller, the beads were shaken dovm and 
the column was clamped and washed with 20 ml of RO water. The column was washed 
with 5 X 1 ml 0.3 % HCl and the drops were collected into a glass vial. The column was 
then washed again with 10 ml RO water and 10 ml 0.1 M bicarbonate buffer, and stored 
in 0.1 M bicarbonate buffer at 4 °C. A 100 pi aliquot of the purified I^^^-labelled GIP 
was counted on a Gamma counter (section 2.1) and diluted to give 5000 cpm/100 pi. 
The purified I^^^-labelled GIP (lOOpl) was added to every tube in the assay (see table
2.1), the contents were vortex mixed and the tubes stored for 48 h at 4 °C.
2.2.2.6 Preparation o f second antibody reagents
1. Normal rabbit serum (NRS) was diluted 1 in 135 with assay diluent and added to the 
assay (50 pl/tube).
2. Donkey anti-rabbit (DAR) antiserum diluted 1 in 16 with assay diluent and added to 
the assay (50 pl/tube). The second antibodies were added to every tube except totals.
3. A 14% polyethylene glycol (PEG) solution was prepared in 0.04m  phosphate buffer 
(section 2 .2 .1) and added to every tube (100 pl/tube) except totals.
2.2.2.7 Assay protocol
On the first day the assay diluent, standards, quality controls, samples and antiserum 
were prepared. The reagents were added to the assay tubes in the order shown in table
2.1. All tubes were set up in duplicate. Quality controls were placed before and after the 
samples to detect any drift in accuracy.
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On the second day affinity-purified I^^^-labelled GIF was added to the assay at 5000 
cpm/100 pi. The purified I^^^-labelled GIP (100 pi) was added to every tube in the assay 
(see table 2.1), the contents were vortex mixed and the tubes stored for 48 h at 4 °C.
On the fourth day the free and the bound antigen were separated. Donkey anti-rabbit 
(DAR), normal rabbit serum (NRS) and polyethylene glycol (PEG) were added to the 
assay (see table 2.1). Tubes were vortex mixed and incubated for four hours at 4 °C, at 
which point they were centrifuged for 30 minutes at 1852 x g. The supernatant was 
aspirated and the radioactivity of the pellet counted on a gamma counter (section 2 .1).
Table 2.1 Protocol for GIP plasma radioimmunoassay
Reagent Totals NSB
Standard
Zero
Standard
Standard NSB
QC
QC NSB
Sample
Sample
Day 1
Assay
Diluent
300 pi 200 pi 100 pi 300 pi 200 pi 300 pi 200 pi
Standard — — 100 pi — - - -
CSS 100 pi 100 pi 100 pi - - - -
QC —  — - - 100 pi 100 pi - -
Sample —  — - - - - 100 pi 100 pi
Anti Sera _  - 100 pi 100 pi - 100 pi - 100 pi
Vortex mix and incubate for 24 hours at 4 °C
Day 2
Label 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 
Vortex mix and incubate at 4 °C for 48 hours
Day 4
NRS -  50 pi 50 pi 50 pi 50 pi 50 pi 50 pi 50 pi
DAR -  50 pi 50 pi 50 pi 50 pi 50 pi 50 pi 50 pi
PEG 14 -  100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi
%________________________________________________________________________________________
Vortex mix, incubate for 4 hours at 4 °C, centrifuge at 1852 x g  for 30 minutes, 
aspirate supernatant, count pellet______________________________________________
* Columns contain volumes of reagents added to the assay mixture.
The intra-assay coefficient of variation (CV) (n= 12) at 68 pmol/1 was 4.3 %, and the 
inter-assay CV at 67 pmol/1 was 4.9 % {n = 8). The limit of detection of the assay was 
28 pmol/1.
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2.2.3 SALIVA AND TISSUE EXTRACT GIF RADIOIMMUNOASSAY (RIA)
The method has been modified from the plasma assay (section 2.2.2) for use with saliva 
samples, tissue extracts and salivary gland extracts in this project.
2.2.3.1 Preparation o f reagents
The assay diluent was prepared with phosphate buffer 0.04 M pH 6.5 (section 2.2.1),
1 % w/v human serum albumin (HSA), and 50,000 KIU/100 ml aprotinin. The assay 
diluent was used throughout the assay for dilution of all reagents. The antiserum, 
standards and iodinated GIF were prepared as for the plasma assay (section 2.2.2) and 
added to the assay in the order shown in table 2 .2 .
Saliva samples (section 2.2.14) and tissue extracts (section 2.3.2) were defrosted 
immediately prior to use. Saliva samples were centrifuged for 10 minutes at 1852 x g 
(Beckman J6) to remove any detritus. Quality controls (QC) were prepared from pooled 
small intestine extracts diluted 1 in 100, 1 in 150 and 1 in 200. These were added to the 
assay at 100 pl/tube.
Tubes were set up to test non-specific binding (NSB) of samples in the absence of 
antiserum (see table 2.2). Data for NSB were required for standards, each quality 
control and each series of saliva samples from an individual subject. For small intestine 
and salivary gland extracts NSB values were necessary for each dilution of each sample. 
Tubes for NSB were set up for standards and QC (see table 2.2).
Tissue extract and saliva samples use a ‘sac-cel’ system (section 2.1) to separate the free 
and the bound antigen. Sac-cel is an anti-rabbit solid phase second antibody complexed 
to cellulose. Sac-cel (100 pi) was added to all tubes except totals. For tissue extract 
assays a 0.2 % Brij (section 2.1) solution in saline was prepared and added to each tube 
(1 ml/tube) except totals, before centrifugation (see table 2.2). Saliva sample assays 
used RO water in place of the Brij solution.
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2.2.3.2 Assay protocol
On the first day the assay diluent, standards, quality controls, samples and antiserum 
were prepared. The reagents were added to the assay tubes in the order shown in table
2.2. All tubes were set up in duplicate. Quality controls were placed before and after the 
samples to detect any drift.
On the second day affinity-purified I^^^-labelled GIF (section 2.2.2.5) was added to the 
assay at 5000 cpm/100 pi. The purified I^^^-labelled GIF (lOOpl) was added to every 
tube in the assay (see table 2 .2), the contents were vortex mixed and the tubes stored for 
48 h at 4 °C.
Table 2.2 Frotocol for saliva and tissue extract GIF radioimmunoassay
Reagent Totals NSB Zero Standard NSB QC NSB Sample
Standard Standard QC Sample
Day 1
Assay 400 pi 300 pi 200 pi 300 pi 200 pi 300 pi 200 pi
Diluent
Standard —  —  — 100 pi - - - -
QC —  —  — - 100 pi 100 pi - -
Sample —  —  — - 100 pi 100 pi
Anti Sera 100 pi 100 pi — 100 pi — 100 pi
Vortex mix and incubate for 24 hours at 4 °c
Day 2
Label 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi
Vortex mix tubes and incubate at 4 °C for 48 hours
Day 4
Anti­ 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi
rabbit
sac-cel
Vortex mix, incubate for 30 minutes at room temperature.
RO water -  1 ml 1 ml 1 ml 1 ml 1 ml 1 ml 1 ml
or 0.2 % 
Brij
solution
Centrifuge at 1852 x g for 30 minutes, aspirate supernatant, count pellet.
* Columns contain volumes of reagents added to the assay mixture.
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On the fourth day the free and the bound antigen were separated. Sac-cel was added to 
all tubes and the contents vortex mixed for 30 seconds. Tubes were left at room 
temperature for 30 min. For tissue extract assays 1 ml of 0.2 % Brij solution was then 
added to each tube (except totals), before centrifuging for 30 minutes at 1852 x g. For 
saliva sample assays 1 ml of RO water was added to each tube (except totals), at which 
point they were centriftiged for 30 minutes at 1852 x g. The supernatant was aspirated 
and the pellet radioactivity measured on a gamma counter (section 2 .1)
The intra-assay coefficient of variation (CV) {n= 12) at 163 pmol/1 was 5.5 %, and the 
inter-assay CV at 158 pmol/1 was 8.62% and at 351 pmol/1 was 6.1% {n = 12). The limit 
of detection of the assay was 10 pmol/1.
2.2.4 PLASMA GLP-1 RADIOIMMUNOASSAY
The method for this RIA is similar to that of GIP (Elliott, 1992). The GLP-1 RIA was 
carried out over four days. On the first day the assay diluent, standards and the 
antiserum were prepared and added, on the second day the affinity-purified I^^^-labelled 
GLP-1 was added, and on the fourth day the bound and the free antigen were separated. 
In this assay the bound antigen was counted.
2.2.4.1 Preparation o f assay diluent
The stock buffer and assay diluent were prepared in the same way as the GIP assay (see 
section 2 .2 .2 .1).
2.2.4.2 Preparation o f antiserum
Specific GLP-1 antiserum (G2-30/6/89) was used for the GLP-1 assay, at an initial 
dilution of 1:6000 in assay diluent. This antiserum was raised in rabbits against 
synthetic human GLP-1 (7-36) amide. The antisera crossreacts 100 % with GLP-1 (1- 
36)amide, and less than 0.2 % with GLP-1 (7-37) and GLP-1 (1-37). The antiserum 
exhibited no detectable crossreactivity with human GIP, GLP-2, glucagon, vasoactive 
intestinal peptide, sectretin and molitin (Elliott et a/., 1993). Antiserum (100 pi) was 
added to all tubes except totals and NSB.
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2.2.4.3 Preparation o f standards, quality controls and samples
Standards were prepared from vials containing precisely 100 ng of lyophilised synthetic 
human GLP-1 (7-36) amide (section 2.1). Vials were reconstituted in assay diluent to 
give a concentration of 32,000 pmol/1. This was then diluted in CSS to give final 
concentrations of 160, 80, 40, 20, 10 and 5 pmol/1, for use in the assay. The QC samples 
used were the same as those used for the GIP RIA (section 2.2.2.3) and were treated in 
the same way. Standards, QC and samples were added to the assay at 200 pl/tube. The 
CSS was prepared and stored as described in section 2.2.2.4. Samples were stored and 
thawed as described for the GIP RIA. CSS was added to the NSB and the zero standard 
at 200 pl/tube.
Tubes were set up to test non-specific binding (NSB) of samples in the absence of 
antiserum. Data for NSB were required for each series of plasma samples, standards and 
for each quality control.
2.2.4.4 Preparation o f affinity-purified f^^-lalelled GLP-1
The method for the preparation of I^^^-labelled GLP-1 is described in section 2.2.6, and 
purified via the same protocol as for GIP (section 2.2.2.S), using a solid phase of sheep 
anti-GLP-1 antibodies coupled to glass beads, and stored in a plastic 7 ml disposable 
column (section 2.1). The purified I'^^-labelled GLP-1 (100 pi) was added to the assay 
at 5000 cpm/100 pi (table 2.3).
2.2.4.5 Preparation o f second antibody reagents
The separation of the free and the bound antigen on day 4 was carried out using a ‘sac- 
cel’ anti-rabbit separation system for all samples (section 2.2.3.1). Sac-cel (100 pi) was 
added to all tubes except totals. For plasma samples 1 ml RO water was added after the 
30 minute incubation.
2.2.4.6 Assay protocol
On the first day the assay diluent, standards, quality controls, samples and antiserum 
were prepared. The reagents were added to the assay tubes in the order shown in table
2.1. All tubes were set up in duplicate. Quality controls were placed before and after the 
samples to detect any drift.
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On the second day affinity-purified I^^^-labelled GLP-1 was added to the assay at 5000 
cpm/100 pi. The purified I*^^-labelled GLP-1 (100 pi) was added to every tube in the 
assay (table 2.1), the contents vortex mixed and the tubes stored for 48 h at 
4°C.
On the fourth day the free and the bound antigen were separated. Sac-cel was added to 
all tubes, and the contents vortex mixed for 30 seconds. Tubes were left at room 
temperature for 30 min. After this time 1ml of RO water was added to each tube (except 
totals), at which point they were centriftiged for 30 minutes at 1852 x g. The 
supernatant was aspirated and the pellet radioactivity measured on a gamma counter 
(section 2 .1)
Table 2.3. Protocol for GLP-1 radioimmunoassay of plasma samples
Reagent Totals NSB
Standard
Zero
Standard
Standard NSB
QC
QC NSB
Sample
Sample
Day 1
Assay
Diluent
200 pi 100 pi 100 pi 200 pi 100 pi 200 pi 100 pi
Standard —  — - 200 pi - - - -
CSS 200 pi 200 pi — - - - -
QC — — - - 200 pi 200 pi - -
Sample -  - - - - - 200 pi 200 pi
Anti Sera _  - 100 pi 100 pi - 100 pi - 100 pi
Vortex mix and incubate for 24 hours at 4 °C
Day 2
Label 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 
Vortex mix tubes and incubate at 4 °C for 48 hours
Pay 4
Anti- -  100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi
rabbit
sac-cel
Vortex mix, incubate for 30 minutes at room temperature
RO water - ______1 ml 1 ml 1 ml 1 ml 1 ml 1 ml 1 ml
Centrifuge at 1852 x g for 30 minutes, aspirate supernatant, count pellet._________
* Columns contain volumes of reagents added to the assay mixture.
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The intra-assay CV at 10.3 pmol/1 was 13.0% {n = 12). The inter-assay CV was 10.6% 
at 15.4 pmol/1 {n = 6). The limit of detection of the assay was 9 pmol/1.
2.2.5 TISSUE EXTRACT GLP-1 RADIOIMMUNOASSAY
The method for this RIA is similar to that of the GIF RIA (Elliott et a l, 1993). The 
GLP-1 RIA was carried out over four days. On the first day the assay diluent, standards 
and the antiserum were prepared and added, on the second day the affinity-purified I^ ^^ - 
labelled GLP-1 was added, and on the fourth day the bound and the free antigen were 
separated. In this assay it was the bound antigen that was counted.
2.2.5.1 Preparation o f reagents
The stock buffer and assay diluent were prepared in the same way as the GIP assay 
(section 2.2.3.1). The antiserum, standards and iodinated GLP-1 were prepared as for 
the plasma assay (section 2.2.4) and added to the assay in the order shown in table 2.2. 
Tissue extracts (section 2.3.2) were stored and thawed as described for the GIP tissue 
extract RIA. Small intestine tissue extracts (200 pi) were diluted 1 in 100 for use in the 
assay. Reagents were added to the assay in the order shown in table 2.4.
Tubes were set up to test non-specific binding (NSB) of samples in the absence of 
antiserum. Data for NSB were required for each series of standards and for each quality 
control. For small intestine and salivary gland extracts NSB were necessary for each 
dilution of each sample. The reagents were added to the assay tubes in the order shown 
in table 2.4. All tubes were set up in duplicate
The separation of the free and the bound antigen on day 4 was carried out using a ‘sac- 
cel’ anti-rabbit separation system for all samples (section 2.2.2.1). Sac-cel (100 pi) was 
added to all tubes except totals. For tissue extract samples 1 ml 0.2 % Brij solution was 
added after the 30 minute incubation.
2.2.5.2 Assay protocol
On the first day the assay diluent, standards, quality controls, samples and antiserum 
were prepared. The reagents were added to the assay tubes in the order shown in table
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2.4. All tubes were set up in duplicate. Quality controls were placed before and after the 
samples to detect any drift.
On the second day affinity-purified I^^^-labelled GIP was added to the assay at 5000 
cpm/100 pi. The purified I^^^-labelled GIP (lOOpl) was added to every tube in the assay 
(see table 2.1), the contents were vortex mixed and the tubes stored for 48 h at 4 °C.
On the fourth day the free and the bound antigen were separated. Sac-cel was added to 
all tubes, and the contents vortex mixed for 30 seconds. Tubes were left at room 
temperature for 30 min. For tissue extract assays 0.2 % Brij (1 ml) in saline solution 
was then added to each tube except totals, before centrifuging for 30 minutes at 1852 x 
g. The supernatant was aspirated and the pellet radioactivity measured on a gamma 
counter (section 2 .1).
Table 2.4. Protocol for GLP-1 radioimmunoassay of tissue extracts
Reagent Totals NSB Zero Standard NSB QC NSB Sample
Standard Standard QC Sample
Day 1
Assay 400 pi 300 pi 100 pi 200 pi 100 pi 200 pi 100 pi
Diluent
Standard —  —  — 200 pi — — — —
QC —  —  — - 200 pi 200 pi - -
Sample —  —  — - - - 200 pi 200 pi
Anti Sera 100 pi 100 pi — 100 pi — 100 pi
Vortex mix and incubate for 24 hours at 4 °c
Day 2
Label 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi
Vortex mix tubes and incubate at 4 °C for 48 hours
Day 4
Anti­ 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi
rabbit
sac-cel
Vortex mix, incubate for 30 minutes at room temperature.
0.2 % -  1 ml 1 ml 1 ml 1 ml 1 ml 1 ml 1 ml
Brij
solution
Centrifuge at 1852 x g for 30 minutes, aspirate supernatant, count pellet._____________
*Colunms contain volumes of reagents added to the assay mixture.
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The separation of the free and the bound antigen on day 4 was carried out using a ‘sac- 
cel’ anti-rabbit separation system for all samples. Sac-cel (100 pi) was added to all 
tubes except totals. For tissue extract samples 0.2 % brij solution (1 ml) was added after 
30 min incubation.
The intra-assay CV at 46 pmol/1 was 7.4 %{n = 6) and at 78 pmol/1 was 5.6 %{n = 6) 
The inter-assay CV at 40 pmol/1 was 6.6 % { n = l )  and at 74 pmol/1 was 9.4 %{n = 7). 
The limit of detection of the assay was 9 pmol/1.
2.2.6 PREPARATION OF l ‘“ -LABELLED GIP OR GLP-1 (7-36) AMIDE
The preparation of I'^^-labelled GIF or GLP-1 was carried out separately from the RIA. 
All reagents were prepared in the laboratory, and the procedure was carried out in a 
fume cupboard in a radiation-controlled area. Specific personal protection equipment 
was worn during the iodination.
2.2.6.1 Preparation o f reagents
Three grams of Sephadex G-15 (section 2.1) were allowed to swell overnight in 15 ml 
of 0.1 M sodium acetate pH 5.0. On the morning of the iodination a disposable 7 ml 
column was attached to a clamp and 30 cm of 1 mm PVC tubing was attached. The 
column was filled with the swollen Sephadex and 15 ml protein elution buffer (0.5 M 
sodium acetate containing 0.5 % HSA and 500 KlU/ml aprotinin) was passed through it.
Human GIP and GLP-1 (section 2.1) were weighed out prior to the iodination on a 
microbalance (5 pg GIP or 3 pg GLP-1 (7-36) amide). The peptides were transferred to 
an auto analyser cup and dissolved in 10 pi of 0.4 M phosphate buffer pH 7.4 (section 
2.2.1).
Immediately before the iodination Chloramine T (section 2.1) and sodium 
metabisulphite solutions were prepared. The chloramine T solution was prepared by 
adding 5 ml 0.4 M phosphate buffer pH 7.4 (section 2.2.1) to 7.5 mg chloramine T. The 
sodium metabisulphite solution was prepared by adding 5 ml 0.4 M phosphate buffer pH
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7.4 to 10 mg sodium metabisulphite. The solutions were roller mixed for 2 minutes 
prior to use.
8
. 7
Free iodine
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Fraction (number)
Figure 2.1 Typical plot of radioactivity against fraction number from GIP iodination
6 II25-labelled 
GLP-1
Free iodine
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Figure 2.2 Typical plot of radioactivity against fraction number from GLP-1 iodination
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2.2.6.2 Iodination protocol
The container of Nal^^  ^ (Anachem) was carefully removed from the lead pot and 10 pi 
of Nal^^  ^ was dispensed into the autoanalyser cup containing the GIP or GLP-1 
solution. To start the reaction 10 pi of chloramine T solution was added to the 
autoanalyser cup. The reagents were mixed constantly for 12 to 15 seconds with a 
pipette when 20 pi of sodium metabisulphite solution was added to stop the reaction. 
The contents of the autoanalyser cup were then mixed with 200 pi of protein elution 
buffer and transferred to the column. The iodinated peptide was eluted from the column 
with protein elution buffer.
Twenty fractions were collected from the column using a drop counter (10 drops per 
fraction). The radioactivity of 10 pi of each fraction was counted for 10 seconds and the 
counts per minute were plotted against fraction number (see figures 2.1 and 2.2). The 
first peak in radioactivity corresponds to the iodinated GIP or GLP-1 peptide and the 
second peak corresponds to the free iodine. Three fractions were stored and tested from 
an iodination, the fraction with the highest counts per minute from the peptide peak and 
the fractions immediately before and after this.
2.2.7 PLASMA INSULIN RADIOIMMUNOASSAY (RIA)
This assay was based on a published method (Albano et ah, 1972), and was carried out 
over 3 days. On the first day the assay diluent, standards and the antiserum were 
prepared, on the second day the 1^ ^^-labelled insulin was added, and on the third day the 
bound and the free antigen were separated. In this assay the bound antigen was counted.
2.2.7.1 Preparation o f assay diluent
Stock 0.04 M phosphate buffer pH 7.4 (section 2.2.1) was prepared in advance for this 
assay, and 0.5 % w/v bovine serum albumin (BSA) was added to prepare the assay 
diluent. This assay diluent was used in the assay for the dilution of all reagents.
2.2.7.2 Preparation o f antiserum
Insulin antiserum was raised in a guinea pig immunised with porcine insulin conjugated 
to egg albumin. The antisera was used at a final dilution of 1:10,000 in the assay, and
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added to all tubes except totals and NSB at 100 pi per tube. The antisera crossreacts 100 
% with human insulin, 42 % with human proinsulin, 76 % with Des 64-65- 
biosynthesised proinsulin and 61 % with des 31-32 biosynthesised proinsulin.
22.13 Preparation o f standards, quality controls and samples
Insulin standards (National Institute of Biological Standards and Controls) were stored 
ffeeze-dried. To each vial, 1 ml of assay diluent was added to give a concentration of 
1,500 pmol/1. This was then diluted to give standards of 1,500, 750, 375, 188, 94, 47 
and 23 pmol/1 for use in the assay. The plasma QC used were the same as those used for 
the GIF RIA (section 2.2.2.3) and were treated in the same way. Standards, QC and 
samples were added to the assay at 50 pl/tube.
The CSS was prepared and stored as described in section 2.2.2.4. Samples were stored 
and thawed as described for the GIF plasma RIA (section 2.2.2.3). CSS was added all 
standards at 50 pl/tube. Tubes were set up to test non-specific binding (NSB) of 
samples in the absence of antiserum. Data for NSB were required for each series of 
plasma samples, standards and for each quality control.
2.2.7.4 Preparation o f -labelled insulin
1^^^-labelled insulin was obtained from Dr S. Hampton, University of Surrey. The 
radioactivity of fractions of I'^^-labelled insulin were measured on a gamma counter 
(section 2 .1) and diluted with assay diluent to give 10,000 cpm/100 pi. 1^^^-labelled 
insulin (100 pi) was added to each tube (see table 2.5).
2.2.7.5 Preparation o f second antibody reagents
The separation of the free and the bound antigen in plasma sample assays used a second 
antibody system. Normal guinea-pig serum (NGFS) (section 2.1) was used at a dilution 
of 1 in 200 and added to the assay at 100 pl/tube. Donkey anti-guinea-pig antiserum 
(DAGFS) (section 2.1) was diluted as indicated for each batch and added to the assay at 
100 pl/tube. Folyethylene glycol was used in a 4 % w/v solution made up in 0.04 M 
phosphate buffer pH 7.4 (section 2.2.1), this was added to the assay at 700 pl/tube.
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2.2.7.6 Assay protocol
On the first day the assay diluent, standards, quality controls, samples and antiserum 
were prepared. The reagents were added to the assay tubes in the order shown in table
2.5. All tubes were set up in duplicate. Quality controls were placed before and after the 
samples to detect any drift.
On the second day I^^^-labelled insulin was added to the assay at 10,000 cpm/100 pi. 
The I^^^-labelled insulin (100 pi) was added to every tube in the assay (see table 2.5), 
the contents vortex mixed and the tubes stored for 24 h at 4 °C.
On the fourth day the free and the bound antigen were separated. NGFS, DAGF and 
FEG were added to all tubes except totals (see table 2.5). Contents were vortex mixed 
and incubated for 2 h at 4 °C, at which point they were centriftiged for 30 minutes at 
1852 X g. The supernatant was aspirated and the pellet radioactivity measured on a 
gamma counter (section 2 .1).
Table 2.5 Frotocol for insulin plasma radioimmunoassay
Reagent Totals NSB
Standard
Zero
Standard
Standard NSB
QC
QC NSB
Sample
Sample
Day 1
Assay 350 pi 250 pi 200 pi 350 pi 250 pi 350 pi 250 pi
Diluent
Standard 50 pi _
CSS 50 pi 50 pi 50 pi - - -
QC - - - - 50 pi 50 pi - -
Sample 
Anti Sera
— —
100 pi 100 pi 100 pi
50 pi 50|xl
100 w
Vortex mix and incubate for 24 hours at 4 °c
Day 2
Label 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 Hi
Vortex mix tubes and incubate at 4 °C for 24 hours
Day 3
NGFS — 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 nl
DAGFS — 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 |il
FEG 4% - 700 pi 700 pi 700 pi 700 pi 700 pi 700 pi 700 nl
Vortex mix, incubate for 2 hours at 4 °C centrifuge 1852 x g  for 30 minutes, aspirate 
supernatant and count pellet__________________________________________________
* Columns contain volumes of reagents added to the assay mixture.
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The intra-assay CV at 44 pmol/1 was 10.5% (« = 10). The inter-assay CV at 47 pmol/1 
was 8.8 % (« = 10) and at 277 pmol/1 was 9.6 % (« = 7). The limit of detection of the 
assay was 10 pmol/1.
2.2.8 SALIVA AND TISSUE EXTRACT INSULIN RADIOIMMUNOASSAY 
(RIA)
This assay was modified from the method described in section 2.2.6, and was carried 
out over 3 days. On the first day the assay diluent, standards and the antiserum were 
prepared, on the second day the I^^^-labelled insulin was added, and on the third day the 
bound and the free antigen were separated. In this assay the bound antigen was counted.
2.2.8.1 Preparation o f reagents
The assay diluent, antiserum and standards were prepared as described in section
2.2.7.1. Tissue extract and saliva QC samples (see sections 2.2.14 and 2.3.2) were 
prepared from pooled rat pancreas extracts diluted to 1:5000, 1:10,000 and 1:20,000 
stored in 1 ml aliquots at -20 °C until use. Standards, QC and samples were added to 
the assay at 50 pl/tube. The antiserum (section 2.2.7.1) was used at a final dilution of 
1:10,000 in the assay, and added to all tubes except totals and NSB at 100 pi per tube.
The I^^^-insulin was prepared as described in section 2.2.7.1, and was added to the assay 
at 10,000 cpm/100 pi. I^^^-labelled insulin was added to each tube at 100 pl/tube.
For tissue extract and saliva sample assays the separation of the free and the bound 
antigen was made using an anti-guinea-pig ‘sac-cel' preparation (section 2.1). Sac-cel 
(100 pi) was added to all tubes at except totals. For tissue extract assays 1 ml of 0.2 % 
Brij (section 2.1) (in 0.9 % NaCl) solution was then added to each tube except totals, 
and for saliva sample assays 1 ml of RO water was added.
2.2.8.2 Assay protocol
On the first day the assay diluent, standards, quality controls, samples and antiserum 
were prepared. The reagents were added to the assay tubes in the order shown in table
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2.6. All tubes were set up in duplicate. Quality controls were placed before and after the 
samples to detect any drift in accuracy.
On the second day I^^^-labelled insulin was added to the assay at 10,000 cpm/100 pi. 
The I^^^-labelled insulin (100 pi) was added to every tube in the assay (see table 2.6), 
the contents vortex mixed and the tubes stored for 24 h at 4 °C.
Table 2.6 Protocol for insulin saliva and tissue extract radioimmunoassay
Reagent Totals NSB Zero Standard NSB QC NSB Sample
Standard Standard QC Sample
Day 1
Assay 400 pi 300 pi 250 pi 350 pi 250 pi 350 pi 250 pi
Diluent
Standard —  — — 50 pi — — — -
QC -  - - - 50 pi 50 pi - -
Sample —  — - - - - 50 pi 50 pi
Anti Sera — 100 pi 100 pi — 100 pi - 100 pi
Vortex mix and incubate for 24 hours at 4 °c
Day 2
Label 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi
Vortex mix tubes and incubate at 4 °C for 24 hours
Day 3
Anti- 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi 100 pi
guinea pig
sac-cel
Vortex mix, incubate for 30 minutes at room temperature
RO water -  1 ml 1 ml 1 ml 1 ml 1 ml 1 ml 1 ml
or 0.2 % 
Brij
solution
Centrifuge at 1852 x g  for 30 minutes, aspirate supernatant and count pellet
* Columns contain volumes of reagents added to the assay mixture.
On the third day the free and the bound antigen were separated. Sac-cel was added to all 
tubes except totals, and the contents vortex mixed for 30 seconds, and the tubes left at 
room temperature for 30 min. For tissue extract assays 1 ml of 0.2 % Brij (section 2.1) 
solution was then added to each tube (except totals), before spinning for 30 minutes at 
1852 X g. For saliva sample assays 1 ml of RO water was added to each tube (except
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totals), at which point they were centrifuged for 30 minutes at 1852 x g. The 
supernatant was aspirated and the pellet radioactivity measured on a gamma counter 
(section 2 .1)
The intra-assay CV (n = 20) at 571 pmol/1 was 9.8 %. The inter-assay CV at 188 pmol/1 
was 6.7% (n=  12) and at 360 pmol/1 was 5.1 % (« = 10). The limit of detection of the 
assay was 20 pmol/1.
2.2.9 a-AMYLASE ACTIVITY
Salivary a-amylase activity was measured using an automated Cobas Mira analyser and 
a colorimetric method (section 2 .1), with benzilidene-blocked /?-nitrophenol- 
maltoheptaoside (bl-GypNP) as the substrate. Two indicator enzymes are used in this 
method, glucoamylase to cleave the amylase reaction products, and a-glucosidase to 
release the p-nitrophenol. The terminal glucose of the substrate is chemically blocked 
preventing cleavage by the indicator enzymes. The reaction sequence can be seen in the 
following diagram.
a-amylase
Bl-GvpNP ------------------- > bl-Gs + G4-pNp
glucoamylase
G2.5-pNP -^glucose + pNP-glucoside
a-glucosidase
a-glucosidase
PNP-glucoside --------------------> glucose + pNP
Samples were analysed at a wavelength of 405 nm, measurements were made against 
air.
Saliva samples were centrifuged at 1825 x g for 10 minutes prior to analysis. Saliva 
samples were diluted 1 + 99 with 0.9 % w/v NaCl, and the results were multiplied by 
100. To test for accuracy and reproducibility quality control samples were run at the
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beginning and end of each assay. The intra-assay coefficient of variation (CV) {n = 4) at
106.5 U/1 was 1.2 %, and the inter-assay CV (« = 18) at 114.9 U/1 was 3.7 %.
2.2.10 SALIVARY TOTAL PROTEIN
Salivary total protein was measured with an automated Cobas Mira analyser using the 
Biuret method (section 2.1). Cupric ions, in alkaline solutions interact with protein 
peptide bonds to from a coloured complex. The absorbance of the sample was read at 
546 nm. The intra-assay coefficient of variation (CV) {n = 4) at 59.8 g/1 was 0.9 %, and 
the inter-assay CV {n =18) at 59.6 g/1 was 1.3 %.
2.2.11 PLASMA GLUCOSE
Plasma glucose was measured using an automated Cobas Mira analyser and an 
enzymatic ultraviolet test (section 2.1). The method converts plasma D-glucose and 
adenosine triphosphate (ATP) to D -glucose-6-phosphate and adenosine diphosphate 
(ADP) via the enzyme hexokinase (HK). D -glucose-6-phosphate and NAD^ are then 
converted to D -gluconate-6-phosphate and NADPH by the enzyme Glucose-6- 
phosphate dehydrogenase (G6P-DH). The formation of NADPH is directly related to 
the glucose concentration and is measured photometrically at 340 nm.
HK
D -glucose + ATP -----------------------> D -glucose-6-phosphate + ADP
G6P-DH
D -glucose-6-P + NAD^ > D -gluconate-6-phosphate + NADPH + H^
Quality control samples were run at the beginning and end of each assay. The intra­
assay coefficient of variation (CV) {n = 4) at 3.80 mmol/1 was 0.4 %, and the inter-assay 
CV {n =18) at 3.85 mmol/1 was 0.9 %.
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2.2.12 PLASMA TRIACYLGLYCEROL
Plasma triacylglycerol (TAG) were measured using an enzymatic colorimetric test 
(section 2.1), on an automated Cobas Mira analyser. Plasma TAG was broken down to 
from dihydroxyacetone phosphate and hydrogen peroxide by the enzymes lipase, 
glycerol kinase (GK) and glycerol phosphate oxidase (GPO). In the presence of 
peroxidase the hydrogen peroxide effects the oxidative coupling of 4-aminoantipyrine 
and 4-chlorophenol to form a red coloured quinoneimine derivative. The colour 
intensity is directly proportional to the TAG concentration and is measured 
photometrically at 500 nm.
lipase
Triglycerides --------------------> glycerol + fatty acids
Glycerol + ATP
GK
■> glycerol-3-P + ADP
Glycerol-3-phosphate + O2
GPO
■> dihydroxyacetone phosphate +H2O2
Quality controls were run at the beginning and end of each assay. The inter-assay 
coefficient of variation CV («=10) at 0.78 mmol/1 was 2.9 %.
2.2.13 PLASMA NON-ESTERIFIED FATTY ACIDS (NEFA)
Plasma non-esterified fatty acids were measured using an enzymatic colorimetric 
method (section 2.1), on an automated analyser (Cobas mira plus).
When plasma NEFA were treated with acyl-CoA synthetase in the presence of ATP, 
magnesium cations and Co A, the thiol esters of CoA were formed (acyl CoA). Two 
byporducts were also formed, adenosine monophosphate (AMP) and pyrophosphate 
(PPi). Hydrogen peroxide was formed by the oxidation of acyl-CoA by acyl-CoA 
oxidase (ACOD). The H2O2 in the presence of added peroxidase leads to the oxidative 
condensation of 3-methy 1-V-ethy 1- (P-hydroxy-ethyl)-aniline (MEHA) with 4-
53
CHAPTER 2
aminoantipyrine forming a purple complex, which absorbs at 550 nm. To prevent 
interference from ascorbic acid it is removed from the sample with ascorbate osidase.
 ^ ACS
NËFA + ATP + CoA --------------------> Acyl-CoA + AMP + Ppi
ACOD
Acyl-CoA + O2----------------------------------------------> 2,3-trans-Enoyl-CoA + H2O2
POD
2H2O2 + MEHA + 4-aminoantipyrine--------------------> Coloured adduct
Samples were analysed at a wavelength of 550 nm. Quality control samples were run at 
the beginning and end of each assay. The inter-assay coefficient of variation (CV) (n =13) 
at 0.97 mmol/1 was 2.2 %.
2.2.14 PLASMA AND SALIVA SAMPLE COLLECTION
Blood samples were collected from human subjects by cannula (section 2.1) placed into a 
forearm vein. After collection of each blood sample the cannula was flushed with saline 
(section 2.1). Blood samples were collected at the time points described for each 
investigation.
Blood was collected into 5 ml lithium heparin tubes (section 2.1) for the analysis of 
insulin and GIP, and into 5 ml lithium heparin tubes (section 2.1) containing aprotinin 
(section 2.1) (1000 KIU per ml of blood) for the analysis of GLP-1. Blood was collected 
into 1 ml flouride oxalate tubes (section 2.1) for glucose analysis, and 2.5 ml EDTA tubes 
(section 2.1) for triacylglyceride and non-esterified fatty acid analysis. All blood samples 
were centrifuged immediately at 1825 x g for 10 minutes and the plasma was aliquotted 
into 3 ml plastic disposable tubes (section 2.1) and immediately frozen to -20 °C until 
analysis.
Saliva samples (2 ml) were collected into 5 ml scintilation vials (section 2.1). Subjects 
‘spaf directly into the scintilation vials, which were marked with a line to indicate the 
amount of saliva required. Subjects were allowed to rinse their mouth with water prior to 
providing a saliva sample, but not during the sample. All saliva samples were centrifuged
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immediately at 1825 x g for 10 minutes to remove particulate matter and the saliva was 
aliquotted into 3 ml plastic disposable tubes (section 2.1) and immediately frozen to -20 
°C until analysis.
2.2.15 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY ANALYSIS
For HPLC two solvents were used. Solvent A was 0.1 % triflouroacetic acid (section
2.1) in RO water, and solvent B was 0.1% triflouroacetic acid in 70 % acetonitrile 
(section 2.1. A flow rate of 1.3 ml per minute was used, and the run time was 38 
minutes. The solvent gradient can be seen in table 2.14. The wavelengths used were 
205, 215 and 280 nm. Thermo separation products supplied the autosampler (AS 1000), 
the binary pump (P2000) and the detector (UV 6000). Chromquest software was used. 
The column was 4.6 x 250 mm, 5 p. C l8, 300 A (Phenomenex). Fractions were 
collected using a Foxy Junior fraction collector (Isco).
Table 2.7 Solvent gradient for HPLC method
Time (minutes) Solvent A Solvent B
0 65 35
15 35 65
17 10 90
19 10 90
21 90 10
29 90 10
32 65 35
38 65 35
Insulin and human GIP standards were dissolved in solvent A for HPLC analysis. 
Fractions were collected over 4-minute periods until 20 minutes (i.e. five periods of 4 
minutes). The fractions (4 ml) were dried using a speed vac, and reconstituted with 500 
pi of assay diluent (section 2.2.1). Fractions were then analysed by radioimmunoassay.
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2.3 THE DEVELOPMENT AND VALIDATION OF METHODS FOR 
DETECTION OF PEPTIDE HORMONE IMMUNOREACTIVITY IN RAT 
SALIVARY GLAND EXTRACTS AND HUMAN SALIVA.
2.3.1 INTRODUCTION
The purpose of this work was to develop and validate methods required to determine 
whether or not GIF, GLP-1 and insulin-like immunoreactivity could be detected in 
extracts of rat salivary glands and human saliva. The presence of insulin-like 
immunoreactivity (ILI) in salivary glands has been well documented in the literature 
(Perez-Castillo & Blazquez, 1980; Murakami et a l, 1982; Shubnikova et a l, 1984; 
Patel et a l, 1986; Smith et a l, 1986a; Deville de Perrier et a l, 1989; Deville de Perrier 
et a l, 1992; Taouis et a l, 1995). Only two references to the presence of GIP in the 
salivary glands have been documented (Tseng et a l, 1993; Tseng et a l, 1995). There 
are no references concerning the presence of GLP-1 in the salivary glands in the current 
literature, although there are references to the presence of glucagon-like 
immunoreactivity (Bhathena et a l, 1977; Lawrence et a l, 1977; Perez-Castillo & 
Blazquez, 1980).
There are reports of ILI in human and mouse saliva (Fekete et a l, 1993; Kerr et a l, 
1995) in the literature. For ILI within the salivary glands and saliva to originate from 
local synthesis one would expect to find evidence of the precursors of insulin to be 
present in the salivary glands. However not a single reference has been made to the 
presence of insulin precursors or C-peptide in salivary glands or saliva. There are 
however reports of the absence of insulin precursors in the salivary glands. Using 
column chromatography of extracts from rat and human SPG no peak corresponding to 
proinsulin was found (Murakami et al, 1982) and the presence of mature preproinsulin 
RNA species was absent from the SSG of rats (Cooper & Clarke, 1985). To date, there 
have been no reports of GIP or GLP-1-like immunoreactivity in human saliva.
Radioimmunoassay (RIA) has been traditionally used to determine the hormone content 
of plasma and small intestine extracts. For the measurement of these hormones in 
salivary gland extracts and saliva it was necessary to validate using RIA as a method of 
analysis for these peptide hormones in saliva. This was achieved by analysing the saliva
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at different dilutions and comparing the results for parallelism (section 2.13.1) and by 
spiking saliva with a known concentration of standard and calculating the percentage 
recovery (see section 2.13.2).
Rat salivary submandibular and parotid gland extracts and human saliva were analysed 
by RIA at different dilutions in assay diluent (section 2.2.2). The aim of using a number 
of dilutions was to test for ‘parallelism’ between the results of all dilutions of the same 
sample. For example if sample A gave a value of 40 pmol/1 at a 1 in 5 dilution then at a 
1 in 10 dilution the value should be 20 pmol/1, and so on. Conventionally, parallelism is 
said to have occurred if one value falls between 80 and 120 % of the other (Chard, 
1987). If parallelism is not seen then it is probable that either there are interfering 
substances present in the sample, or that the peptide immunoreactivity detected is not 
structurally identical to the peptide used for the RIA standards.
Recovery experiments were carried out to assess the presence of interfering substances 
that may be giving a false signal in the RIA for GIF and insulin rat salivary gland 
extract and human saliva, and to further validate the presence of GIF-like and insulin­
like immunoreactivity in rat salivary glands. Samples were analysed with and without a 
known amount of standard added to the final assay mixture. Samples without added 
standard were diluted 1 in 5 in assay diluent, and samples that were spiked with 
standard were diluted 1 in 5 to give a known concentration of standard in the reaction 
mixture. This gave a final concentration of 100 pmol/1 for GIF and 94 pmol/1 for the 
insulin samples.
From the results of the assay it was possible to determine the percentage recovery of the 
spiked sample relative to the unspiked sample. A good percentage recovery would be 
between 85 and 115 %, and within this range it could be accepted that there were no 
significant interfering substances present in the assay. Between the range 70 and 130 %, 
it would not be possible to be sure that there was not an interfering substance present 
within the sample, and further validation of the method would be required.
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2.3.2 EXTRACTION OF RAT SALIVARY GLANDS
Rats were killed by asphyxiation with CO2, to prevent damage to the salivary glands.
The anatomy of the salivary glands is shown in figure 1.4. Small intestine, pancreas and 
salivary glands were dissected firom rats. Tissues were immediately cleaned under 
running water, wrapped in foil and placed into liquid nitrogen. Tissues were then 
weighed and stored at -20 °C until required. Salivary submandibular glands were fi*ozen 
to -70 °C and crushed to a powder using a pestle and mortar before extraction, as they 
were very fibrous.
Two extraction methods for tissue were compared, an acid ethanol (Kenny, 1955) and 
an acetic acid extraction method (Tseng et al., 1993). To compare the effectiveness of 
the extraction techniques the small intestine was divided in half along the meniscus and 
each half extracted with a different technique. Similarly, either the right or the left lobe 
of the SSG was randomly assigned to a particular extraction method.
2.3.2.1 Acid ethanol extraction
Keimy (1955) developed the acid ethanol extraction. Acidified ethanol solution (750 ml 
absolute ethanolj 250 ml RO water: 15 ml 36 % w/v HCl) was added to the tissue at 
5 ml/g wet weight of tissue, in a universal glass vessel. All procedures were performed 
using a cold tray at 4 °C, or on ice. The tissue was cut into small pieces before 
homogenising with a stainless steel homogeniser until a smooth liquid was produced. 
The homogenate was incubated for 24 hours at 4 °C, before centrifuging for 10 minutes 
(15 minutes for salivary glands) at 1852 x g (Beckman J6). The supernatant was 
decanted, aliquoted into disposable tubes, and stored at -20 °C.
2.3.2.2 Acetic acid extraction
2 M acetic acid was added to tissue at 5 ml/g wet weight of tissue. This was then 
homogenised as with the acid ethanol extraction, and placed in a Pyrex test tube. Tubes 
were placed into a boiling water-bath for 30 minutes. Marbles were placed on the top of 
each tube to minimise water loss by evaporation Tubes were weighed before and after 
boiling, then readjusted with water. Tubes were then chilled on ice before centrifuging 
and decanting as with the acid ethanol extraction method and stored at -20 °C.
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Extracts of salivary gland and small intestine samples were diluted with assay diluent 
prior to addition to the radioimmunoassay. It was found that at the low dilution factors 
used for salivary gland extracts (1 in 5, 1 in 10 and 1 in 15) it was necessary to adjust 
the pH of the sample to pH 6.5 with 10 M NaOH prior to addition to the assay. This was 
most evident with the acetic acid extracts. The addition of the alkali was included in the 
dilution factor. This was not necessary with the small intestine samples as these were 
diluted at 1:100, 1:150 and 1:200, and such large dilutions exceeded the inherent buffer 
capacity of the extract, raising the pH value to a region that did not adversely affect the 
assay.
2.3.2.3 Results o f comparison o f extraction technique
To investigate the destruction of the hormone during this extraction technique a known 
concentration of standard (350 pmol/1) was also boiled in acetic acid and then analysed 
by RIA. Samples were set up in duplicate. Following boiling in acetic acid the level was 
detected at 403 pmol/1 {n = 2). This apparent increase in immunoreactivity was caused 
by evaporation of the acetic acid during the extraction process. These data indicated that 
the acetic acid extraction method would give deceptive results for tissue extracts treated 
in this manner.
All small intestine and salivary gland extracts from the two extraction techniques 
evaluated were assayed at three dilutions so that ‘parallelism’ could be compared 
between samples. If a sample shows true ‘parallelism’, then once corrections have been 
made for the dilution factor, all dilutions should give the same value. Data are shown 
from GIF radioimmunoassays carried out on small intestine and SSG tissue extracts (see 
tables 2.8 and 2.9).
Statistical analysis using a one way ANNOVA found no significant difference between 
RIA results from dilutions of small intestine from the acid ethanol extraction (p = 0.25) 
and found significant differences between dilutions for the acetic acid extraction 
ip = 0.04). In contrast the SSG data gave significantly different data for dilutions using 
the acid ethanol extraction (p = 0.01) but not with the acetic acid extraction {p = 0.5)
59
CHAPTER 2
Table 2.8 Comparison of acidified ethanol and acetic acid extraction techniques for the 
determination of peptide hormone levels in rat small intestine fi*om fed rats (mean ± 
SEM, n = 5)
Dilution Acid ethanol Acetic acid extraction
factor Extraction -
Mean nmol/g SEM Mean nmol/g SEM
wet weight wet weight
1 in 100 167 14 303 31
1 in 150 163 13 234 10
1 in 200 140 5 230 14
Table 2.9 Comparison of acidified ethanol and acetic acid extraction techniques for the
determination of peptide hormone levels in rat salivary submandibular glands (SSG)
intestine fi’om fed rats (mean ± SEM, n = 5)
Dilution Acid ethanol Acetic acid extraction
factor Extraction
Mean nmol/g SEM Mean nmol/g SEM
wet weight wet weight
1 in 10 15.9 2.7 24.2 7.4
1 in 15 20.2 1.9 26.1 3.3
1 in 20 26.4 1.7 32.2 2.4
Higher concentrations of GIP were found in extracts of both the small intestine and SSG
with the acetic acid extraction. However, when a known concentration of standard was
treated according to the acetic acid extraction technique an apparently higher
concentration was detected via the RIA than had been added to the sample. Also, a 
greater degree of parallelism was found with the acid ethanol extracts in the small 
intestine samples (the control tissue) compared with those extracted in acetic acid. The 
acid ethanol extraction technique has been used for the determination of insulin in 
salivary glands (Deville de Perrier et al., 1992; Patel et al., 1986). From these data it 
was decided to use the acid ethanol extraction method for tissue samples in further 
studies.
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2.3.3 GIP-LIKE IMMUNOREACTIVITY IN RAT SALIVARY GLANDS AND 
HUMAN SALIVA
2.3.3.1 GIP-like immunoreactivity in rat salivary submandibular and parotid glands 
GIF-like immunoreactivity has been measured in rat salivary glands. Extracts were 
made from the salivary submandibular gland (SSG) and the parotid gland (SPG) 
(section 2.3.1). Extracts from the small intestine were used as a positive control for the 
hormone GIP.
The results of parallelism studies for GIP in extracts of rat SSG can be seen in table 
2.10. The concept of parallelism is explained in section 2.3.1. The concentration of GIP 
in extracts of SPG was below the sensitivity of the assay for GIP. Poor parallelism was 
found for GIP in the extracts of SSG. The apparent concentration of GIP increased in 
the extracts at the higher dilutions (16 nmol/g wet weight at 1 in 5 dilution and 26.4 
nmol/g wet weight at 1 in 20).
Table 2.10 GIP-like immunoreactivity (nmol/g wet weight) in salivary gland extracts at 
three dilutions (mean ± SEM, n = 6)
Dilution nmol/g ww SEM Relative immunoreactivity (%)
1 in 10 16 2.7 1 in 10 to 1 in 20 165
1 in 15 20.2 1.9 1 in 10 to 1 in 15 126
l in  20 26.4 1.7 1 in 15 to 1 in 20 131
The analysis of small intestine (SI) extracts for GIP and GLP-1 by RIA is well 
validated; these hormones were originally isolated from the small intestine. SI extracts 
were analysed at different dilutions (table 2 .11) to compare the parallelism in a 
chemically characterised source of GIP with GIP-like immunoreactivity found in the 
salivary glands.
61
CHAPTER 2
Table 2.11 Parallelism of GIP and GLP-1 in small intestine extracts (« = 6)
Dilution nmol/g ww SEM Relative immunoreactivity (%)
1 in 100 32.5 4.8 l in  100 to l in  150 114
1 in 150 37.1 6.0 l in  100 to l in  200 73
1 in 200 27.2 5.8 I i n l 5 0 t o l i n 2 0 0  84
2.3.3.2 Recovery experiment to assess presence o f interfering substances in rat salivary 
gland extracts for analysis by GIP RIA
Samples were prepared by dilution with assay diluent (section 2.2.2). Samples without 
added standard were diluted 1 in 5 in assay diluent, and samples that were spiked with 
standard were diluted 1 in 5 to give a known concentration of standard in the reaction 
mixture. This gave a final concentration of 100 pmol/1 for GIP samples.
The results from the recovery of known concentrations of standard in SSG can be seen 
in table 2.12. The principle of the recovery experiment is described in section 2.3.1. The 
mean percentage recovery of 100 pmol/1 GIP-like immunoreactivity (GLI) from extracts 
of rat SSG was found to be 204 %. From the results of the GIP recovery it would appear 
that there is an interfering substance present in the SSG extract.
Table 2.12 Mean percentage recovery of GIP (100 pmol/1) from radioimmunoassay of 
spiked and unspiked salivary submandibular gland (SSG) extracts {n = 6, mean ± SEM)
Unspiked samples Samples spiked with % recovery
100 pmol/1 standard
Mean 219 423 204
SEM 66.7 8L3 23.7
The results from the recovery experiment of GLI in extracts of rat SSG and the poor 
parallelism found between dilutions indicate that there is an interfering substance in rat 
SSG extracts for the GIP radioimmunoassay.
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2.3.3.3 Determination o f GIP-like immunoreactivity in saliva.
Saliva samples from two human volunteers were analysed by GIF radioimmunoassay at 
two dilutions, 1 in 2 and 1 in 5 for subject 1 and 1 in 3 and 1 in 5 for subject 2, the mean 
values of all dilutions of samples can be seen in table 2.13. The percentage difference 
between values for each dilution fell between the ranges for an acceptable level of 
parallelism (section 2.3.1). A Students /-test was used to assess differences between 
values obtained for the different dilutions and there were found to be no significant 
differences between the dilutions for subject \ ip = 0.35) or for subject 2{p = 0.23).
Table 2.13 Salivary GIP-like immunoreactivity (pmol/1) in saliva samples analysed by 
RIA at different dilutions to test for parallelism (« =14)
Dilution factor 1 in 2 
or 1 in3
1 in 5 Relative immunoreactivity 
(%)
Subject 1 Mean pmol/1 115.9 43.6
SEM 12.3 6.8 1 in 5 to 1 in 2 94
Mean x dilution 231.8 218.1
Subject 2 Mean pmol/1 30.2 15.3
SEM 3.2 2.0 1 in 5 to 1 in 3 108
Mean x dilution 90.7 76.7
2.3.3.4 Recovery experiment to assess presence o f interfering substances in human 
saliva for analysis by GIP RIA
Samples without added standard were diluted 1:2 in assay diluent, and samples that 
were spiked with standard were diluted to give a known concentration of standard in the 
reaction mixture. Spiked saliva samples were prepared in the following manner 100 pi 
saliva, 50 pi assay diluent and 150 pi (200 pmol/1) GIP standard. This gave a final 
concentration of 100 pmol/1 of standard in the reaction mixture for GIP samples.
The results from the recovery of known concentrations of standard in saliva can be seen 
in table 2.14. The principle of the recovery experiment is described in section 2.3.1. The
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mean percentage recovery of 100 pmol/1 GIP from human saliva was 104 %; this is 
within the acceptable range set out in section 2.3.1.
Table 2.14 Mean percentage recovery of GIP (100 pmol/1) from radioimmunoassay of 
spiked and unspiked saliva samples {n = 6, mean ± SEM)
Unspiked samples Samples spiked with Mean %
100 pmol/1 standard recovery
Mean 40 143 104
SEM 15 10 5
For the purposes of this experiment these are very good recoveries with the peptide 
hormone GIP in saliva, which when taken with the parallelism data, would suggest that 
the GIP seen in saliva is genuine GIP-like immunoreactivity and not due to interference.
2.3.3.5 Detection o f the peptide hormones in extracts o f rat SSG and SPG and human 
saliva via HPLC
Further verification of the detection of GIP in rat salivary glands was carried out using 
high performance liquid chromatography (HPLC). A method was set up to detect 
standard solutions of insulin and GIP (section 2.2.15). Samples of pure insulin (section
2.1), human GIP (section 2.1), rat salivary gland extracts (section 2.3.2) and human 
saliva (section 2.2.14) were run through the same method and fractions were collected, 
rotary evaporated, freeze-dried and then analysed by RIA. The concentration of the 
peptide hormones in saliva and the salivary gland extracts were below the limit of 
detection of the HPLC, and it was therefore not possible to see the absorbance of the 
hormones on the chromatograms.
Samples of GIP standard (section 2.1), salivary submandibular gland (SSG) extract 
(section 2.3.2), salivary parotid gland (SPG) extract (section 2.3.2) and human saliva 
(section 2.2.14) were run on the HPLC. The fractions were collected as described 
above. The human GIP standard was found to elute from the column at 13 minutes, this 
can be seen in the chromatogram (figure 2.6). A blank run (solvent A) has been shown 
for comparison (figures 2.3 and 2.4). RIA of fractions collected from HPLC of SSG 
extract produced GLI between 16 and 20 minutes (figures 2.7 and 2.8); this was later
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than that of pure GIP. It was not possible to detect GLI from fractions collected from 
salivary parotid gland extracts (figures 2.9 and 2.10) or human saliva (figures 2.11 and 
2 .12).
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Figure 2.3 Chromatogram of a blank HPLC run
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Figure 2.4 Apparent GIP concentration (pmol/1) assessed by RIA in 4-minute fractions 
collected following chromatogram of a blank sample (solvent A)
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Figure 2.5 Chromatogram of pure human synthetic GIF
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Figure 2.6 Apparent GIP concentration (pmol/1) assessed by RIA in 4-minute fractions 
collected following chromatography of pure human GIP
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Figure 2.7 Chromatogram of an extract from rat salivary submandibular gland
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Figure 2.8 Apparent GIP concentration (pmol/1) as assessed by RIA in 4-minute 
fractions collected following chromatography of an extract from rat salivary 
submandibular gland
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Figure 2.9 Chromatogram of an extract from rat salivary parotid gland
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Figure 2.10 Apparent GIP concentration (pmol/1) assessed by RIA in 4-minute fractions 
collected following chromatography of an extract from rat salivary parotid gland 
(Note expanded scale compared with figures 2.4, 2.6 and 2.8)
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Figure 2.11 Chromatogram of human saliva
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Figure 2.12 Apparent GIP concentration (pmol/1) assessed by RIA in 4-minute fractions
collected following chromatography of human saliva
(Note expanded scale compared with figures 2.4, 2.6 and 2.8)
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2.3.4 INSULIN-LIKE IMMUNOREACTIVITY IN RAT SALIVARY GLANDS 
AND HUMAN SALIVA
2.3.3.1 Insulin-like immunoreactivity in rat salivary submandibular and parotid glands 
Insulin-like immunoreactivity has been measured in rat salivary glands. Extracts were 
made from the salivary submandibular gland (SSG) and the parotid gland (SPG) 
(section 2.3.2).
The results of the parallelism test can be seen in table 2.14. The parallelism found in the 
insulin samples was good for both the SSG and the SPG extracts (table 2.15), and fell 
within the acceptable range as described in section 2.3.1. The salivary gland extracts 
were assayed at two dilutions, 1 in 5 and 1 in 10. Statistical analysis using a students t- 
test found no significant difference between RIA results from dilutions of SSG {p = 
0.70) or SPG {p = 0.71).
Table 2.15 Insulin-like immunoreactivity (nmol/g wet weight) in salivary 
submandibular and salivary parotid gland extracts at two dilutions (mean ± SEM, n = 6)
Dilution nmol/g
weight
wet SEM Relative immunoreactivity 
(%)
SSG l in  5 0.99 0.1 -
l in  10 0.93 0.1 1 in 5 to 1 in 10 94
SPG l in  5 1.50 0.3
l in  10 1.64 0.3 1 in 5 to 1 in 10 109
2.3.4.2 Recovery experiment to assess presence o f interfering substances in rat salivary 
gland extracts for analysis by insulin RIA
Samples were prepared by dilution with assay diluent (section 2.2.7.1). Samples without 
added standard were diluted 1 in 5 in assay diluent, and samples that were spiked with 
standard were diluted 1 in 5 to give a known concentration of standard in the reaction 
mixture. This gave a final concentration of 94 pmol/1 for the insulin samples.
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The results from the recovery of known concentrations of standard in the extracts of 
SSG and SPG can be seen in table 2.16. The mean percentage recovery of 94 pmol/1 
from extracts of rat SSG was found to be 102 %. For the purposes of this experiment 
this is good recovery with the peptide hormone insulin in extracts of SSG. The mean 
percentage recovery of 94 pmol/1 insulin from extracts of rat SPG was 89%. This is 
within the acceptable range where it is possible to state that there are no interfering 
substances present in SPG extracts for the insulin radioimmunoassay.
Table 2.16 Mean percentage recovery of insulin (94 pmol/1) from radioimmunoassay of 
spiked and unspiked salivary submandibular gland (SSG) extracts {n = 6, mean ± SEM) 
and salivary parotid gland (SPG) extracts (« = 12, mean ± SEM)
Unspiked samples Samples spiked with 94 
pmol/1 standard
% recovery
SSG 28.4 125 102
SSG SEM 4.7 5
SPG 213 107 89
SPG SEM 1.0 9
2.3.4.2 Determination o f insulin-like immunoreactivity in human saliva 
Saliva samples from ten human subjects were analysed by insulin radioimmunoassay at 
two dilutions, 1 in 5 and 1 in 10. The mean values of all dilutions of samples can be 
seen in table 2.17. These samples were chosen as the individual values for insulin in 
saliva were highest postprandially and therefore gave greater sensitivity for this 
exercise. These values fall between the ranges for an acceptable level of parallelism.
Students f-test was used to assess differences between values obtained for the different 
dilutions, there were found to be no significant differences between the dilutions for 
sample \{p  = 0.50) or for sample 2{p = 0.48).
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Table 2.17 Salivary insulin-like immunoreactivity in saliva samples analysed by RIA at 
different dilutions to test for parallelism (« =10)
Time Dilution factor l i n S l in  10 Relative immunoreactivity 
(%)
Sample 1 Mean pmol/1 20.5 11.9
SEM 3.4 1.9
Mean x dilution 103 119 1 in 5 to 1 in 10 116
Sample 2 Mean pmol/1 19.4 11.6
SEM 3.9 2.1
Mean x dilution 96.9 116 1 in 5 to 1 in 10 119
2.S.4.4 Recovery experiment to assess presence o f interfering substances in human 
saliva for analysis by insulin RIA
Samples without added standard were diluted 1 in 3 in assay diluent, and samples that 
were spiked with standard were diluted to give a known concentration of standard in the 
reaction mixture. Spiked saliva samples were prepared in the following manner 100 pi 
saliva, 50 pi assay diluent and 150 pi (188 pmol/1) insulin standard solution. This gave a 
final concentration of 94 pmol/1 for the insulin samples.
The results from the recovery of known concentrations of standard in saliva can be seen 
in table 2.18. The principle of the recovery experiment is described in section 2.3.1. The 
mean percentage recovery of 94 pmol/1 insulin from human saliva was 106 %, this is 
within the acceptable range described in section 2.13.
Table 2.18 Mean percentage recovery of insulin (94 pmol/1) from radioimmunoassay of 
spiked and unspiked saliva samples {n = 6, mean ± SEM)
Unspiked samples Samples spiked with 100 pmol/1 % recovery
standard
Mean 85.8 185 106
SEM 22 23 6.4
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For the purposes of this experiment these were acceptable recoveries with the peptide 
hormone insulin in saliva, which when taken with the parallelism data, would suggest 
that the insulin seen in saliva is an insulin-like immunoreactivity and not due to 
interference.
2.3.4.5 Detection o f the peptide hormones in rat extracts o f rat SSG and SPG and 
human saliva via HPLC
Further verification of the detection of insulin in rat salivary gland extract and human 
saliva was carried out using high performance liquid chromatography (HPLC). A 
method was set up to detect standard solutions of insulin. Samples of pure insulin 
(section 2.1), rat salivary gland extracts (section 2.3.2) and human saliva (section 
2.2.14) were run through the same method and fractions were collected, rotary 
evaporated, ffeeze-dried and then analysed by RIA (section 2.2.15). The chromatograms 
for the blank (solvent A) run, SSG extract and SPG extract are shown in section 2.3.3.5 
(figures 2.3, 2.7 and 2.9)
Samples of insulin standard (section 2.1), salivary submandibular gland (SSG) extract 
(section 2.3.2), salivary parotid gland (SPG) extract (section 2.3.2) and human saliva 
(section 2.2.14) were run on the HPLC. The fractions were collected as described 
above. The human insulin standard was found to elute from the column at 13 minutes, 
this can be seen in the chromatogram (figures 2.14 and 2.15). A blank run (solvent A) 
has been shovm for comparison (figures 2.3 and 2.13). RIA of fractions collected from 
HPLC of human saliva produced ILl between 10 and 18 minutes (figures 2.18 and 
2.19); this was the same as that of pure insulin. It was not possible to detect ILl fi*om 
fi*actions collected from extracts of SSG (figures 2.7 and 2.16) or extracts of SPG 
(figures 2.9 and 2.17).
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Figure 2.13 Apparent insulin concentration (pmol/1) assessed by RIA in 4-minute 
fractions collected following chromatography of a blank sample (solvent A)
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Figure 2.14 Chromatogram of pure human synthetic insulin
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Figure 2.15 Apparent insulin concentration (pmol/1) assessed by RIA in 4-minute 
fractions collected following chromatography of pure human insulin
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Figure 2.16 Apparent insulin concentration (pmol/1) assessed by RIA in 4-minute 
fractions collected following chromatography of extract from SSG 
(Note expanded scale compared with figures 2.13 and 2.15)
75
CHAPTER 2
o
sa
100
80
60
40
20 □ , D □ [=□
6 10 14 18 22
Time (minutes from start of run)
□
26
Figure 2.17 Apparent insulin concentration (pmol/1) assessed by RIA in 4-minute 
fractions collected following chromatography of an extract from SPG 
(Note expanded scale compared with figures 2.13 and 2.15)
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Figure 2.18 Chromatogram of human saliva 60 minutes postprandially
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Figure 2.19 Apparent insulin concentration (pmol/1) assessed by RIA in 4-minute 
fractions collected following chromatography of human saliva
2.3.5 GLP-l-LIKE IMMUNOREACTIVITY IN RAT SALIVARY GLANDS AND 
HUMAN SALIVA
GLP-1-like immunoreactivity has been measured in rat salivary glands and human 
saliva. Extracts were made from the salivary submandibular gland (SSG) and the 
parotid gland (SPG). Extracts from the small intestine were used as a positive control 
for the hormone GLP-1.
The analysis of SSG and SPG extracts gave values for GLP-1 below the sensitivity of 
the standard curve at all dilutions (<12 pmol/1). Therefore it was not possible to 
demonstrate the presence of this hormone in salivary gland extracts.
Table 2.19 Parallelism of GLP-1 in small intestine extracts {n = 6)
Dilution nmol/g ww SEM Relative immunoreactivity (%)
1 in 50 27.8 3.3 1 in 50 to 1 in 100 100
1 in ICO 27.8 6.7 1 in 50 to 1 in 150 90.6
1 in 150 25.2 7.3 1 in 100 to 1 in 150 90.6
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All human saliva samples tested were found to be below the sensitivity of the standard 
curve, and it was therefore concluded that GLP-1 was not present in human saliva.
2.3.6 DISCUSSION
2.3.6.1 Comparison o f two extraction techniques
In the comparison between the extraction methods it was hoped to show better 
parallelism with one method than the other. The acidified ethanol method has been used 
previously for the extraction of insulin-like immunoreactivity from the salivary glands 
(Deville de Perrier et a l, 1992). Levels of the GIP in the small intestine were much 
higher compared with salivary submandibular gland GIP-like immunoreactivity, 
therefore the results were more precise and the parallelism was easier to demonstrate. 
The acetic acid method was unsatisfactory on account of concentration of the sample 
due to evaporation whilst boiling, making it necessary to weigh samples before and 
after boiling to adjust for volume loss. It also consistently over-recovered when samples 
were spiked with a standard of known concentration. As better parallelism was achieved 
with the small intestine extracts prepared using the acid ethanol extraction than the 
acetic acid extraction, this method was chosen for future use.
2.3.6.2 GIP-like immunoreactivity in rat salivary glands and human saliva.
The results of the parallelism studies and recovery experiment for GIP-like 
immunoreactivity in salivary submandibular gland (SSG) extracts were poor and 
indicate the presence of matrix effects in the SSG extract, or a different molecular form 
of GIP. There is some convincing evidence, albeit by a single worker, of the presence of 
GIP-like immunoreactivity in salivary glands, although little detail is given about assay 
conditions used. GIP mRNA has been found in ductal cells of rat SSG, mRNA levels 
increased after an oral glucose load (Tseng et a l, 1994). This work also described how 
immunoreactive GIP levels in salivary gland extracts increased by 50% after a glucose 
load.
The RIA results for fractions collected from HPLC analysis of salivary submandibular 
gland extracts (SSG) indicated that GIP-like immunoreactivity (GLI) was present in the 
fractions collected. However the GLI present in the SSG extract eluted off the HPLC
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column at a time different to human GIP that was run as a standard. This observation 
combined with the possible matrix effects demonstrated by the parallelism data and the 
recovery experiment suggest the GLI seen in rat SSG extracts has a molecular form 
different to that of human GIP. Unfortunately it has not been possible to further 
characterise the GLI seen in rat SSG extracts in this project. Therefore GLI is worth 
measuring in the salivary glands but with the understanding that the method may not be 
measuring the same peptide as found in the small intestine.
From the results of section 2.3.3 it was decided not to carry out further analysis on GIP 
in salivary parotid gland extracts, as this hormone if present was below the limit of 
detection of the assay available, and was not detected in RIA of fractions collected from 
HPLC analysis.
No reference to the presence of GIP in human saliva has been found. From the data 
presented here it is proposed that there is GIP present in human saliva. The results from 
the parallelism studies and the recovery experiment support this. However, it was not 
possible to detect unequivocally GIP from fractions collected from HPLC analysis of 
saliva, although the fraction in which GIP would be expected gave a slightly higher 
result than the other fractions.
2.3.6.3 Insulin-like immunoreactivity in rat salivary glands and human saliva 
The data from both the parallelism and recovery experiments for insulin-like 
immunoreactivity (ILl) in rat SSG and SPG fell within the acceptable range for RIA . 
From the results it is evident that immunoreactive insulin was detected in SSG and SPG 
extracts. However it was not possible to detect ILl in the fractions collected from HPLC 
analysis.
The presence of insulin-like immunoreactivity (ILl) in the salivary glands is 
documented in the literature. A variety of methods have been used to determine the 
presence of ILl in salivary glands, for instance gel electrophoresis on mouse SSG 
extracts (Shubnikova et a l, 1984), PCR on mouse SSG and SPG extracts (Kerr et a l, 
1995), immunocytochemistry on SSG (Patel et a l, 1986; Smith & Toms, 1986b) and 
SPG (Smith & Toms, 1986b; Patel et a l, 1986; Smith et a l, 1986a).
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The data from both the parallelism and recovery experiments for insulin-like 
immunoreactivity (ILl) in human saliva fell within the acceptable range for RIA. ILl 
was detected in the fractions collected from HPLC analysis of human saliva, and the ILl 
was found to elute at the same time as the insulin standard. From the results it is evident 
that ILl was detected in human saliva. ILl has been reported in both human (Fekete et 
al, 1993) and mouse saliva (Kerr et a l, 1995).
2.3.6.4 GLP-1 like immunoreactivity in rat salivary glands and human saliva 
Although GLP-I was found not to be present in saliva, its possible presence in the 
salivary glands cannot be ruled out. The levels seen in our experiments were below the 
level of sensitivity of our assay (9 pmol/1), but with a more sensitive assay it might be 
possible to determine the presence of a glucagon-like peptide in the salivary glands. 
Reports in the literature have shown the presence of a 'glucagon-like peptide' in salivary 
glands (Bhathena et a l, 1977; Lawrence et al, 1977; Perez-Castillo & Blâzquez, 1980), 
but other workers have shown this to be an artefact of the methods used (Tahara et al, 
1983)
From the results of section 2.3.3 it was decided not to carry out further analysis on 
GLP-I in rat salivary gland extracts or human saliva.
2.4 CONCLUSIONS
GIP is present in human saliva, and GIP-like immunoreactivity is detected in extracts of 
rat SSG. GLP-1 (7-36) amide is not present in rat salivary gland extracts or human 
saliva. Insulin-like immunoreactivity is present in extracts of rat SSG and SPG and 
human saliva.
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INVESTIGATION OF THE EFFECTS OF DIET ON 
SALIVARY HORMONE CONTENT OF RAT SALIVARY
GLANDS
CHAPTERS
3.1 INTRODUCTION
From the results of the initial method development and validation work reported in 
chapter 2 it was decided to investigate the effects of dietary stimulus on salivary gland 
insulin-like and GIF-like peptide hormone levels in rats. Although the investigation of 
GIP-like immunoreactivity (GLI) in extracts of salivary glands did not produce 
conclusive evidence that this hormone was present in the rat salivary glands, there was 
stronger evidence for the presence of GLI in human saliva. Therefore the investigation 
into the presence of this hormone in the salivary glands has been continued.
GIF and insulin are both found in cellular storage granules in rat intestine and pancreas 
respectively (Tseng et a l, 1994), it is therefore likely that the hormones GIF and insulin 
are stored in secretory granules within the salivary glands. To test this hypothesis 
salivary glands were collected from both fasted and fed rats and the levels of GLI and 
ILI found in extracts of these salivary glands were compared.
Red wine and black tea provide two of the largest sources of dietary phenols and tannins 
in the European diet. Dietary tannins have been shown to bind to salivary proline-rich 
proteins (FRF) (Charlton et a l, 1996), indeed habitual consumption of sources of 
dietary tannins has been shown to increase the amount of FRF secreted from the 
salivary glands of rats and mice (Mehansho et a l, 1992; Mehansho et a l, 1996). FRF 
are secreted mainly from the salivary parotid gland (Muenzer et a l, 1996). It is 
therefore possible that consumption of polyphenols from red wine and black tea may 
modulate the endocrine function of the salivary glands.
Other workers have previously shown that metabolites of red wine polyphenols, for 
example flavonoids such as catechin, are found in plasma after consumption of red wine 
at typical dietary doses (Donovan et a l, 1999). The consumption of red wine with a 
mixed meal has been shown to reduce plasma glucose levels in volunteers compared 
with a meal consumed with water, but no effect was seen on plasma insulin (Gin et al, 
1999). This may mean that the consumption of red wine has an effect on other 
hormones involved in the enteroinsular axis.
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As a population the UK habitually drink black tea. The term black tea does not relate to 
the lack of milk in the beverage but rather to the process used to manufacture the tea. 
Part of the dose of some polyphenols (flavonols and flavanols) from black tea is partly 
absorbed by man (He & Kies, 1994). It is not known whether theaflavins and 
thearubigins are absorbed unchanged in man, but it has been demonstrated in vitro that 
they have antioxidant properties (Yoshino et a l, 1994).
The general aims of these experiments were primarily to investigate the 
immunoreactive-hormone content of rat salivary glands under different forms of dietary 
manipulation. The small intestine is a source of authentic GIF and GLF-1; therefore the 
small intestine was investigated as well. Pilot studies were carried out to investigate the 
effects of black tea and red wine consumption on the immunoreactive-hormone content 
of the salivary glands in conjunction with other workers who required certain tissues for 
other purposes. Specifically the objectives of this study were
1) To determine levels of GIF and insulin in rat salivary glands taken from animals in 
both the fasted and the fed state
2) To investigate the effects of dietary red wine polyphenols on salivary gland and 
small intestine peptide hormones
3) To investigate the effects of drinking whole black tea on salivary gland and small 
intestine peptide hormones
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3.2 METHODS
3.2.1 EXPERIMENTAL DESIGN
3.2.1.1 Investigation ofsalivary peptide hormone immunoreactivity in salivary glands from 
fasted and fed rats.
The effect of food consumption on the endocrine function of the salivary glands was 
studied. Two groups of six male Wistar albino rats, young adults weighing between 200 
and 250 g in weight, were assigned randomly to feed ad lib or fast for 17 hours 
(overnight). GIF and insulin levels in extracts of rat salivary submandibular glands (SSG) 
and parotid glands (SFG), small intestine and pancreas were measured.
Animals were sacrificed by asphyxiation with CO2. The salivary glands, small intestine 
and pancreas were dissected, washed in saline and snap frozen at -80 °C and stored at 
-20 °C until extraction.
3.2.1.2 Red wine CRT study.
This experiment was carried out in conjunction with Professor Dolara of the University of 
Florence. The experiment was primarily designed to investigate the effects of red wine 
complex phenols and tannins (RWCFT) on Dimethylhydrazine (DMH)-induced nuclear 
aberrations in the colon of rats. Red wine complex phenols and tannins were prepared 
separately and provided by Dr Cheynier of INRA, Montpellier France.
Thirty-two male Fischer F344 (Nossan, Correzzana, Milan, Italy) rats were randomly 
divided into 4 groups of animals. The average weight at the start of the experiment was 
100 g. Prior to the start of the experiment the animals were fed on standard rat chow. 
During the experiment the animals were fed a high fat diet (230 g/kg com oil w/w, 20 g/kg 
w/w cellulose and 1.3 g/kg w/w calcium). This diet is designed to mimic that of western 
populations at high risk for colon cancer. All dietary components were purchased from 
Ficcioni (Gessate, Milan, Italy).
Two groups (B and D) were fed red wine complex phenols and tannins (RWCFT) for 
ten days (57 mg/kg). On the tenth day group D (« = 13) was treated by gavage with 
dimethylhydrazine (DMH; 20 mg/kg body weight), and group B (« = 3) was treated by
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gavage with 0.9 % NaCl. Two control groups (A and C) were not treated with red wine 
condensed tannins, but on the tenth day group C (w = 13) were treated as above with 
DMH and group A (« = 3) were treated with saline. The animals were treated with 
DMH as part of a separate experiment as described above.
Table 3.1 Experimental plan of diet (control or red wine condensed tannins) and treatment 
with DMH
GROUP NO OF RATS DIET TREATMENT
A 3 control Saline
B 3 Red wine OPT Saline
C 13 control DMH
D 13 Red wine OPT DMH
The salivary submandibular glands (SSG) and small intestine (SI) were removed after 
sacrifice washed in saline and snap frozen at -80 °C. The tissues were stored at -20 °C and 
were sent to the University of Surrey for extraction and analysis.
3.2.1.3 Pilot investigation on the effects o f black tea consumption on salivary hormone 
secretion in rat
This study was carried out in conjunction with Mr N. McCardle at the University of 
Surrey. This experiment was designed to investigate the effects of black tea as a source 
of drinking water on the endocrine function of the salivary glands and also to 
investigate the antimutagenic properties of black tea. As part of the collaborative project 
the animals were treated with 2-amino-3-methylimidazo (4,5-/) quinoline (IQ), a 
pyrolysis mutagen formed in heated fresh foods, to induce liver enzyme activity.
Twelve young adult male Wistar albino rats, average weight 150 g, were randomly 
divided into 3 groups of 4 animals. One group was given whole black tea extract 2.5 % 
w/v (Keemun tea) to drink, one group was given decaffeinated black tea extract, 2.5 % 
w/v (decaffeinated Ceylon tea), and a control group was given water to drink. Food and
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drink were allowed ad libitum for 37 days. Rats were treated with IQ in com oil on day 
34, at 5 mg/kg body weight as part of a separate experiment.
Tea extracts were prepared by a 2.5 % w/v infusion for 10 minutes in freshly boiled 
water. This was then filtered through cotton wool to remove the leaves. The extracts 
were prepared the evening before use, and stored ovemight at 4 °C wrapped in foil. 
Animals' drinking bottles were also wrapped in foil to prevent degradation of the tea 
polyphenols by light.
Animals were sacrificed on day 37 by asphyxiation with CO2. The salivary glands, 
small intestine and pancreas were dissected, washed in saline and snap frozen at -80 °C, 
and stored at -20 °C until extraction.
3.2.2 SAMPLE COLLECTION AND ANALYSIS
Salivary glands, small intestine and pancreas were extracted by an acid-ethanol 
extraction (section 2.3.2.2) and stored at -20 °C until required. Insulin-like, and GIP- 
like immunoreactivity and GLP-1 were determined by RIA techniques (sections 2.2.3,
2.2.5 and 2.2.8).
3.2.3 STATISTICAL ANALYSIS
Data are expressed in the text as mean ± standard error of the mean (SEM). Statistical 
analysis was carried out using a statistical package (Graph Pad Instat, graph pad 
software, San Diego, Califomia, USA). Data were compared with the Kolmogorov- 
Smimov test for normal distribution and transformed if necessary. One-way analysis of 
variance (ANOVA) was used to assess variation between groups. The Tukey-Kramer 
multiple comparisons test was used to compare differences between groups when ANOVA 
gave values p  < 0.05.
Unless stated in the text, parametric statistical tests were employed for analysis of data. 
Where data could not be transformed to comply with a normal distribution, analysis of 
variance (ANOVA) was tested using Kmskal-Wallis non-parametric tests, when p  <
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0.05 post hoc analysis was carried out using Dunns comparison of the difference in the 
sum of ranks between two columns and the expected average difference.
Values of/7 < 0.05 were considered significant.
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3.3 RESULTS
3.3.1 INVESTIGATION OF SALIVARY PEPTIDE HORMONE 
IMMUNOREACTIVITY IN SALIAVRY GLANDS FROM FASTED AND FED 
RATS
3.3.1.1 Weights o f salivary glands from fasted andfed rats
Salivary gland weights from fasted and fed rats are shown in figure 3.1. There were no 
significant differences in the weights of either the salivary submandibular glands (SSG) or 
the salivary parotid glands (SPG) from fed or fasted rats (/? = 0.13 and 0.92 respectively).
3"Cc
■I
I
1
•s
I
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0
□  Submandibular gland 
■  Parotid gland
Fed Fasted
Figure 3.1 Weights (g) of rat salivary glands from fasted and fed rats {n = 6, mean ± 
SEM)
3.3.1.2 Salivary gland and pancreatic insulin-like immunoreactivity (ILI) from fasted and 
fed rats
Insulin-like immunoreactivity (ILI) in extracts of salivary glands from fasted and fed rats 
are shown in table 3.2 and figure 3.2. Insulin in extracts of pancreas from fed and fasted 
rats is shown in table 3.2. The concentration of ILI (nmol/g wet weight) was found to be 
significantly higher in extracts of SSG and SPG from fed rats than the equivalent extract 
from fasted rats (p = 0.009 and < 0.001 respectively). Total ILI (nmol/tissue) in extracts of
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SSG and SPG from fed rats were significantly higher than in extracts of SSG and SPG 
from fasted rats {p = 0.006 and < 0.001 respectively). The concentration of ILI (nmol/g 
wet weight) was higher in extracts of SPG compæ*ed with ILI in extracts of SSG, but the 
differences failed to meet significance {p — 0.06). The levels of insulin in extracts of the 
pancreas from fasted rats were higher those in extracts of pancreas from fed rats.
Table 3.2 Insulin-like immunoreactivity in extracts of salivary submandibular (SSG) and 
parotid glands (SPG) from fed and fasted rats {n = 6)
Tissue nmol/g wet weight SEM nmol/tissue SEM
SSG Fed 0.99 0.1 0.69 0.1
Fasted 0.56 0.01 0.31 0.1
SPG Fed 1.50 0.3 0.93 0.1
Fasted 0.50 0.1 0.29 0.1
Pancreas Fed* 3320 NA 2590 NA
Fasted 15300 796 10700 1330
*  77 =  2
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Figure 3.2 Insulin-like immunoreactivity (ILI) (nmoFg wet weight) in rat salivary gland 
extracts from fasted and fed rats {n = 6, mean ± SEM)
*p < 0.05 ** /> < 0.01 Increased ILI in extracts of salivary glands from fed compared 
with fasted rats
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3.3.1.3 Salivary submandibular gland GIP-like immunoreactivity from fasted andfed rats 
GIP-like immunoreactivity (GLI) in extracts of salivary submandibular gland (SSG) from 
fasted and fed rats is shown in figure 3.3. There was a non-significant increase in GLI 
concentration (nmol/g wet weight) in extracts of SSG from fed rats compared with fasted 
rats (9.47 ± 1.79 and 5.47 ± 1.67 respectively, /? = 0.12). Also, there was a non-significant 
difference in the total GLI content (nmol/tissue) per gland from fed or fasted rats (7.52 ±
1.5 and 3.49 ± 1.1 respectively) {p = 0.08).
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Figure 3.3 GIP-like immunoreactivity (nmol/g wet weight) in rat salivary 
submandibular gland extracts from fasted and fed rats (n = 6, mean ± SEM)
3.3.1.4 Peptide hormone levels in rat small intestine from fed and fasted rats 
GIP levels in extracts of small intestine from fasted and fed rats (top 20 cm) are shown in 
figure 3.4. There were no significant differences between the GIP levels in extracts of 
small intestine from fed or fasted rats (41.9 ± 10.7 and 32.5 ± 4.9 nmol/g wet weight 
respectively) ip = 0.84). Also, there were no significant differences in the total GIP 
(nmol/tissue) in the top 20 cm of small intestine from fed or fasted rats (45.1 ± 13.0 and
29.1 ± 4.5) (p = 0.57).
GLP-1 levels in extracts of small intestine from fasted and fed rats (top 20 cm) are shown 
in figure 3.5. There were no significant differences between the GLP-1 levels attributable
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to feeding (fed 30.5 ± 7.0 and fasted 27.8 ± 3.3 nmol/g wet weight respectively) (p = 0.99). 
Also, there were no significant differences in the total GLP-1 immunoreactivity in the top 
20 cm of small intestine fed or fasted rats (30.9 ± 6.5 and 23.9 ± 4.6 nmol/tissue 
respectively) (p = 0.67).
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Figure 3.4 GIP-like immunoreactivity (nmol/g wet weight) in the top 20 cm of the small 
intestine from fasted and fed rats {n = 6, mean ± SEM)
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.5 GLP-1 concentration (nmol/g wet weight) of the top 20 cm of the small 
from fasted and fed rats {n = 6, mean ± SEM)
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3.3.2 RED WINE CPT STUDY.
3.3.2.1 Weights o f salivary submandibular glands
The weights of salivary submandibular glands (SSG) following consumption of red wine 
complex phenols and tannins (RWCPT) are shown in figure 3.6. There were no significant 
differences between the weights of SSG following any of the treatments {p = 0.28). The 
mean weights (g) were group A (control and saline) 0.43 ± 0.06, group B (RWCPT and 
saline) 0.42 ±0.01, group C (control and DMH) 0.40 ± 0.02 and group D (RWCPT and 
DMH) 0.45 ±0.01.
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Figure 3.6 Weights (g) of salivary submandibular glands from rats treated with red wine 
complex phenols and tannins and dimethylhydrazine (mean ± SEM)
3.3.2.2 Salivary gland insulin-like immunoreactivity (ILI)
The insulin-like immunoreactivity (ILI) in extracts of rat salivary submandibular glands 
following consumption of red wine complex phenols and tannins (RWCPT) can be seen 
in figure 3.7. There were no significant differences in the concentration of ILI (nmol/g 
wet weight) in extracts of SSG between the groups. Neither the red wine condensed 
tannins nor the DMH had any effect on ILI levels in the SSG. The mean concentration of 
ILI (nmol/g wet weight) were as follows: group A (saline and saline) 0.45 ± 0.07, group B 
(RWCPT and saline) 0.51 ± 0.05, group C (saline and DMH) 0.45 ± 0.04 and group D 
(RWCPT and DMH) 0.47 ± 0.02 respectively.
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Also, there were no significant differences between groups seen in the total amount of ILI 
(nmol/tissue) in extracts of SSG. The mean values for the total amount of ILI (nmol/tissue) 
in the SSG were as follows: group A (saline and saline) 0.17 ± 0.03, group B (RWCPT and 
saline) 0.14 ± 0.02, group C (saline and DMH) 0.18 ± 0.02 and group D (RWCPT and 
DMH) 0.21 ± 0.01 respectively.
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Figure 3.7 Insulin-like immunoreactivity (nmoFg wet weight) in rat salivary glands 
(mean ± SEM) following consumption of red wine CPT
3J.2.3 Salivary gland GIP-like immunoreactivity (GLI)
Levels of GIP-like immunoreactivity (GLI) in extracts of salivary submandibular gland 
from this experiment were below the level of sensitivity of the standard curve (10 
pmoFl, equivalent to 0.25 nmoFg wet weight).
3.3.2.4 GIP levels in rat small intestine
The GIP concentration (nmol/g wet weight) in extracts of rat small intestine following 
red wine tannin consumption can be seen in figure 3.8. One way analysis of variance of 
GIP concentration (nmoFg wet weight) showed a significant variation across the four 
groups {p = 0.02), but post hoc analysis indicated no significant difference between the 
means of GIP concentration from the SI of different groups. The mean concentrations of 
GIP (nmoFg wet weight) in the SI were as follows: group A (control and saline) 276 ±21,
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group B (RWCPT and saline) 251 ± 28, group C (control and DMH) 398 ± 30 and group 
D (RWCPT and DMH) 318 ± 26 respectively.
There were no significant differences between total GIP content (nmol/tissue) of whole 
rat SI from rats fed red wine tannins compared with controls or rats that were treated 
with DMH compared with saline {p = 0.12). The mean values of the total GIP 
(nmol/tissue) in rat SI were as follows: group A (control and saline) 800 ± 54, group B 
(RWCPT and saline) 637 ± 100, group C (control and DMH) 958 ± 85 and group D 
(RWCPT and DMH) 899 ± 75 respectively.
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Figure 3.8 GIP concentration (nmol/g wet weight) in rat small intestine following 
consumption of red wine CPT (mean ± SEM)
3.3.2.4 GLP-1 levels in rat small intestine
The GLP-1 content (nmol/tissue) in extracts of rat small intestine following red wine 
tannin consumption can be seen in figure 3.9. There were no significant differences in 
GLP-1 concentrations (nmol/g wet weight) arising from consumption of red wine 
tannins compared with saline {p = 0.12). The mean concentrations (nmol/g wet weight) of 
GLP-1 in the SI were as follows; group A (control and saline) 83 ± 1.3, group B (RWCPT 
and saline) 88 ± 1.1, group C (control and DMH) 90 ± 1 and group D (RWCPT and DMH) 
91+2 respectively.
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One way analysis of variance of GLP-1 content showed a significant difference across 
the four groups {p = 0.02), there was a significant increase in the total amount of GLP-1 
in the SI from rats following the red wine tannin and DMH diet compared with the 
control diet and DMH. The mean values of the total GLP-1 (nmol/tissue) in rat SI were as 
follows: group A (control and saline) 240 ± 22, group B (RWCPT and saline) 222 ± 8, 
group C (control and DMH) 215 ± 8 and group D (RWCPT and DMH) 257 ± 10 
respectively.
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Figure 3.9 Total amount of GLP-1 (nmol/tissue) in rat small intestine following 
consumption of red wine CPT (mean ± SEM)
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3.3.3 PILOT INVESTIGATION ON THE EFFECTS OF BLACK TEA 
CONSUMPTION ON SALIVARY HORMONE SECRETION IN RAT
3.3.3.1 Salivary gland weights
The weights of salivary submandibular glands (SSG) following black tea consumption are 
shown in figure 3.10. There were no significant differences between the weights of SSG 
following consumption of any of the beverages {p = 0.33). The mean weights (g) of SSG 
following consumption of black tea were as follows; water 0.51 ± 0.03, decaffemated 
black tea 0.56 ±0.02 and whole black tea 0.52 ± 0.02.
The weights of salivary parotid glands (SPG) following black tea consumption are shovm 
in figure 3.10. There was a trend towards increased SPG weights following consumption 
of whole black tea compared with decaffeinated black tea, and decaffeinated black tea 
compared with water {p = 0.06). The mean weights (g) of SPG following black tea 
consumption were as follows: water 0.37 ± 0.06, decaffeinated black tea 0.48 ±0.04 and 
whole black tea 0.55 ± 0.04.
□  Salivary submandibular gland B  Salivary parotid gland
T
’ •' I
W ater Decaffemated black tea
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Whole black tea
Figure 3.10 Weights of rat salivary glands following black tea consumption (n -  4, 
mean ± SEM)
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3.3.3.2 Insulin-like immunoreactivity (ILI) in rat salivary glands 
The insulin-like immunoreactivity (ILI) in extracts of salivary submandibular glands 
(SSG) from rats following black tea consumption can be seen in figure 3.11. There was 
a non-significant increase in ILI concentration (nmol/g wet weight) following 
consumption of decaffeinated black tea compared with the water (p = 0.06). The mean 
concentration of ILl (nmol/g wet weight) of rat SSG were as follows: water 1.0 ± 0.5, 
decaffeinated black tea 1.9 ± 0.4 and whole black tea 1.5 ± 0.2.
There was a non-significant increase in total ILl (nmol/tissue) in extracts of SSG from 
rats following consumption of decaffeinated black tea compared with the water {p = 
0.08). The mean values of the total amount of ILl (nmol/tissue) in the SSG following black 
tea consumption were as follows: water 0.55 ±0.1, decaffeinated black tea 1.1 ± 0.2 and 
whole black tea 0.8 ± 0.1.
The insulin-like immunoreactivity (ILI) in extracts of salivary parotid glands (SPG) from 
rats following black tea consumption can be seen in figure 3.11. There were no significant 
differences between groups in ILI concentration in the SPG {p = 0.24). The mean 
concentration of ILI (nmol/g wet weight) of rat SPG were as follows: water 1.5 ± 0.1, 
decaffeinated black tea 2.0 ±0.1 and whole black tea 2.7 ± 0.4.
There were significant differences in the total ILl (nmol/tissue) of SPG following 
consumption of black tea (p = 0.009). The total ILI (nmol/tissue) in extracts of SPG 
from rats was significantly higher following consumption of whole black tea compared 
with the water (/? < 0.01) and there was a trend towards higher levels of ILl the SPG 
following consumption of whole black tea compared with decaffeinated black tea (p < 
0.1). The mean values of the total amount of ILl (nmol/tissue) in extracts of SPG from rats 
following black tea consumption were as follows: water 0.57 ±0.1, decaffeinated black tea 
0.97 ±0.1 and whole black tea 1.47 ± 0.2 respectively.
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Figure 3.11 Total insulin-like immunoreactivity in rat salivary submandibular and 
parotid glands following black tea consumption {n = 4, mean ± SEM)
* p < 0.05 Whole black tea compared with water control
3.3.3.3 GIP-like immunoreactivity in salivary submandibular glands
Levels of GIP-like immunoreactivity (GLI) in extracts of salivary submandibular glands 
from rats in this experiment were below the level of sensitivity of the standard curve (10 
pmol/1, equivalent to 0.25 nmol/g wet weight).
3.3.3.4 Weights o f small intestine (SI)
The weights (g) of the small intestine (SI) (top 20 cm, duodenum) following 
consumption of water, decaffeinated black tea and whole black tea were as follows 1.12 
± 0.05, 1.04 ± 0.06 and 1.21 ± 0.05 respectively. There was no significant difference in 
the weights of SI following consumption of water, decaffeinated black tea or whole 
black tea (p = 0.12)
3.3.3.J GIP immunoreactivity in top 20 cm o f rat small intestine (SI)
The GIP in extracts of small intestine (SI) (top 20 cm, duodenum) from rats following 
black tea consumption can be seen in figure 3.12. There were no significant between 
group differences in GIP concentration (nmol/g wet weight) using non-parametric tests
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(p = 0.43). The mean concentrations of GIP (nmol/g wet weight) in the SI following black 
tea consumption were as follows; water 70 ± 8, decaffeinated black tea 72 + 7 and whole 
black tea 83 ± 4.
In contrast to the concentration, differences were found in the total GIP content of the 
SI. Total GIP content (nmoPtissue) of the SI was significantly higher following 
consumption of whole black tea compared with decaffeinated black tea (p < 0.01), there 
were no other significant differences between groups. The mean values of the total GIP 
(nmoPtissue) in rat SI following black tea consumption were as follows: water 76 ± 11, 
decaffeinated black tea 75+6 and whole black tea 99 ± 4.
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Figure 3.12 Total GIP content (nmoPtissue) in top 20 cm rat small intestine following 
black tea consumption (n = 4, mean ± SEM)
* p < 0.05 whole black tea compared to decaffeinated black tea
3.3.3.6 GLP-1 immunoreactivity in top 20 cm of rat small intestine (SI)
The GLP-1 in extracts of small intestine (SI) (top 20 cm, duodenum) from rats 
following black tea consumption can be seen in figure 3.13. There were no significant 
differences between groups in GLP-1 concentration (nmol/g wet weight) of the top 20 
cm of SI (p = 0.49). The mean concentrations of GLP-1 (nmoPg wet weight) in the SI 
following black tea consumption were as follows; water 7.7 ± 1, decaffeinated black tea
7.2 ± 1 and whole black tea 9.2 ± 2 respectively.
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There were no significant differences between groups in the total GLP-1 content 
(nmoPtissue) of the top 20 cm of SI (p = 0.33). The mean values of the total amount of 
GLP-1 (nmoPtissue) in the rat SI following black tea consumption were as follows: water
8.5 ± 1, decaffeinated black tea 7.5 ± 1 and whole black tea 11.3 ± 3 respectively.
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Figure 3.13 GLP-1 concentration (nmol/g wet weight) in top 20 cm rat small intestine 
following black tea consumption {n = 4, mean ± SEM)
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3.4 DISCUSSION
3.4.1 INVESTIGATION OF SALIVARY PEPTIDE HORMONE 
IMMUNOREACTIVITY IN SALIVARY GLANDS FROM FASTED AND FED 
RATS.
Pancreatic insulin levels were lower in the fed rats than the fasted rats. This was to be 
expected, as in the fed state, plasma glucose levels increase and insulin secretion from 
the pancreas is stimulated. Insulin is synthesised and secreted from the pancreas when 
plasma glucose levels rise above 4 mmol/1 and synthesis and secretion continues until 
plasma glucose levels return to below 4 mmol/1.
Insulin levels in SSG and SPG extracts were significantly higher in n fed rats 
compared with fasted. It has been postulated in the literature that ILI from the salivary 
glands may have an endocrine role in carbohydrate metabolism, (Deville de Perrier et 
al, 1997; Deville de Perrier et al, 1989), and that ILI from the salivary glands 
contributes to plasma insulin levels. Pancreatic insulin is secreted following glucose 
absorption, and therefore insulin levels are lower in fed animals than fasted. For the 
pattern of ILI in extracts of salivary glands from fasted and fed rats to be consistent with 
a role in carbohydrate metabolism, ILI in extracts of salivary glands would have to be 
higher in fasted animals compared with fed, although it should be noted that insulin 
levels from the salivary glands of fed rats will alter depending on the time difference 
between sampling relative to feeding. Since the experimental observations were in fact 
the opposite of those expected, it is therefore possible that the insulin in the salivary 
glands has no biological role or that it has a local or paracrine effect within the salivary 
glands.
Small intestine levels of GIP and GLP-1 were not significantly different from the fasted or 
fed rats. It was e?q)ected that the GIP and GLP-1 concentration of the small intestine 
would be lower in fed rats than in fasted rats. In the fed state GIP and GLP-I are secreted 
from the small intestine into the circulation, therefore the levels of GIP and GLP-1 would 
be lower in the small intestine of fed animals than in fasted. Plasma levels of GIP and 
would be higher in fed animals compared with lasted animals, plasma was not 
analysed in this experiment.
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There was a trend towards increasing levels of GIP-like immunoreactivity (GLI) in 
extracts of SSG from fed rats compared with those from fasted. These findings are 
supported by data from other workers. Tseng et al (1994) found GIP mRNA in ductal 
cells of rat SSG and levels of this mRNA increased after an oral glucose load. These 
investigators also described how GLI in salivary gland extracts increased by 50% after a 
glucose load (Tseng et al, 1995). These observations suggest that the GLI found in the 
salivary glands is neither involved in the metabolism of nutrients, nor contributes to 
plasma levels of the hormone. Plasma levels of GIP rise following food, and SI levels 
decrease. Therefore, for salivary gland GLI levels to be consistent with a role in nutrient 
metabolism levels of GLI from SSG extracts would have to be lower in the fed state 
than the fasted and this was not observed in this study.
Rat salivary submandibular and parotid gland weights were not significantly different 
from either fasted or fed rats. It was not expected that the weights of either gland would 
be affected as neither feeding nor fasting necessarily causes hypertrophy of the salivary 
glands.
3.4.2 RED WINE CPT STUDY
Salivary submandibular gland (SSG) weights were not significantly different in rats 
following a diet supplemented with red wine complex phenols and tannins, or treatment 
with DMH. Other workers have also demonstrated that consumption of dietary tannins 
does not cause hypertrophy of SSG (Mehansho et a l, 1983). As SSG do not secret 
proline-rich proteins (PRP) (Ferreira et a l, 1992), which are secreted into saliva and 
bind to dietary tannins (Mehansho et al, 1992) there is no reason for dietary tannins to 
induce hypertrophy of this gland:
Red wine CPT in the diet was found to have no effect on the insulin levels in rat 
submandibular glands. The animals were given the red wine tannin-rich diet for 10 
days, before injection with DMH as part of a carcinogenisis experiment. DMH is used 
to induce colon tumours in rats. Other workers have demonstrated that tannins fed to 
mice and rats caused a net loss in body mass in the first three days of ingestion, the 
subsequent gain in body mass correlated with induction of PRP synthesis (Mehansho et 
al, 1983). SSG do not secrete PRP (Ferreira et a l, 1992), and therefore it is possible
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that 10 days was not long enough for the red-wine tannins to modulate the ILI content 
within rat SSG.
Levels of GIP-like immunoreactivity (GLI) in extracts of SSG were below the level of 
sensitivity of the standard curve (10 pmol/1 equivalent to 0.25 nmol/g wet weight, see 
section 2.2.3). As the levels of GLI were below the level of sensitivity of the standard 
curve the effects of red wiue CPT consumption on the mean levels of GLI in rat SSG 
could not be compared. It is possible to conclude however, that the consumption of red 
wine CPT did not increase levels of GLI to a detectable level.
The total amount of GLP-1 was lower in the upper intestine following red wine CPT 
compared to the normal rat chow. Consumption of red wine or tannic acid with a mixed 
meal by volunteers induced a smaller increase in blood glucose levels than a meal 
consumed with the same volume of water or ethanol. This effect was insulin independent 
(Gin et a l, 1999). GLP-1 is secreted in response to the absorption of nutrients, and the 
magnitude of GLP-1 secretion is dependent on the level of nutrient absorption (Schirra et 
al, 1996). It is possible that dietary red wine CPT may increase gut transit times. If 
gut transit time were increased by red wine polyphenols then the subsequent rise in 
plasma glucose levels following food ingestion would be of a lower magnitude and 
occur over a longer period of time. Therefore GLP-1 secretion from the small 
intestine would occur over a longer period of time, and levels extracted from the small 
intestine would be lower for longer following food ingestion.
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A longer time period of exposure to the red wine complex phenols and tannins may have 
had a greater effect on the levels of peptide hormones examined. Flavonoids from red 
wine, such as catechin, have been shown to be present in human plasma following 
consumption of one or two glasses of wine (Donovan et a l, 1999). This means that some 
red wine polyphenols are absorbed by the body. Due to the collaborative nature of this 
experiment it was not possible to analyse plasma samples, it is possible that the levels of 
plasma GIF and GLP-1 may have supported the findings from the small intestine extracts.
In this experiment the animals were injected with DMH as part the protocol for a 
collaborative experiment investigating the effects of red Avine polyphenols on colon 
cancer. Although DMH was not found to have any effects, the experimental protocol 
would have been improved if the animals had not been treated with DMH or saline prior to 
sacrifice. Due to time constraints, and a lack of availability of the red wine polyphenol 
preparation it was not possible to run this experiment separately from the collaborative 
project.
3.4.3 PILOT INVESTIGATION ON THE EFFECTS OF BLACK TEA 
CONSUMPTION ON SALIVARY HORMONE SECRETION IN RAT
Salivary submandibular gland weights were not affected by consumption of either 
decaffeinated or whole black tea compared with water. The SSG does not secrete PRP 
(Ferreira et a l, 1992), and is not known to secrete any other protein that may bind to, or is 
secreted in response to, dietary tannins. Therefore no change in the weights of SSG were 
expected.
There was a trend towards increasing SPG weights following consumption of 
decaffeinated black tea compared with water, and whole black tea compared with 
decaffeinated black tea. Exposure to dietary tannins leads to an increase in the amount of 
PRP secreted from the salivary parotid gland (Mehansho et a l, 1992; Mehansho et a l, 
1996; Ferreira et a l, 1992). Other workers have observed increased SPG but not
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SSG weights following consumption of dietary tannins for three days. This increase in 
SPG weight coincided with increased levels of PRP synthesis (Mehansho et al, 1983). 
The increase in weight of SPG following consumption of black tea compared with water 
was probably due to increased synthesis of PRP, in response to ingestion of dietary 
tannins.
There was a statistically significant higher amount of ILI in extracts of SPG from rats 
following consumption of whole black tea compared with water, and a non-significant 
increase in ILI in extracts of SPG from rats following consumption of decaffeinated 
black tea compared with water. It would appear from these data that consumption of 
both black tea polyphenols and caffeine lead to an increase in ILI in extracts of rat SPG.
The pattern of increase in ILI and weight in SPG from rats following consumption of 
decaffeinated black tea and whole black tea was the same. Salivary gland hypertrophy 
following consumption of dietary tannins was coincident with the synthesis of PRP 
from that gland (Mehansho et al, 1983). It is possible that the increase in ILI in SPG 
correlates with an increase in synthesis of PRP from this gland, and therefore also that 
ILI in SPG may be involved in the synthesis of these PRP.
There was a non-statistically significant increase in ILI in extracts of SSG following 
consumption of decaffeinated black tea compared with water. Since there was no 
increase in ILI following consumption of whole black tea, the non-significant increase 
in ILI seen in the SSG following decaffeinated black tea would appear to be caused by 
black tea polyphenols, and not caffeine. The number of animals used in this study was 
small and it is possible that with a larger number of animals this effect would have been 
statistically significant.
Levels of GIP-like immunoreactivity (GLI) in the extracts of SSG were below the level 
of sensitivity of the standard curve (10 pmol/1, equivalent to 0.25 nmol/g wet weight, 
see section 2.2.3). Because of this the data were not presented and therefore no 
conclusions about the effects of black tea on GLI in SSG can be drawn from this 
experiment. It is possible to conclude however that the consumption of red wine CPT 
did not increase levels of GLI to a detectable level.
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In the small intestine the consumption of whole black tea led to an increase in the total 
amount of GIP in the tissue, compared with the decaffeinated black tea control. Since 
there was no difference in GIP levels in the SI following consumption of decaffeinated 
black tea compared with water, this effect must be due to the caffeine content of tea. 
GIP secretion occurs in response to the absorption of nutrients, and fat has been shown 
to be is a potent secretagogue for GIP (Morgan, 1996). It is possible that caffeinated 
black tea has caused a change in gut transit time and nutrient absorption, leading to this 
alteration in GIP profile within the SI.
Consumption of black tea was shown to have no effect on small intestine GLP-1 content 
of the top 20 cm portion of the SI. GLP-1 is normally most abundantly located in the 
large intestine. Due to the collaborative nature of this work, the large intestine was not 
available for analysis in this experiment. It is possible that dietary tannins would have 
effects on the colon GLP-1 different from those on the small intestine GLP-1.
From the data presented here it would appear that consumption of black tea and black 
tea polyphenols increase ILI in the salivary parotid glands. However, this experiment 
only used a small number of animals within each group, and the animals were treated 
with IQ (a pyrolysis mutagen formed in heated fresh foods to induce liver enzyme 
activity) the day before sacrifice, either or both of which might have compromised the 
results. The plasma levels of peptide hormones were not measured in this experiment. It 
was therefore decided to carry out a further experiment with a larger number of animals, 
and to investigate further the effects of caffeine on the peptide hormones in the salivary 
glands and plasma.
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3.4.4 SUMMARY AND CONCLUSIONS
ILI and GLI were detected at higher levels in extracts of rat salivary obtained from 
fasted rats compared with fed rats. Salivary gland ILI and GLI are not involved in 
glucose metabolism. The functions of ILI and GLI in the salivary glands are more likely 
to be paracrine effects within the salivary glands, or local effects in the buccal cavity.
Consumption of red wine polyphenols did not affect the weight of the SSG or ILI levels 
in extracts of SSG, or GIF levels in the small intestine. Consumption of red wine 
polyphenols increases the levels of GLP-1 in the SI. It is possible that red wine 
polyphenols may affect gut transit times.
Consumption of whole black tea causes hypertrophy of the SPG, and increased ILI 
within that gland. Black tea polyphenols may change gut transit times. A further 
experiment was conducted on the basis of these findings, please see chapter 4.
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CHAPTER FOUR 
INVESTIGATION OF THE EFFECTS OF BLACK TEA 
CONSUMPTION ON SALIVARY HORMONE 
SECRETION IN RATS
CHAPTER 4
4.1 INTRODUCTION
The pilot study (chapter 3) showed potentially important differences in insulin 
concentrations within the salivary glands as a result of black tea consumption, but the 
numbers of animals used within each group of the study were too small for unequivocal 
conclusions to be drawn. Also the study design did not allow effects of caffeine to be 
properly investigated and due to the collaborative nature of the experiment, animals had 
been exposed to the carcinogen IQ and this might have confounded the observations by 
some unknown mechanism(s). Therefore it was decided to re-investigate the effects of 
black tea on a larger number of animals and remedy all of the omissions from the pilot 
study with respect to controls.
Black tea consumption has been linked with reduced levels of plasma glucose. In a 75- 
day feeding study in year old rats, reduced plasma glucose levels were seen following 
consumption of both green and black tea (Zeyuan et al, 1998). The pattern of blood 
glucose response to a test meal in human volunteers was modulated by consumption of 
tea with the meal compared with the same volume of water (Young & Wolever, 1998). 
Although it is known that some polyphenols reduce glucose absorption through the 
jejunum (Rodriguez et al, 1982; Welsh et a l, 1989) which possibly explains the 
reduced plasma glucose levels following tea consumption, it is possible that black tea 
polyphenols also exert an effect on circulating plasma hormones of the enteroinsular 
axis.
Moreover, black tea polyphenols have been demonstrated to have effects on the salivary 
glands. Proline-rich proteins (PRP) and histidine-rich proteins (HRP) are secreted in 
saliva from the parotid gland. It has been shown that PRP and HRP bind dietary tannins 
(Mehansho et al, 1996). Isoproterenol is used to induce hypertrophy of the salivary 
glands (Marmary et al, 1994). Isoproterenol and dietary tannins both stimulate a similar 
change in gene expression in the rat parotid gland (Mehansho et a l, 1992). It is possible 
that dietary tannins such as those present in black tea may cause hypertrophy of the 
salivary glands. Black tea inhibits salivary a-amylase activity in vitro (Zhang & 
Kashket, 1998), a-amylase is secreted from the parotid gland. As dietary polyphenols 
are known to induce secretion of PRP from the parotid gland and to inhibit salivary a-
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amylase activity it is possible that black tea polyphenols may modulate the secretion of 
insulin-like and GIP-like immunoreactivity from the salivary glands.
The results of the pilot study indicated that consumption of black tea polyphenols might 
cause hypertrophy of rat SPG and increase levels of ILI in this gland. Consumption of 
whole black tea modulated levels of GIP in the small intestine.
The aims of this experiment were to confirm and extend the results of the pilot study by 
investigating the effects of chronic black tea ingestion on circulating and tissue peptide 
hormone levels in rats. This experiment was designed to determine the effects of 
caffeine and black tea polyphenols by the use of appropriate control groups. Any effects 
of black tea polyphenols were distinguishable from those of caffeine by the use of 
decaffeinated black tea and whole black tea drinking groups. As the commercial 
decaffeinated black tea used consisted of a different blend of black teas compared with 
the commercial whole black tea (and hence probably different black tea polyphenols), 
additional control was achieved by preparing decaffeinated black tea and recaffeinating 
it. A caffeine solution-drinking group was used to determine the effects of caffeine, and 
to further distinguish between any effects of black tea polyphenols and caffeine. As 
plasma was not analysed in the pilot study the effects of black tea consumption on the 
circulating hormone levels was also investigated as well as those of the small intestine.
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4.2 METHODS
4.2.1 STUDY DESIGN
Fifty male Wistar albino rats (Banton and Kingman) were divided into five groups of 
ten animals. The various black tea preparations were given in their drinking water as 
follows: control, i.e. water, whole black tea extract (2.5 % Keemun tea), decaffeinated 
black tea (2.5 % decaffeinated Ceylon tea), recaffeinated black tea (2.5 % decaffeinated 
Ceylon tea with caffeine) and caffeine (760 mg/1).
4.2.2 STUDY PROTOCOL
Food and drink were allowed ad libitum for 4 weeks (B&K Rat and Mouse expanded 
diet). Animals were tail-marked for identification, and maintained on a 12 h night/day 
cycle for the duration of the study. Body weights were measured on day one and then 
weekly until the day of termination. Fresh drinking fluid was given to the animals daily, 
and daily consumption was monitored.
Black tea extracts were prepared by brewing a 2.5 % (w/v) infusion for 10 min in 
freshly boiled water, and then by filtering through cotton wool to remove the tea leaves. 
Black tea extracts were prepared on the evening before use and stored overnight at 4 °C. 
The caffeine solution was prepared by adding boiling water to preweighed caffeine 
powder (760 mg/1). Recaffeinated tea was prepared by brewing the tea in a 760 mg/1 
caffeine solution made up in freshly boiled water.
Animals were sacrificed, after an overnight fast, on day 28 by cardiac puncture and the 
salivary glands and small intestine were removed, washed in saline and frozen to -80 
°C. Tissue samples were then stored at -20 °C until extraction. Tissue samples were 
extracted using an acid-ethanol extraction (section 2.3.2.2) aliquoted in to 3 ml 
disposable tubes (section 2.1) and frozen to -20 °C until required.
Rat blood was stored on ice until centrifuged (1825 x g) for 10 min, the plasma was 
separated and aliquoted into 3 ml tubes and frozen at -20 °C until analysis.
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4.2.3 SAMPLE ANALYSIS
Plasma samples were analysed by radioimmunoassay for GIF, GLP-1 and insulin 
(sections 2.2.2, 2.2.4 and 2.2.7). Plasma glucose levels were determined using an 
automated enzymatic analyser (section 2.2.11). Analysis of insulin-like and GIP-like 
immunoreactivity and GLP-1 in tissue extracts were by RIA techniques (sections 2.2.3,
2.2.5 and 2.2.8).
4.2.4 STATISTICAL ANALYSIS
Data are expressed in the text as mean ± standard error of the mean (SEM). Statistical 
analysis was carried out using a statistical package (Graph Pad Instat, graph pad 
software, San Diego, California, USA). Data were compared with the Kolmogorov- 
Smimov test for normal distribution and transformed if necessary. One-way analysis of 
variance (ANOVA) was used to assess variation between groups. The Tukey-Kramer 
multiple comparisons test was used to compare differences between groups when ANOVA 
gave values p  < 0.05. Unless otherwise stated in the text, parametric statistical tests were 
employed for analysis of data.
Where data could not be transformed to comply with a normal distribution, analysis of 
variance (ANOVA) was tested using ICruskal-Wallis non-parametric tests, when p < 
0.05 post hoc analysis was carried out using Dunns comparison of the difference in the 
sum of ranks between two columns and the expected average difference.
Values oip<  0.05 were considered significant.
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4.3 RESULTS
4.3.1 RAT BODYWEIGHT GAIN
The initial and final bodyweights of the animals following black tea consumption are 
shown in figure 4.1. The average weight gain (%) over 28 days following consumption 
of water, decaffeinated black tea, whole black tea, recaffeinated black tea and caffeine 
solution were 124 ± 3, 123 ± 6.1, 112 ± 5.0, 84 ± 3.2, 86 ± 2.8 respectively. There were 
significant differences in the percentage weight gain between groups over the 28 days 
ip = 0.0002). Between group comparisons found a significant reduction in weight gain 
following consumption of recaffeinated black tea compared with water and 
decaffeinated black tea {p < 0.05 and 0.001 respectively), and a significant decrease in 
bodyweight gain following consumption of caffeine solution compared with 
decaffeinated black tea {p < 0.001).
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Figure 4.1 Rat bodyweight (g) prior to and following consumption of water, black tea or 
caffeine solution (77 =10, mean ± SEM)
* p < 0.05 Reduced weight gain following consumption of recaffeinated black tea 
compared with water
** p < 0.01 Reduced weight gain following consumption of recaffeinated black tea and 
caffeine solution compared with decaffeinated black tea
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4.3.2 WEIGHTS OF SALIVARY GLANDS
The weights of salivary submandibular glands (SSG) at termination following black tea 
consumption are shown in figure 4.2. There were no significant differences between the 
weights of SSG following consumption of any of the beverages {p = 0.16).
The weights of salivary parotid glands (SPG) following black tea as drinking water are 
also shown in figure 4.2. There were no significant differences between the weights of 
SPG following any of the beverages {p = 0.15).
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Figure 4.2 Weights of rat salivary glands following black tea as drinking water {n= 10, 
mean ± SEM)
14
CHAPTER 4
4.3.3 PLASMA HORMONE AND METABOLITE CONCENTRATIONS
Circulating insulin levels from rats following consumption of water, decaffeinated, whole 
and recaffeinated black tea, and caffeine are shown in figure 4.3. There was a non­
significant decrease in plasma insulin levels following the consumption of decaffeinated 
black tea compared with the water control (p < 0.1). There were no significant differences 
in plasma insulin levels following consumption of any of the beverages ip = 0.13).
Circulating GIF levels from rats following consumption of water, decaffeinated, whole and 
recaffeinated black tea, and caffeine are shown in figure 4.4. There were no significant 
differences in plasma GIF levels following consumption of any of the beverages 
0? = 0.28).
Circulating GLP-1 levels from rats following consumption of water, decaffeinated, whole 
and recaffeinated black tea, and caffeine are shown in figure 4.5. There were no significant 
differences in plasma GLP-1 levels following consumption of any of the beverages 
ip = 0.82).
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Figure 4.3 Plasma insulin concentration (pmol/1) in rats following consumption of 
water, black tea or caffeine solution (77 =10, mean ± SEM)
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Figure 4.4 Plasma GIP concentration (pmol/1) in rats following consumption of water, 
black tea or caffeine solution (t? =10, mean ± SEM)
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Figure 4.5 Plasma GLP-1 concentration (pmol/1) in rats following consumption of 
water, black tea or caffeine solution (77 =10, mean ± SEM)
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Circulating glucose levels from rats following consumption of water, decaffeinated, whole 
and recaffeinated black tea, and caffeine solution are shown in figure 4.6. Plasma glucose 
values varied significantly following consumption of water, decaffeinated, whole and 
recaffeinated black tea and caffeine solution {p = 0.02). There were significantly higher 
glucose levels following consumption of decaffeinated black tea compared with the 
whole black tea, recaffeinated black tea and caffeine {p < 0.05, 0.05 and 0.01 
respectively). Plasma glucose levels were higher following consumption of water 
compared with whole black tea, recaffeinated black tea and water (not significant).
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Figure 4.6. Plasma glucose values (mmol/1) from rats following consumption of water, 
black tea or caffeine solution (77 =10, mean ± SEM)
* p < 0.05 Lower plasma glucose levels following consumption of whole and 
recaffeinated black tea compared with decaffeinated black tea
** p < 0.01 Lower plasma glucose levels following consumption of caffeine solution 
compared with decaffeinated black tea
17
CHAPTER 4
4.3.3 SALIVARY GLAND IMMUNOREACTIVITY
4.2.3.1 Insulin-like immunoreactivity in salivary submandibular glands 
Insulin-like immunoreactivity (ILI) concentrations in extracts of the salivary 
submandibular gland (SSG) from rats following consumption of water, decaffeinated, 
whole and recaffeinated black tea and caffeine solution are shown in figure 4.7. The mean 
total amounts of ILI (nmol/gland) in rat SSG following consumption of water, 
decaffeinated, whole and recaffeinated black tea and caffeine were 0.44 ±0.1, 0.36 ±0.1, 
0.28 ±0.1, 0.22 ±0.1, 0.36 ± 0.1 respectively. There was a non-significant decrease in 
ILI levels in rat SSG following consumption of recaffeinated black tea and caffeine 
compared with water when data is expressed either as the total ILI content of the SSG 
or per gram wet weight (p = 0.13 and 0.1 respectively).
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Figure 4.7. ILI concentration (nmol/g wet weight) in rat salivary submandibular glands 
extracts following consumption of water, black tea or caffeine solution (77 =10, mean ± 
SEVO
4.3.3.2 GIP-like immunoreactivity in salivary submandibular glands 
GIP-like immunoreactivity (ILl) in extracts of the salivary submandibular gland (SSG) 
from rats following consumption of water, decaffeinated, whole and recaffeinated black 
tea and caffeine solution are shown in figure 4.8. A similar pattern was observed when
CHAPTER 4
GLI was expressed as a concentration (nmol/g wet weight). The mean concentration of 
GLI (nmol/g wet weight) in rat SSG following consumption of water, decaffeinated, whole 
and recaffeinated black tea and caffeine solution were 12.5 ± 0.55, 12.2 ± 0.31, 14.3 ± 
0.58, 14.4 ± 0.85, 14.7 ± 0.41 respectively. Total GIP-like immunoreactivity (GLI) 
content (nmol/tissue) and concentration (nmol/g wet weight) of the SSG varied 
significantly between the groups {p = 0.017) as judged using non-parametric tests. 
There was significantly more GLI following consumption of the caffeine solution 
compared with the water control {p = 0.0001) and the decaffeinated black tea (p = 
0.029). There was a trend towards higher amounts of GLI following consumption of the 
recaffeinated black tea compared with the water control and the decaffeinated black tea 
(p = 0.063 and 0.089 respectively).
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Figure 4.8 Total GIP-like immunoreactivity content (nmol) of rat salivary 
submandibular glands following consumption of water, black tea or caffeine solution {n 
=10, mean ± SEM)
* p < 0.05 Lower GLI in extracts of rat SSG following consumption of decaffeinated 
black tea compared with caffeine solution
** p < 0.01 Higher GLI in extracts of rat SSG following consumption of caffeine 
solution compared with water
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4.3.3.3 Insulin-like immunoreactivity in salivary parotid glands
Insulin-like immunoreactivity (ILI) concentration in extracts of the salivary parotid glands 
(SPG) from rats following consumption of water, decaffeinated, whole and recaffeinated 
black tea, and caffeine solution are shown in figure 4.9. A similar pattern was observed 
when ILI was expressed as a concentration (nmol/g wet weight). The total ILI 
(nmol/gland) in rat SPG following consumption of water, decaffeinated, whole and 
recaffeinated black tea and caffeine solution were 0.37 ± 0.03, 0.29 ± 0.03, 0.30 ± 0.04, 
0.34 ± 0.03, 0.39 ± 0.04 respectively. Total ILI content (nmol/gland) of the SPG did not 
vary significantly between the groups ip ^ 0.184). Mean ILI concentration of SPG 
varied significantly between groups ip = 0.0037), between group comparisons of means 
found significantly higher concentrations of ILI in SPG following consumption of a 
caffeine solution compared with decaffeinated black tea and whole black tea (p < 0.01 
and 0.05 respectively).
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Figure 4.9. Insulin-like immunoreactivity concentration (nmol/g wet weight) of rat 
salivary parotid glands extracts following consumption of water, black tea or caffeine 
solution (« =^ 10, mean ± SEM)
* p < 0.05 lower concentration of ILI in extracts of rat SPG following consumption of 
whole black tea compared with caffeine solution
** p < 0.01 lower concentration of ILI in extracts of rat SPG following consumption of 
decaffeinated black tea compared with caffeine solution
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4.3.4 SMALL INTESTINE
4.3.4.1 GIP in extracts from top 20 cm portion o f small intestine
GIP levels in extracts of the top 20 cm of small intestine (duodenum) from rats following 
consumption of water, decaffeinated, whole and recaffeinated black tea and caffeine 
solution are shown in figure 4.10. The total GIF (nmol/tissue) in rat small intestine 
(duodenum) following consumption of water, decaffeinated, whole and recaffeinated black 
tea and caffeine solution were 77.9 ± 6.3, 78.8 ± 7.4, 131 ± 16, 200 ± 31, 158 ± 14 
respectively.
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Figure 4.10 GIF concentration (nmol/g wet weight) of rat small intestine (duodenum)
following consumption of water, black tea or caffeine solution {n = 6, mean ± SEM)
* p < 0.05 higher concentration GIF in extracts of rat SI following consumption of 
whole black tea compared with water or decaffeinated black tea
** /) < 0.01 higher concentration of GIF in extracts of rat SI following consumption of 
recaffeinated black tea and caffeine compared with decaffeinated black tea and water
The GIF concentration (nmol/g wet weight) from extracts of the top 20 cm of the small 
intestine was significantly higher following consumption of whole black tea, 
recaffeinated black tea and caffeine solution compared with water {p < 0.05, 0.001 and 
0.001 respectively) and the decaffeinated black tea {p < 0.05, 0.001 and 0.001 
respectively). Total GIF content (nmol/tissue) of the top 20 cm of the small intestine
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was significantly higher following consumption of recaffeinated black tea and caffeine 
solution compared with water (p < 0.01 and p < 0.05 respectively) and the decaffeinated 
black tea (p < 0.01 and p < 0.05 respectively).
4.3.4.2 GIP in extracts from rat small intestine
GIF levels in extracts of the whole small intestine from rats following consumption of 
water, decaffeinated, whole and recaffeinated black tea, and caffeine solution are shown in 
figure 4.11. There were no significant differences following consumption of the water, 
decaffeinated, whole and recaffeinated black tea and caffeine solution in total GIF content 
(nmol/tissue) of the whole small intestine (p = 0.17) using non-parametric tests.
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Figure 4.11. Total GIF content (nmol/tissue) of rat small intestine (whole) following 
consumption of water, black tea or caffeine solution {n = 6, mean ± SEM)
4.3.4.3 GLP-I in extracts from rat small intestine
GLF-1 levels in extracts of the whole small intestine from rats following consumption of 
water, decaffeinated, whole and recaffeinated black tea and caffeine solution are shown in 
figure 4.12. There were no significant differences seen following consumption of water, 
decaffeinated, whole and recaffeinated black tea and caffeine solution with either the total
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GLP-1 content (nmol/tissue) or the GLP-1 concentration (nmol/g wet weight) of the rat 
small intestine 
(p = 0.84).
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Figure 4.12. Total GLP-1 content (nmol/tissue) of rat small intestine (whole) following 
consumption of water, black tea or caffeine solution {n = 6, mean ± SEM)
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4.4 DISCUSSION
Approximately 84 % of the total antioxidant activity of tea are solubilised within a five- 
minute brew (Prior & Gao, 1999); although it has been estimated that the average brew 
time for a mug of tea is 30 seconds. To gain the maximal amount of tea polyphenols 
into solution, whilst also being reasonably representative of human consumption, a ten- 
minute brew was used in this experiment.
4.4.1 SALIVARY GLAND IMMUNOREACTIVITY
Consumption of black tea and caffeine had no significant effect on insulin-like 
immunoreactivity (ILI) in SSG. There was a non-significant decrease in ILI following 
consumption of caffeinated black teas and caffeine solution. It would appear from these 
data that the presence of caffeine in black tea led to reduced levels of ILI in the SSG 
compared with the water control, although this was not statistically significant. These 
data are not consistent with the results from the pilot study described in section 3.3.3.
In the pilot study there was a trend (p < 0.1) towards increased amounts of ILI in the 
SSG following decaffeinated black tea as drinking water. It was thought that the greater 
statistical power associated with a larger number of animals might have allowed the 
detection of a statistically significant difference. The ILI concentrations in extracts of 
SSG from the water control groups were not significantly different (0.64 ±0.1 and 1.0 ± 
0.5 pilot) in the two experiments. It must be concluded therefore that the differences 
seen between the two experiments are due to the slight differences in protocol, namely 
the administration by gavage of the carcinogen IQ in the pilot study and the method of 
termination.
Levels of ILI in extracts of SPG were significantly higher following consumption of 
caffeine compared with decaffeinated and whole black tea. There was a non-statistically 
significant decrease in ILI in extracts of SPG following decaffeinated, whole and 
recaffeinated black tea compared with water. It would appear therefore that the decrease 
in ILl in extracts of SPG was mediated by the polyphenolic content of the black tea and 
not caffeine, as consumption of caffeine solution lead to higher levels of ILl compared
124
CHAPTER 4
with water control and black tea. These differences were not statistically significant and 
therefore need to be interpreted with caution.
In the pilot study ILI in extracts of SPG was significantly higher following consumption 
of whole black tea compared with water (section 3.3.3.2). With a larger group of 
animals there was no significant difference between the water control group and the 
caffeine group, but the caffeine group had significantly higher total ILI in the SPG 
compared with the decaffeinated black tea and the whole black tea. The results from the 
pilot study suggested that caffeinated black tea increased ILI in extracts of SPG. With a 
larger group of animals the results suggest that any increases seen in the pilot 
experiment were due to the caffeine content of the tea.
It would appear from these data presented in this experiment that the differences seen in 
ILl of the salivary glands from the pilot study (section 3.3.3.1) were a result of the 
interindividual differences between a small number of animals, rather than a true effect 
of decaffeinated black tea and whole black tea consumption. There were differences in 
experimental protocol between the two experiments. In the pilot study the animals were 
housed in metabolic cages following injection with the carcinogen IQ. In the pilot study 
the animals were sacrificed by CO2 compared with cardiac puncture in this experiment.
It is also possible that these slight differences in protocol led to the differences in 
findings.
The presence of caffeine in the drinking water was found to increase the amount of GIP- 
like immunoreactivity (GLI) in the extracts of SSG compared with the water control 
group and the decaffeinated black tea group. One of the known functions of small 
intestinal GIP is the inhibition of gastric acid secretion; this is discussed as a possible 
function for GLI in saliva in chapter 5. If GIP in the salivary glands were involved with 
inhibition of gastric acid secretion, then GLI would be secreted from SSG in the 
absence of food. In this experiment food was withdrawn from the animals 17 hours 
prior to termination, therefore GLI would be secreted from storage granules within the 
salivary glands to aid in the inhibition of gastric acid secretion. If caffeine consumption 
causes increased amounts of GLI in the salivary glands, then it is possible that caffeine 
consumption reduced the amount of GIP secreted from the SSG, and therefore less 
potent inhibition of gastric acid secretion. This is supported by the known stimulation of
125
CHAPTER 4
pentagastrin stimulated gastric acid secretion by caffeine and caffeinated drinks (Cohan 
et al, 1971; McArthur et al, 1982). These data are consistent with the hypothesis that 
salivary gland and saliva GLI are involved in the inhibition of gastric acid secretion.
Since there was no significant difference between the water and the decaffeinated black 
tea drinking groups it would appear that black tea polyphenols have no effect on the 
levels of GLI in SSG.
4.4.2 BODY WEIGHT GAIN AND SALIVARY GLAND WEIGHTS
To investigate the effects of black tea consumption on body weight gain the rats were 
weighed prior to the start of the experiment and before termination. There was a 
reduction in body weight gain following consumption of recaffeinated black tea 
compared with water and decaffeinated black tea, and following caffeine consumption 
compared with caffeine solution. A similar reduction in body weight gain was seen in 
rats given black tea extract (30 g/kg feed) for 14 days, compared with rats fed a control 
diet (Sugiyama et al, 1999). These workers also supplemented diets with different 
fractions obtained from green tea, and found that fractions containing 87 % caffeine 
caused a significant reduction in body weight gain, whereas a fraction containing 83 % 
catechins caused no reduction in weight gain. These findings suggest that caffeine may 
lead to a failure to thrive, and hence reduced weight gain.
Administration of isoproterenol and various types of large mass polyphenols 
(condensed and hydrolysable tannins) leads to hypertrophy of the salivary glands 
(Marmary et al, 1994). It was therefore hypothesised that consumption of black tea 
polyphenols might induce hypertrophy of the salivary glands in this study. To assess 
this possibility the weights of the individual glands were determined. Habitual 
consumption of dietary condensed and hydrolysable tannins leads to increased amounts 
of salivary proline-rich proteins (PRP) produced in saliva (Mehansho et al, 1992). PRP 
are mainly produced in the salivary parotid gland (Muenzer et a l, 1996) and black tea 
polyphenols bind to PRP (Clifford et al, 1996). However, the consumption of black tea 
and caffeine solution did not significantly increase the weights of either the SSG or SPG 
compared with the water control, indicating that black tea polyphenols do not behave 
the same as condensed and hydrolysable tannins. In this regard, although black tea
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polyphenols are frequently referred to as tannins, these substances are chemically 
distinct.
4.4.3 PLASMA HORMONE AND METABOLITE CONCENTRATIONS
Plasma glucose levels were lower following consumption of whole and recaffeinated 
black tea and caffeine solution compared with decaffeinated black tea. Since there were 
no differences between glucose levels following consumption of decaffeinated black tea 
compared with water, this would appear to be due to the consumption of caffeine rather 
than black tea polyphenols. The consumption of decaffeinated black tea, whole black 
tea, recaffeinated black tea and caffeine as drinking water had no effect on insulin, GIP 
or GLP-1 levels in plasma. The experiment showed no effects on the plasma peptide 
hormone levels attributable to caffeine.
Similar reductions in plasma glucose following caffeinated tea have been reported. 
Black tea decreased blood glucose by 22 % in a 75 day feeding experiment where rats 
were fed black tea extract or water, this effect was not dose dependent (Zeyuan et a l , 
1998). These workers did not use a control group consuming caffeine solution, therefore 
it is not possible to ascertain whether the reduction in plasma glucose was caused by the 
tea polyphenols or the caffeine content of the teas. In vivo experiments have indicated 
that dietary phenolic compounds inhibit the intestinal transport of sugar by interactions 
with the sodium transporter (Rodriguez et al, 1982; Welsh et al, 1989). Cinnamates are 
transported into intestinal mucosa by Na"^  dependent pathway (Wolffram et a l, 1995).
Tea extract inhibited mucosal uptake of glucose and sodium in rats in vivo and inhibited 
activity of isolated Na R^- ATPase in vitro (Kreydiyyeh et al, 1994). However, our 
results suggest that the reduced plasma glucose levels seen in this experiment were 
caused by caffeine and not black tea polyphenols.
Although differences were seen in plasma glucose levels following consumption of 
black tea and caffeine solution compared with water and decaffeinated black tea, it has 
to be noted that the levels of plasma glucose seen in the control rats and the 
decaffeinated black tea group were higher than would normally be expected. Normal 
values for plasma glucose range between 4 and 6 mmol/1 in plasma. Values reported in 
the literature have been at the same level as reported in this experiment. Plasma glucose
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levels were reported at 8.6 ± 0.4 mmol/1 in 3.5 month old rats, and 10.6 ± 0.3 mmol/1 in 
11 month old rats (Deville de Perrier et a l, 1992) and 8.7 mmol/1 in young adults 
(Sugiyama e/ûf/., 1999).
4.4.4 SMALL INTESTINE
In the pilot black tea study (section 3.3.3.4) a significant increase in the total GIP 
content of the top 20 cm of the SI was found following consumption of whole black tea. 
These data are supported by the findings of this experiment where consumption of the 
caffeinated drinks led to an increase in levels of GIP in this portion of the SI.
There was an increased amount of GIP in the top 20 cm of the small intestine following 
consumption of recaffeinated black tea and caffeine solution compared with water and 
decaffeinated black tea. This increase was found for both the concentration and total 
amount of GIP in this portion of the SI. This would appear to be a caffeine effect rather 
than a black tea polyphenol effect since there were no statistically significant 
differences between the water and the decaffeinated black tea drinking groups. GIP 
secreting cells are mainly located in the top 20 cm of the small intestine (SI) (duodenum 
and upper jejunum). Since GIP is present in storage granules within cells during the 
fasted state but released following food (Tseng et a l, 1994), it is expected to see higher 
amounts of GIP in the SI of fasted rats compared with the SI of fed rats. It is possible 
that as most glucose is absorbed through the top 20 cm of the small intestine, and lower 
levels of plasma glucose were seen following consumption of the caffeinated drinks that 
caffeine acts on the top 20 cm portion of the small intestine. If the rate absorption of 
nutrients were reduced in the duodenum, then the release of GIP from the duodenum 
would also be reduced leading to higher levels of GIP in the fasted state. It would 
appear that the consumption of caffeine might alter gut transit time.
The consumption of decaffeinated black tea, whole black tea, recaffeinated black tea 
and caffeine solution had no effect on GLP-1 levels in rat small intestine. No significant 
differences were seen in the data from the pilot black tea study where only the top 20 
cm of the SI were analysed. It would appear from these pooled data that black tea and 
caffeine consumption have no effect on GLP-1 in SI.
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Overall effects seen in this study indicate that caffeine has a greater effects on the 
hormones insulin, GIF and GLP-1 than black tea polyphenols. The significant effects 
found in this experiment have occurred between the caffeinated and the non-caffeinated 
drinks. For instance decreased plasma glucose in the caffeine consuming groups 
compared to non-caffeinated increased GIP in the duodenum following consumption of 
caffeinated drinks compared to non-caffeinated.
There were differences found between the results of the pilot study and the study 
presented in this chapter. These differences were primarily in the insulin-like 
immunoreactivity of the salivary glands and not the small intestine. It is possible that as 
the same effect was seen in the SI in the two experiments that the differences could be 
due to the experimental protocol from the pilot study. It is possible that the treatment by 
gavage of the animals in the pilot study caused stress and therefore affected the ILI of 
the salivary glands.
It was expected that consumption of whole black tea and recaffeinated black tea would 
produce the same effects. In most cases consumption of recaffeinated black tea 
produced results, which were similar to those following consumption of caffeine 
solution, and there were differences between the effects of whole black tea and 
recaffeinated black tea consumption. The level of caffeine was the same in the 
recaffeinated black tea and caffeine solution. It is probable that there was a higher 
amount of caffeine in the recaffeinated black tea group than in the whole black tea 
group. Unfortunately the caffeine levels in the whole black tea group were not checked 
following the initial estimation of the amount of caffeine present in the whole black tea 
brewed by this protocol so it is impossible to verify if this is true.
4.4.5 SUMMARY AND CONCLUSIONS
This experiment has demonstrated that the consumption of the caffeine-containing 
solutions by rats may lead to a failure to thrive. Caffeine caused a reduction in plasma 
glucose levels and reduced body weight gain that was independent of black tea 
polyphenols. Consumption of black tea polyphenols or caffeine did not alter circulating 
levels of GIP, GLP-1 or insulin in a statistically significantly manner.
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Consumption of black tea polyphenols and caffeine did not significantly affect salivary 
gland weights. Caffeine consumption increased the levels of ILI and GLI in the SPG 
and SSG respectively. Black tea polyphenols did not affect salivary gland ILI or GLI. 
Consumption of neither black tea polyphenols nor caffeine had any effect on whole 
small intestine levels of GIP or GLP-1, but caffeine consumption increased levels of 
GIP in the duodenum and upper jejunum.
In conclusion the differences between the pilot study and this study were probably due 
to the differences in experimental protocol and also the greater statistical power 
afforded by the larger numbers of animals used in this study. The experiment has 
demonstrated that consumption of black tea polyphenols does not affect circulating or 
tissue levels of insulin, GIP or GLP-1 in rats. In contrast, caffeine consumption leads to 
reduced body weight in rats, and has effects on plasma glucose and tissue levels of GIP 
and insulin. The consequences of these effects in rats if they were to occur in humans 
are speculative and need clarification by further investigation. It is possible that 
consumption of caffeine may increase gut transit time.
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CHAPTER FIVE 
INVESTIGATION OF SALIVARY HORMONE 
SECRETION FOLLOWING FOOD INTAKE AND SHAM
FEEDING IN MAN
CHAPTERS
5.1 INTRODUCTION
The peptide hormones insulin, glucose-dependent insulinotropic polypeptide (GIF) and 
immunoreactive glucagon-like material have been reported in rat salivary glands 
(Taouis et a l, 1995; Tseng et al, 1995; Perez-Castillo & Blâzquez, 1980). Initial work 
using radioimmunoassays (RIA) confirmed the presence of insulin-like and GIF-like 
immunoreactivity in human saliva (section 2.3). GIF potentiates insulin secretion 
(Morgan et al, 1988). If secreted into saliva these hormones may have paracrine effects 
in the mouth and/or endocrine effects on the stomach and small intestine.
Not a single reference has been made to the presence of insulin precursors or C-peptide 
in salivary glands or saliva. There are however reports of the absence of insulin 
precursors in the salivary glands. The presence of mature preproinsulin RNA species 
was absent from the SSG of rats (Cooper & Clarke, 1985) and using column 
chromatography of extracts from rat and human SFG no peak corresponding to 
proinsulin was found (Murakami et al, 1982). Froinsulin is cleaved to produce 
equimolar amounts of C-peptide and insulin, it is therefore possible that C-peptide 
would be present in human saliva in equimolar amounts. This was investigated within 
this chapter.
The physical presence of food in the mouth may stimulate hormone secretion from the 
salivary glands. Reproducible cephalic phase insulin responses have been shown in both 
obese and non-obese male human volunteers (Teff et a l, 1993). A cephalic phase 
response to food can lead to an increase in salivation to a significant extent in normal 
weight human subjects (Teff et al, 1993), but will not always occur in obese subjects 
(Karhunen, 1997). It is therefore possible that salivary hormone secretion into saliva 
could be modulated by the physical action of mastication of food in the mouth and not 
by the ingestion of food into the stomach.
Sham feeding of an oral fat load (full fat cream cheese and crackers) following 
ingestion of oil in capsules has been shown to increase plasma TAG compared with the 
sham feeding of non-fat cream cheese and crackers and full fat cream cheese and 
crackers on their own (Mattes, 1996). This suggests that oral exposure to dietary fat can
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influence postprandial lipid metabolism. Sham feeding during intragastric 
administration of glucose led to 33% lower levels of plasma glucose compared with 
intragastric administration of glucose without sham feeding (Teff & Engleman, 1996). 
This indicates that oral stimulation influences both the rate and extent of glucose 
homeostasis. The mechanisms for this are not known but if the physical presence of 
food in the mouth were to modulate the secretion of the hormones involved in the 
enteroinsular axis then this may explain this effect.
The aims of this experiment were twofold. Firstly the experiment was designed to 
investigate the plasma and saliva peptide hormone and metabolite response to a mixed 
meal, to see if the saliva peptide hormone immunoreactive response matches that of the 
circulating peptide hormones. Secondly the experiment was designed to examine the 
plasma and saliva peptide hormone and metabolite response to a sham fed meal to 
determine whether the physical presence of food in the mouth stimulated the-secretion 
of these hormones, or modulated the levels of postprandial metabolites.
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S.2 METHODS
5.2.1 STUDY DESIGN
This was a random within-subject crossover comparison of hormone concentrations in 
saliva and plasma when either chewing and swallowing a mixed meal or when the meal 
was chewed and expectorated (sham feeding). GIF and insulin were measured in both 
blood and saliva samples taken at identical time points before and at intervals after each 
meal.
5.2.2 SUBJECTS
Twelve subjects were investigated, six men and six women. Subjects had a BMI 
between 21 and 28, and were aged between 21 and 35. Subjects attended the clinical 
investigation unit on two occasions. Subjects were excluded if they had significant 
current or previous medical history, were receiving regular medication apart from oral 
contraceptives, which may affect gastrointestinal or central nervous systems, consumed 
more than 20 units of alcohol, or smoked. Subjects were provided with an information 
sheet and gave written consent to participate in this study. They were interviewed and a 
venous blood sample was taken for haematological screening (Full Blood Count). Their 
GF was informed of the study. The University of Surrey Ethics Committee approved the 
study protocol.
5.2.3 STUDY PROTOCOL
Two test meals separated by at least seven days were given to the subjects in a 
randomised study. The meal (total energy content 1708 kJ, containing 40 % total energy 
as carbohydrate, 40 % as fat and 20 % as protein) consisted of cream cheese and 
crackers, and a 200 ml glass of sugar-free orange squash. Subjects refrained from 
consuming alcohol for 24 h prior to the study days, and fasted overnight prior to each 
study day.
On arrival at the Clinical Investigation Unit at the University of Surrey at 0800h on each
study day, a cannula was placed into an antecubital vein, under local anaesthetic if
preferred by the volunteer, by a qualified doctor or nurse. Basal venous blood and saliva
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samples (14 ml and 2 ml respectively) were then taken simultaneously. This was 
repeated after 15 minutes, immediately before the meal was given.
After the second basal samples were taken each subject was asked to consume their 
meal. On one occasion, in random order, the meal was chewed and swallowed or it was 
chewed and expectorated (sham fed). A period of 15 minutes was allowed for the meal 
to be consumed or sham fed, before the first postprandial samples of blood and saliva 
were taken. Samples were then taken every fifteen minutes up to 60 minutes 
postprandially and a final sample was taken at 90 minutes.
5.2.4 SAMPLE ANALYSIS
Plasma was separated immediately by centrifugation at 1825 x g for 10 minutes with 
suitable preservatives (see section 2.2.14) and stored at -20 °C until analysis. Plasma 
samples were analysed by RIA for the measurement of GIF, GLF-1 and insulin (see 
sections 2.2.2, 2.2.4 and 2.2.7) and by automated enzymatic methods for TAG, NEFA 
and glucose (see sections 2.2.11, 2.2.12 and 2.2.13).
Saliva was centrifuged (10 minutes at 1825 x g) to remove all particulate matter and 
stored at -20 °C. Saliva samples were analysed by RIA for the measurement of GIF and 
insulin (see sections 2.2.3 and 2.2.8). Saliva total protein and amylase activity were 
analysed by automated enzymatic methods (see sections 2.2.9 and 2.2.10).
5.2.5 STATISTICAL ANALYSIS
Data are expressed in the text as mean ± standard error of the mean. Statistical analysis 
was achieved using the Statistica for Windows statistical software package (StatSoft Inc, 
2300 East 14^*^ St, Tulsa OK 74104, USA). Data were compared with the Kolmogorov- 
Smimov test and transformed if necessary. Comparison between the meals was performed 
by repeated measures analysis of variance (RM-ANOVA) with time and treatment as 
within-subject factors. Significant differences were located using Duncans multiple range 
test of critical ranges for multiple corrections.
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Total and incremental areas under the curve were calculated by the trapezoidal rule. One 
way-analysis of variance (ANOVA) with treatment as the within-subject factor was used 
to determine significant differences between the total and incremental area under the curve 
following the meals.
Values ofp< 0.05 were considered significant.
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5.3 RESULTS
5.3.1 PLASMA PEPTIDE HORMONE RESPONSE
5.3.1.1 Circulating insulin following a mixed meal and sham feeding
The change over time in circulating insulin levels following the swallowed and the 
sham fed meals can be seen in figure 5.1. Basal circulating insulin levels were 41.1 ± 11 
pmol/1 and achieved peak values 45 minutes following the swallowed meal at 308 ± 89 
pmol/1 {p = 0.002), they fell to 117 ± 34 pmol/1 90 min after the swallowed meal. The 
baseline values did not differ between treatments. Circulating mean insulin levels rose 
from 38.2 ± 11 pmol/1 to 70.8 ± 20 pmol/1, 45 min following the sham fed meal, this 
increase was not significant {p = 0.24). Ninety minutes after the sham fed meal levels 
fell to 42.3 ± 12.2 pmol/1. Circulating insulin values were significantly higher following 
the swallowed compared with the sham fed meal with respect to time x treatment {p = 
0.004). The total response (total area under the curve, TAUC) for plasma insulin to the 
swallowed meal was 312 ± 8.1 pmol/1 x h, and 82.6 ± 1.7 pmol/1 x h for the sham fed 
meal. The TAUC was significantly higher following the swallowed meal compared with 
the sham fed meal (p = 0.009).
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Figure 5.1. Plasma insulin concentration (pmol/1) in volunteers following a swallowed 
and sham fed mixed meal {n= 12, mean ± SEM)
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S. 3.1.2 Circulating GIP following a mixed meal and sham feeding 
The change over time in circulating GIF levels following the swallowed and the sham 
fed meals can be seen in figure 5.2. Basal circulating GIF levels were 13.0 ± 0.1 pmol/1, 
mean levels increased to a maximum 45 minutes following the swallowed meal at 268 ± 
66 pmol/1 {p = 0.003). Circulating GIF levels were 184 ± 25 pmol/1 90 min after the 
swallowed meal. The mean baseline values did not differ between treatments. 
Circulating mean basal GIF levels were 13 ± 0.1 pmol/1 and were 13.0 ± 0 pmol/1 45 
minutes following the sham fed meal. Circulating mean GIF levels did not increase 
following the sham fed meal (p = 0.99).
Circulating GIF levels were significantly higher following the swallowed compared 
with the sham fed meal with respect to time x treatment {p = 0.04). The total response 
(TAUC) for plasma GIF to the swallowed meal was 237 ± 25 pmol/1 x h, and 19.8 ± 0.4 
pmol/1 X h for the sham fed meal. The TAUC was significantly higher following the 
swallowed meal compared with the sham fed meal {p < 0.001)
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Figure 5.2. Flasma GIF concentration (pmol/1) in volunteers following a swallowed and 
sham fed mixed meal {n^  12, mean ± SEM)
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5.5.1.3 Circulating GLP-1 following a mixed meal and sham feeding 
The change over time in circulating GLP-1 levels following the swallowed and the 
sham fed meal can be seen in figure 5.3. Basal circulating GLP-1 levels were 8.6 ± 2.2 
pmol/1, and achieved mean peak values 30 min following the swallowed meal at 29.3 ±
4.2 pmol/1 ip = 0.003). Circulating GLP-1 levels were 19.7 ± 2.2 pmol/1 90 min after the 
swallowed meal. The mean baseline values did not differ between treatments. 
Circulating GLP-1 levels did not increase following the sham fed meal {p = 0.19).
Circulating GLP-1 levels were significantly higher following the swallowed compared 
with the sham fed meal with respect to time x treatment (p < 0.001). The total response 
(TAUC) for plasma GLP-1 to the swallowed meal was 31.8 + 3.8 pmol/1 x h, and 19.3 ±
2.1 pmol/1 X h for the sham fed meal. The TAUC was significantly higher following the 
swallowed meal compared with the sham fed meal {p < 0.001).
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Figure 5.3 Plasma GLP-1 concentration (pmol/1) in volunteers following a swallowed 
and sham fed mixed meal (« = 12, mean ± SEM)
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5.3.2 PLASMA POSTPRANDIAL METABOLITE RESPONSES
J.3.2.1 Plasma TAG response to a mixed meal and sham feeding 
The plasma TAG responses to the swallowed and the sham fed meal can be seen in 
figure 5.4. Mean basal plasma TAG levels were 0.85 ± 0.1 mmol/1; mean levels 
decreased 30 minutes following the swallowed meal to 0.75 ± 0.1 mmol/1, this decrease 
was not however significant {p = 0.33), and rose significantly to 1.00 ± 0.1 mmol/1 90 
minutes after the swallowed meal {p = 0.001). The mean baseline values were different 
between treatments. Mean basal plasma TAG levels were 0.96 ±0.13 mmol/1 before the 
sham fed meal; levels were 0.97 ± 0.1 mmol/1 and 0.96 ± 0.1 mmol/1 30 and 90 minutes 
following the sham fed meal respectively. Mean plasma TAG levels did not alter 
following the sham fed meal.
Plasma TAG levels were significantly different following the swallowed compared with 
the sham fed meal with respect to time x treatment {p = 0.047). The total response 
(TAUC) for plasma TAG to the swallowed meal was 1.37 ± 0.1 mmol/1 x h, and 1.44 ± 
0.2 mmol/1 x h for the sham fed meal. The TAUC was not significantly higher 
following the swallowed meal compared with the sham fed meal (p = 0.635).
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Figure 5.4 Plasma TAG (mmol/1) in volunteers following a swallowed and sham fed 
mixed meal (« = 12, mean ± SEM)
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5.3.2.2 Plasma glucose response to a mixed meal and sham feeding 
The plasma glucose responses to the swallowed and the sham fed meal can be seen in 
figure 5.5. Basal plasma glucose levels were 4.87 ± 0.1 mmol/1; mean levels increased 
30 minutes following the swallowed meal to 5.26 ± 0.2 mmol/1, this increase was not 
however significant {p = 0.057). Plasma glucose levels were 4.48 ± 0.2 mmol/1 90 min 
after the swallowed meal. Mean basal plasma glucose levels were 4.75 ± 0.1 mmol/1 
before the sham fed meal; levels were 4.85 ±0.1 mmol/1 and 4.65 ±0.1 mmol/1 30 and 
90 minutes following the sham fed meal respectively. Plasma glucose levels did not 
increase following the sham fed meal {p = 0.15).
Plasma glucose levels were significantly higher following the swallowed compared with 
the sham fed meal with respect to time x treatment {p = 0.003). The total response 
(TAUC) for plasma glucose to the swallowed meal was 7.21 ± 0.2 mmol/1 x h, and 6.63 
± 0.6 mmol/1 x h for the sham fed meal. The TAUC was not significantly higher 
following the swallowed meal compared with the sham fed meal (p = 0.42).
Swallowed meal 
Sham fed meal5.5
I
3
M 4.5
C Q
E
.2
^  4
3.5
9030 45 60 750 15
Time (minutes from start of meal)
Figure 5.5 Plasma glucose levels (mmol/1) in volunteers following a swallowed and 
sham fed mixed meal {n= 12, mean ± SEM)
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5.3.2.3 Plasma NEFA response to a mixed meal and sham feeding
The plasma NEFA responses to the swallowed and the sham fed meal can be seen in
figure 5.6. Basal plasma NEFA levels were 0.474 ± 0.04 mmol/1, levels decreased
significantly 90 minutes following the swallowed meal to 0.183 ± 0.02 mmol/1
{p < 0.001). The mean baseline values did not differ between treatments. Plasma NEFA
levels were 0.454 ± 0.1 mmol/1 90 minutes following the sham fed meal, and levels did
not decrease following the sham fed meal {p = 0.84).
Plasma NEFA levels were significantly lower following the swallowed compared with 
the sham fed meal with respect to time x treatment {p = 0.004). The total response 
(TAUC) for NEFA to the swallowed meal was 0.401 ± 0.03 mmol/1 x h, and 0.645 ± 0.1 
mmol/1 X h for the sham fed meal. The TAUC was significantly lower following the 
swallowed meal compared with the sham fed meal (p = 0.03).
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Figure 5.6 Plasma NEFA levels (mmol/1) in volunteers following a swallowed and sham 
fed mixed meal {n = 9, mean ± SEM)
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5.3.3 SALIVARY PEPTIDE HORMONE IMMUNOREACTIVITY
5.3.3.1 Salivary insulin-like immunoreactivity following a mixed meal and sham feeding 
The change over time in salivary insulin-like immunoreactivity (ILI) following the 
swallowed and the sham fed meal can be seen in figure 5.7. Mean basal ILI in saliva 
was 25.8 ± 5.1 pmol/1. ILI increased significantly to reach mean peak levels 60 minutes 
following the swallowed meal at 97 ± 18 pmol/1 {p = 0.001). ILI in saliva was 83.7 ± 15 
pmol/1 90 minutes after the swallowed meal. The mean baseline values did not differ 
between treatments. ILI in saliva levels were 27.1 ± 8 pmol/1 60 minutes following the 
sham fed meal; ILI did not increase following the sham fed meal {p = 0.91).
ILI in saliva was significantly higher following the swallowed meal compared with the 
sham fed meal with respect to time x treatment {p < 0.001). The total response (TAUC) 
for saliva ILI to the swallowed meal was 100.6 ± 13 pmol/1 x h, and 46.1 ± 6  pmol/1 x h 
for the sham fed meal. The TAUC was significantly higher following the swallowed 
meal compared with the sham fed meal (p < 0.001).
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Figure 5.7 The concentration as insulin of the salivary insulin-like immunoreactivity 
(pmol/1) in volunteers following a swallowed and sham fed mixed meal (n= 12, mean ± 
SEM)
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5.3.3.2 Salivary C-peptide-like immunoreactivity following a mixed meal and sham 
feeding
The change over time in salivary C-peptide-like immunoreactivity (C-PLI) following 
the swallowed and the sham fed meal can be seen in figure 5.8. Mean basal salivary C- 
PLI was 56.9 ± 13 pmol/1; C-PLI levels were 34.5 ± 7 and 39.9 ± 7 pmol/1 at 60 and 90 
minutes respectively following the swallowed meal. C-PLI did not increase following 
the swallowed meal {p = 0.12). The mean baseline values did not differ between 
treatments. Salivary C-PLI levels were 49.5 ± 13  and 42.9 ± 1 0  pmol/1 60 and 90 
minutes following the sham fed meal; C-PLI did not increase following the sham fed 
meal {p = 0.91).
Salivary C-PLI concentrations were not different following the swallowed meal 
compared with the sham fed meal with respect to time x treatment {p < 0.16). The total 
response (TAUC) for saliva C-PLI to the swallowed meal was 144 ±18 pmol/1 x h, and 
174 ± 31 pmol/1 X h for the sham fed meal. There was no significant difference in 
TAUC following the swallowed meal compared with the sham fed meal (p ^ 0.37).
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Figure 5.8 The concentration as C-peptide of the salivary C-peptide-like 
immunoreactivity (pmol/1) in volunteers following a swallowed and sham fed mixed 
meal (« = 12, mean ± SEM)
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5.3.3.3 Salivary GIP-like immunoreactivity following a mixed meal and sham feeding 
The change over time in salivary GIP-like immunoreactivity (GLI) following the 
swallowed and the sham fed meal can be seen in figure 5.9. Basal GLI in saliva was 186 
± 21 pmol/1, GLI decreased immediately following the swallowed meal to 117 ± 17 
pmol/1 ip < 0.001). GLI in saliva was 113 ±16 pmol/1 90 minutes after the swallowed 
meal. The mean baseline values did not differ between treatments. A similar GLI in 
saliva response was seen following the sham fed meal. GLI in saliva levels dropped 
significantly from 171 ±33 pmol/1 to 71.5 ± 12 pmol/1 at 15 minutes following the sham 
fed meal (p = 0.02); and rose significantly to 124 ± 23 pmol/1 at 90 minutes after the 
sham fed meal (p = 0.04).
There was no significant difference in GLI in saliva following the swallowed compared 
with the sham fed meal with respect to time x treatment {p = 0.7). The total response 
(TAUC) for saliva GLI to the swallowed meal was 168 ± 19 pmol/l/h, and 153 ± 17 
pmol/l/h for the sham fed meal. The TAUC was not significantly different following the 
swallowed meal compared with the sham fed meal (p = 0.18).
400
Swallowed meal
350
Sham fed meal
_  300
I  250 
3
2: 200 
Ü
I  150 
^  100
0 30 45 60 9015 75
Time (minutes from start of meal)
Figure 5.9 The concentration as GIP of the salivary GIP-like immunoreactivity (pmol/1) 
in volunteers following a swallowed and sham fed mixed meal {n= 12, mean ± SEM)
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5.3.4 SALIVARY TOTAL PROTEIN AND a-AMYLASE ACTIVITY
5.3.4.1 Salivary total protein following a mixed meal and sham feeding 
The variation with time in salivary total protein concentration following the swallowed 
and the sham fed meal can be seen in figure 5.10. Basal salivary total protein was 0.91 ± 
0.1 g/1. Total protein increased immediately following the swallowed meal to 1.53 ± 
0.25 g/1 {p < 0.001). Salivary total protein was 1.21 ± 0.50 g/1 90 minutes after the 
swallowed meal. The mean baseline values did not differ between treatments. Salivary 
total protein also increased significantly {p = 0.009) following the sham fed meal from 
0.87 ± 0.11 g/1 to 1.47 ± 0.21 g/1. Ninety minutes after the sham fed meal salivary total 
protein concentration was 1.00 ± 0.10 g/1.
There was no significant difference between the salivary total protein concentration 
following the swallowed compared with the sham fed meal with respect to time x 
treatment (p = 0.3). The total response (TAUC) for saliva total protein to the swallowed 
meal was 1.91 ± 0.6 g/1 x h, and 1.75 ± 0.2 g/1/1 x h for the sham fed meal. The TAUC 
was not significantly different following the swallowed meal compared with the sham 
fed meal {p = 0.38).
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Figure 5.10 Saliva total protein concentration (g/1) in volunteers following a swallowed 
and sham fed mixed meal (« = 12, mean ± SEM)
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5.3.4.2 Salivary a-amylase activity following a mixed meal and sham feeding 
The variation with time in salivary a-amylase activity following the swallowed and the 
sham fed meal can be seen in figure 5.11. Basal salivary a-amylase activity was 47.6 ± 
12 KU/1. a-Amylase activity increased 15 minutes following the swallowed meal to
92.3 ±11.7 KU/1 ip < 0.001). Salivary a-amylase activity was 94.7 ± 16 KU/1, 90 
minutes after the swallowed meal. The mean baseline values did not differ between 
treatments. Salivary a-amylase activity increased following the sham fed meal from
43.5 ± 9.9 KU/1 to 73.8 ± 12.6 KU/1 at 30 minutes {p < 0.001).
There was no significant difference between the salivary a-amylase activity following 
the swallowed compared with the sham fed meal {p = 0.17). The total response (TAUC) 
saliva a-amylase activity to the swallowed meal was 133 ± 19 KU/1 x h, and 106 ± 15 
KU/1 X h for the sham fed meal. The TAUC was significantly different following the 
swallowed meal compared with the sham fed meal {p = 0.04).
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Figure 5.11 Saliva a-amylase activity (KU/1) in volunteers following a swallowed and 
sham fed mixed meal {n= 12, mean ± SEM)
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5.3.5 COMPARISON OF PEPTIDE HORMONE IMMUNOREACTIVITY IN 
SALIVA AND PLASMA
5.3.5.1 Insulin-like immunoreactivity following a swallowed and sham fed  mixed meal 
The variation in time in plasma and saliva ILI following the swallowed and sham fed 
meal can be seen in figure 5.12. It is evident from figure 5.12 that the increase in ILI in 
saliva after the swallowed meal occurs later than that of plasma insulin, and that the 
levels seen in saliva are lower than those found in plasma. Plasma insulin levels began 
to rise significantly 15 minutes after the swallowed meal {p = 0.002), whereas saliva ILI 
levels were not significantly higher until 45 minutes following the meal {p = 0.003). 
The levels of ILI found in saliva were significantly lower than insulin levels in plasma. 
There was no increase in ILI in saliva or plasma insulin concentration following the 
sham fed meal.
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Figure 5.12. Plasma insulin and saliva insulin-like immunoreactivity (pmol/1) in 
volunteers following a swallowed and sham fed mixed meal {n= 12, mean ± SEM)
148
CHAPTER 5
5.3.5.2 GIP-like immunoreactivity following a swallowed and sham fed  mixed meal 
The variation with time in plasma GIF and saliva GIP-like immunoreactivity (GLI) 
following the swallowed and sham fed meal can be seen in figure 5.13. It is evident 
from figure 5.13 that whereas GIP secretion into plasma increases following the 
swallowed meal, GLI in saliva immediately declines. Basal levels of plasma GIP were 
significantly lower than basal saliva GLI {p <0.001). Plasma GIP levels did not increase 
following the sham fed meal in contrast to the rise seen after the swallowed meal, 
whereas GLI in saliva followed a similar pattern of response and fell following both the 
swallowed and the sham fed meal.
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Figure 5.13 Plasma and saliva GIP concentration (pmol/l) in volunteers following a 
swallowed and sham fed mixed meal {n= 12, mean ± SEM)
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5.4 DISCUSSION
Salivary insulin-like immunoreactivity (ILI) increased following the swallowed meal 
without a corresponding increase in C-peptide-like immunoreactivity. The levels of ILI 
in saliva following the swallowed meal in this experiment compare with data previously 
reported in the literature (Fekete et a l, 1993). Proinsulin is cleaved to form insulin and 
C-peptide in equimolar amounts. For ILI in saliva to come from local synthesis within 
the salivary glands, one would expect any increase in ILI in saliva to correspond with a 
simultaneous increase in salivary C-peptide. ILI in saliva is dependent on plasma insulin 
levels, following a venous injection of insulin, ILI in saliva increased without any 
corresponding increase in plasma C-peptide in volunteers (Vallejo et a l, 1984).
The rise in plasma insulin in response to the swallowed meal was quicker and greater 
than the rise in ILI in saliva. These data are consistent with those reported in the 
literature (Fekete et a l, 1993). It seems likely, therefore that the increase in ILI in saliva 
occurs after the food has reached the stomach, and is not stimulated by the physical 
presence of food in the mouth. This was supported by the fact that there was no 
significant change in either plasma insulin or ILI in saliva levels after the sham fed 
meal. This indicates that if ILI in saliva did come from local synthesis, the stimulus for 
secretion of ILI into saliva does not come from the physical presence of food within the 
oral cavity. It also adds weight to the argument that levels of ILI in saliva being 
dependent on plasma insulin levels, and therefore the possibility of ILI in saliva being 
an ultrafiltrate from blood.
Reports in the literature argue for local synthesis of insulin in the salivary glands. 
mRNA for insulin and immunoreactive insulin have been found in both the parotid and 
the submandibular gland of mice (Kerr et a l, 1995) and the SSG of rats (Taouis et al, 
1995). If this was also true in man, this could indicate that immunoreactive insulin 
found in human saliva, as reported here, was not an ultra filtrate from blood, but the 
product of local synthesis in the salivary glands. ILI from mice SSG was found to be 
sensitive to a change in glucose concentration, an increased glucose concentration lead 
to increased insulin secretion by SSG, in vitro (Shubnikova et a l, 1984). One must 
propose therefore that the delay in the rise in salivary immunoreactive insulin, was due
150
CHAPTERS
to the signal for the stimulus to release salivary gland insulin being sent from the 
stomach or the gut and not from the oral cavity.
It has been postulated in literature that salivary insulin has a role in carbohydrate 
metabolism. The levels of insulin in rat salivary glands (sections 2.3.4) and in human 
saliva are lower than those found in the pancreas and plasma. If ILI in saliva is involved 
with CHO metabolism then it is probable that it has only a minor role. It is more 
probable that ILI in saliva has a local paracrine effect within the salivary glands. For 
instance the hormone somatostatin is found in the salivary glands (Deville de Perrier et 
al, 1989), insulin in the pancreas facilitates the secretion of this hormone (Kadowaki et 
al, 1980), it is possible that ILI in saliva has a similar role in the salivary glands.
Salivary GIP-like immunoreactivity (GLI) decreased following both the swallowed and 
the sham fed meal. This would indicate that the stimulus for GLI secretion into saliva 
was not mediated by signals received from the stomach, but from local signals in the 
mouth. The fact that levels decreased following food, and that basal levels of GLI in 
saliva were higher than those of plasma GIP, indicate that GLI in saliva is not an ultra­
filtrate from blood but comes from local synthesis. The levels of GLI increase slowly 
following the initial presence of food in the mouth. A longer sampling period would be 
required to see how long it takes for GLI in saliva to return to basal levels.
Plasma GIP levels increased following food, levels of GLI in saliva decreased following 
food. Plasma GIP levels did not rise following the sham fed meal, levels of GLI in 
saliva decreased following the sham fed meal. GIP in plasma is secreted from the small 
intestine in response to the absorption of nutrients (Morgan et a l, 1988), and we have 
demonstrated that sham feeding does not lead to an increase in plasma GIP levels. Small 
intestine-secreted GIP is involved in the enteroinsular axis and potentiates insulin 
secretion via this pathway (Knapper et al, 1996). The response of GLI in saliva to the 
absorption of nutrients and sham feeding is not consistent with GLI in saliva having a 
role in the entero-insular axis, but rather an entirely different function either within the 
salivary glands.
One function of GIP in circulation is the inhibition of gastric acid secretion (Rossowski
et al, 1998) in the stomach. Gastric emptying occurs approximately 90 min after food
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enters the stomach. These data show that the presence of food in the mouth leads to an 
immediate and drastic decrease in GLI in saliva. From these data it seems possible that 
GLI in saliva plays a role in the regulation of gastric acid secretion, by inhibition of 
gastric acid secretion in the fasted state. GIP inhibits gastric acid secretion by 
stimulating somatostatin release, somatostatin inhibits pentagastrin-stimulated gastric 
acid secretion (Rossowski et al, 1998). Both somatostatin and gastrin have been 
reported in the salivary glands and saliva (Deville de Perrier et a l, 1989; Takeuchi et 
al, 1970). Sham feeding is a potent stimulator of cephalic phase gastric acid secretion 
(Feldman & Richardson, 1986), levels of GLI in saliva decreased immediately 
following sham feeding which would mean reduced inhibition of gastric acid secretion. 
These data provide strong evidence for a role of GLI in saliva in inhibition of gastric 
acid secretion.
This hypothesis is supported by the data from rat experiments (section 3.3.1) where GLI 
was greater in the SSG of rats in the fed state than that found in the fasted rats SSG. 
Increased levels of GIP mRNA in rat SSG following an oral glucose load supported this 
finding (Tseng et a l, 1995). If GIP is stored in storage granules in rat SSG, and the 
function of this hormone is to inhibit gastric acid secretion, then higher amounts of this 
hormone would be extracted in the fed state than in the fasted.
Circulating insulin levels rose following the swallowed meal. Insulin is secreted from 
the pancreas following nutrient ingestion when plasma glucose levels rise above 4 
mmol/1. The rate and magnitude of the increase in plasma insulin corresponded with 
that reported in the literature (Elliott et al, 1993). A non-significant increase in plasma 
insulin levels occurred following the sham fed meal. No food was swallowed during the 
sham fed meal; therefore plasma glucose levels could not have increased and stimulated 
insulin secretion. The increase in plasma insulin following the sham fed meal was 
therefore probably caused by a cephalic phase response.
The cephalic phase insulin response to the sight, smell and taste of food is well
documented (Teff et al, 1991; Teff et al, 1993; Karhunen, 1997). Cephalic phase
insulin release is the neurally mediated secretion of insulin that occurs before nutrient
absorption (Anagnostides et al, 1984). It was therefore expected that a small increase in
plasma insulin would be seen immediately following the sham fed meal. The meal
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administered to the subjects consisted mainly of cream cheese and crackers and 
therefore required only a small amount of mastication. It is possible that a meal that 
would require higher amounts of mastication (such as sandwiches) and therefore greater 
oral sensory stimulation would produce a stronger cephalic phase insulin response.
The increase in plasma insulin following the sham fed meal peaked at 45 minutes 
following ejq)osure to the meal. Cephalic phase responses to the sight and taste of food 
occur immediately following exposure (Teff et a l, 1993). It is therefore likely that this 
apparent increase in plasma insulin was not due to a cephalic phase response but rather 
to the inadvertent swallowing of a small amount of nutrients by volunteers during the 
sham fed meal.
Plasma GIP and GLP-1 concentrations increased following the swallowed meal, but did 
not increase above fasting levels following the sham fed meal. The main site of GIP and 
GLP-1 secretion occurs in the small intestine, in response to the absorption of nutrients 
(Morgan et al, 1988; 0rskov et al, 1994). It was therefore not expected to see any 
increase in plasma GIP or GLP-1 levels following the sham fed meal. The sham feeding 
of an oral fat load after ingestion of oil capsules increased plasma TAG clearance 
compared with a non-fat load (Mattes, 1996). If sham feeding were to alter lipid 
metabolism then it follows that the profiles of the hormones involved in lipid 
metabolism, such as GIP, would be altered as well. Within this experiment we found no 
effect of sham feeding on plasma GIP or GLP-1 levels.
Following the swallowed meal plasma postprandial levels of glucose increased and 
NEFA concentration decreased. TAG levels initially decreased but rose significantly 90 
minutes following the swallowed meal. Following nutrient ingestion glucose and lipids 
in the form of fi'ee fatty acids are absorbed through the microvilli of the small intestine. 
Glucose circulates fi*eely in blood, and dietary fats are transported as TAG to their site 
of utilization or storage. Plasma NEFA levels inversely reflect those of glucose and 
insulin, therefore it was expected that the rise in plasma glucose following the 
swallowed meal should correspond with a decrease in plasma NEFA concentration. The 
postprandial response of glucose, TAG and NEFA to the swallowed meal reflected that 
reported in the literature (Elliott et al, 1993).
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The sham feeding of the same meal did not alter the plasma concentrations of glucose, 
TAG or NEFA. As no nutrients were swallowed, and therefore could not be absorbed, 
during the sham fed meal no alterations in the concentration of plasma glucose, TAG or 
NEFA were expected following this meal. The sham feeding of an oral fat load 
(following ingestion of 50 g of safflower oil) has been shown to increase plasma TAG 
levels relative to the sham feeding of an oral non-fat load (Mattes, 1996). Our data did 
not show any increases in plasma TAG following the sham fed meal. However in the 
present experiment subjects did not ingest a fat load prior to the sham fed meal this may 
explain the differences seen in the effects of sham feeding on plasma TAG levels 
between the present study and those of Mattes.
Salivary total protein increased immediately following both the swallowed and the sham 
fed meals. This would indicate that the signal for salivary protein release came from the 
oral cavity. The stimulation of whole and individual glandular saliva flow from the 
individual glands and whole saliva by the presence of food in the mouth has been 
widely investigated (Fekete et a l, 1993; Karhunen, 1997). Salivary secretion is under 
neural control. Stimulation of the parasympathetic nerve supply and local release of the 
neurotransmitter vasoactive intestinal polypeptide (VIP) leads to pronounced 
vasodilatation of the salivary glands and profuse secretion of watery saliva (Turner 
1993). The concentration of total protein in whole saliva has not been reported in 
response to food.
The composition of human saliva has not been quantified, and has been relatively 
ignored in terms of research. Using the biuret method (section 2.2.10) we have 
determined that basal unstimulated saliva contains less than 1 g/1 of total protein (0 .1  
%). Saliva contains many biologically active components, for instance two enzymes 
involved in nutrient digestion, lingual lipase and a-amylase. Other proteins found in 
saliva include insulin-like growth factor- 1 and vasoactive intestinal polypeptide.
Salivary a-amylase activity increased immediately following both the swallowed and 
the sham fed meals. This would indicate that the signal for salivary amylase release 
came from the oral cavity and not from the stomach. Salivary a-amylase is secreted
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from serous cells within the parotid gland. The parotid gland produces watery saliva, 
which contributes roughly 2 0 % of whole-unstimulated saliva production.
5.4.1 SUMMARY AND CONCLUSIONS
The concentration of ILI in saliva in human saliva is dependent on plasma insulin 
levels. ILI in saliva is not involved in carbohydrate homeostasis, but has local paracrine 
effects. The physical presence of food in the mouth immediately reduces the levels of 
GLI in human saliva. GLI in saliva is not involved with the enteroinsular axis but is 
possibly involved with the inhibition of gastric acid secretion in the fasted state.
Plasma GIP, GLP-1, glucose, TAG and NEFA levels are not altered by the sham 
feeding of a mixed meal i.e. in the absence of nutrient absorption.
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CHAPTER SIX 
INVESTIGATION OF THE EFFECTS OF DIFFERENT 
BEVERAGES ON SALIVA HORMONE SECRETION
CHAPTER 6
6.1 INTRODUCTION
It has been shown that the peptide hormones insulin and GIF are present in human 
saliva (section 2.3.4 and 2.3.3) and it was postulated that by investigating the 
physiological stimulators of these hormones in saliva, it might be possible to elucidate 
their function. The consumption of food was shown to modulate the presence of these 
hormones in saliva (chapter 5), and tissue levels in rodents were altered by consumption 
of whole black tea (chapter 4). It is therefore possible that different dietary constituents, 
such as polyphenols in black tea and red wine, could modulate the levels of these 
hormones in saliva.
Administration of various types of large mass polyphenols leads to hypertrophy of the 
salivary parotid gland in rodents (Marmary et al, 1994), and dietary tannins elucidate a 
change in gene expression in the rat parotid gland (Mehansho et a l, 1992). Proline-rich 
proteins (FRF) in saliva bind dietary tannins (Mehansho et a l, 1996). Tannins fed to 
mice and rats caused a net loss in body mass in the first days of ingestion, and the 
subsequent gain in body mass correlated with the induction of FRF synthesis 
(Mehansho et al, 1983). It is possible that the consumption of dietary polyphenols such 
as those present in black tea and red wine induce FRF synthesis in the salivary glands in 
man.
Citric acid is a known stimulant of saliva flow, and is widely used to stimulate saliva 
flow for individual salivary glands (Ship & Fischer, 1999; Anderesson et a l, 1998)and 
whole saliva (Dawidson et a l, 1998). It has been demonstrated that stimulation of saliva 
flow by citric acid leads to increased flow rates up to 30 seconds after stimulation and a 
return to basal flow rates within two minutes (Duran et a l, 1998). It is not known 
whether citric acid acts to stimulate only the volume flow rate or the mass flow rate of 
solutes in the saliva.
Both black tea and red wine are rich in complex phenols and tannins. Red wine also 
contains alcohol and is quite acidic, thus either or both classes of constituents might 
stimulate FRF secretion and thus possibly also the saliva-associated peptide hormones.
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The aims of this study were to determine whether dietary complex phenols and tannins 
(CPT) in the form of red wine and black tea modulated the secretion of the peptide 
hormones in saliva and salivary total protein. To differentiate between the effects of the 
astringency of red wine and the alcohol content, citric acid and vodka were included to 
act as CPT-free control for red wine. To differentiate between the effects of caffeine and 
other constituents of black tea, decaffeinated black tea was included as a test drink. As 
mean values of salivary GIF-like immunoreactivity are highest in the fasted state and 
mean values of salivary insulin-like immunoreactivity are highest in the fed state the 
effects of these test drinks were investigated both before and after a mixed meal.
In this study, the secretion into saliva of peptide hormones was investigated as a 
response to various test drinks. The hormones GIF and insulin, total protein and a- 
amylase activity were measured from saliva samples taken at identical time points 
before and after various test drinks. Volunteers' perception of dryness of mouth was also 
investigated before and after these oral stimulants. The study was a random within 
subject seven-way crossover design.
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6.2 METHODS
6.2.1 STUDY DESIGN
The study was a random within subject seven-way crossover comparison of salivary 
hormone response to water (125 and 200 ml), vodka (42 ml vodka and 83 ml water), red 
wine (125 ml), black tea with milk (200 ml), decaffeinated black tea with milk (200 ml) 
and citric acid 1 % (125 ml). The washout period was 48 hours.
6.2.2 SUBJECTS
Twelve healthy men and women aged between 20 and 30 were recruited from the 
university by advertisements and ‘word of mouth’. Subjects were excluded if they had 
significant current or previous medical history, were receiving regular medication apart 
from oral contraceptives, which may affect gastrointestinal or central nervous systems 
or consuming more than twenty units of alcohol a week. Subjects attended the Clinical 
Investigation Unit at the University of Surrey on seven separate occasions at least 48 h 
apart to consume water, vodka, red wine, black tea with milk, decaffeinated black tea 
with milk, and citric acid (1 %). Subjects were provided with an information sheet and 
gave written consent to participate in this study.
6.2.1 STUDY PROTOCOL
On seven occasions separated by at least 48 h subjects were given different test drinks 
to swallow. Subjects were, on separate occasions, given the test drink before and after a 
mixed meal. There was an overnight fast prior to each study day.
On arrival at the Clinical Investigation Unit at the University of Surrey at 0800 h on 
each study day, subjects were asked to provide two saliva samples. They were then 
given a test drink to consume, either water (125 and 200 ml), vodka (42 ml vodka and 
83 ml water), red wine (125 ml), black tea (a 2 min brew from a tea bag with 20 ml 
skimmed milk, 2 0 0  ml), decaffeinated black tea (a 2  min brew from a tea bag with 2 0  
ml skimmed milk, 200 ml) or citric acid (1 % solution in 125 ml water). Subjects were 
given five minutes to consume the test drink, after which time a saliva sample was
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collected, a further saliva sample was collected 15 min following the test drink. 
Immediately following this subjects were given a mixed meal (three slices of bread with 
cheese and butter and a muesli bar, 2008 KJ).
At 60 min and 75 min after exposure to the test drink further saliva samples were 
collected. Following this subjects were presented with the same test drink to consume as 
they consumed prior to their meal. Subjects were given five minutes to consume the 
second test drink, after which time a saliva sample was collected, and a further saliva 
sample was collected 15 min following the test drink. A total of 108 ml of saliva was 
collected. All test substances were consumed by sipping the test drink slowly over five 
minutes with the exception of the citric acid, which was consumed in five mouthfuls, at 
one mouthful a minute.
Test Test
Drink Meal Drink
I
-15 0 5 15 60 75 80 90
Sample time points (minutes)
Figure 6.1 Schematic diagram of sample time points and consumption of test drinks
6.2.4 SAMPLE ANALYSIS
Saliva was centrifuged (10 minutes at 1825 x g) to remove all particulate matter and 
stored at -20 °C. Saliva samples were analysed by RIA for the measurement of GIF and 
insulin (see sections 2,2.3 and 2.2.8). Saliva total protein concentration and amylase 
activity were analysed by automated enzymatic methods (see sections 2.2.9 and 2.2.10).
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6.2.5 STATISTICAL ANALYSIS
Data are expressed in the text as mean ± standard error of the mean. Statistical analysis 
was achieved using the Statistica for Windows statistical software package (StatSoft Inc, 
2300 East 14^  ^ St, Tulsa OK 74104, USA). Data were compared with the Kolmogorov- 
Smimov test and transformed if necessary. Comparisons between the test drinks were 
performed by repeated measures analysis of variance (RM-ANOVA) with time and 
treatment as within-subject factors. Significant differences were located using Duncan's 
multiple range test and critical ranges for multiple corrections. Differences between 
individual time points were compared using students r-test.
Values ofj) < 0.05 were considered significant.
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6.3 RESULTS
This experiment was designed to investigate the effects of the test drinks when given to the 
volunteers both following an overnight fast and 60 minutes postprandially.
6.3.1 INSULIN -LIKE IMMUNOREACTIVITY (ILI)
6.3.1.1 Salivary insulin-like immunoreactivity following consumption o f test drinks by 
volunteers after an overnight fast
The change with time in salivary insulin-like immunoreactivity (ILI) following 
consumption of water (125 and 200 ml), citric acid, vodka, red wine, decaffeinated 
black tea and whole black tea after an overnight fast is shown in figure 6.2. Mean basal 
values averaging all treatments for ILI in saliva did not vary (33.1 ± 7.3 pmol/1). 
Students /-test were used to compare between individual time points. ILI in saliva 
increased significantly from basal levels following consumption of citric acid from 31.4 
±5.7 pmol/1 to 45.5 ± 7.5 pmol/1 {p ^  0.02). ILI in saliva did not change significantly 
from basal levels following consumption of any other test drinks.
■  Water 125 ml 
0  Vodka
■  Whole black tea
I Water 200 ml 
IR pH wine
Citric acid
I Decaffeinated black tea
«  30
•a 20
0 5 15
Time (minutes from first test drink)
Figure 6.2 The concentration as insulin of the salivary insulin-like immunoreactivity
(pmol/1) in volunteers following consumption of water (125 and 200 ml), citric acid, red
wine, decaffeinated black tea and whole black tea after an overnight fast (« = 1 1 , mean ±
SEM)
* p = 0.02 Increased levels of ILI in saliva following consumption of citric acid 
compared with basal levels
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Repeated measures ANOVA revealed no significant differences between ILI in saliva 
levels following consumption of water (125 ml and 200 ml), citric acid, vodka, red 
wine, decaffeinated black tea and whole black tea after an overnight fast with respect to 
treatment and time x treatment (/? = 0.13 and 0.09).
6.3.1.2 Salivary insulin-like immunoreactivity following consumption o f test drinks by 
volunteers 60 minutes postprandially
The change over time in salivary insulin-like immunoreactivity (ILI) following 
consumption of water (125 and 200 ml), citric acid, vodka, red wine, decaffeinated 
black tea and whole black tea, 60 minutes following a mixed meal is shown in figure 
6.3. Levels of ILI in saliva increased following the meals {p < 0.0001). Basal samples 
taken at 45 and 60 minutes following consumption of the meal (60 minutes and 75 
minutes following consumption of the first test drink, corresponding to -15 and 0  in 
figure 6.3) were increasing. Mean basal values, averaging all treatments, were 72.4 ±
4.4 pmol/1 at 45 minutes following consumption of the meal and 90.4 ± 10.7 pmol/1 at 
60 minutes following the meal.
□  Water 125 ml
□  Citric acid 
H Red wine
H Whole black tea
■  Water 200 ml
□  Vodka
□  Decaffeinated black tea
E 120
■15 150 5
Time (minutes from second test drink)
Figure 6.3 The concentration as insulin of the salivary insulin-like immunoreactivity 
(pmol/1) in volunteers following consumption of water (125 and 200 ml), citric acid, red 
wine, decaffeinated black tea and whole black tea 60 minutes after a test meal {n = 1 1 , 
mean ± SEM)
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Repeated measures ANOVA revealed no significant differences between levels of ILI in 
saliva following consumption of water (125 ml and 200 ml), citric acid, vodka, red 
wine, decaffeinated black tea and whole black tea with respect to treatment and time x 
treatment (p = 0.44 and 0.28).
6.3.2 GIP-LIKE IMMUNOREACTIVITY
6.3.2.1 Salivary GIP-like immunoreactivity following consumption o f test drinks by 
volunteers after an overnight fast.
The change with time in salivary GIP-like immunoreactivity (GLI) following 
consumption of water (125 and 200 ml), citric acid, vodka, red wine, decaffeinated 
black tea and whole black tea after an overnight fast is shown in figure 6.4. Basal values 
for GLI in saliva did not change. Mean basal levels of GLI in saliva levels, averaging all 
treatments, were 267 ± 48 pmol/1. Students /-test were used to compare between 
individual time points. Levels of GLI in saliva decreased significantly from basal values 
following consumption of citric acid (from 277 ± 32 to 112 ± 34 pmol/1,7? = 0.0017), 
decaffeinated black tea (from 268 ±51 to 194 ± 32 pmol/1, p = 0.03) and whole black 
tea (from 256 ± 38 to 182 ± 19 pmol/1,/? = 0.008). There was a trend towards decreased 
GLI in saliva from basal levels following consumption of red wine (from 266 ± 67 to 
166 ± 29 pmol/1, /? = 0.07). GLI in saliva did not change significantly from basal levels 
following consumption of any other test drinks.
Repeated measures ANOVA revealed no significant differences between levels of GLI 
in saliva levels following consumption of water (125 ml and 200 ml), citric acid, vodka, 
red wine, decaffeinated black tea and whole black tea after an overnight fast with 
respect to time x treatment {p = 0.13).
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400
350
n  Water 125 ml 
n  Vodka
H Whole black tea
■  Water 200 ml 
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Figure 6.4 The concentration as GIF of the salivary GIP-like immunoreactivity (pmol/1) in 
volunteers following consumption of water (125 and 200 ml), citric acid, red wine, 
decaffeinated black tea and whole black tea after an overnight fast 11, mean ± SEM)
p = 0.002 Decreased levels of GLI in saliva following consumption of citric acid 
compared with basal levels
** p = 0.03 Decreased levels of GLI in saliva following consumption of decaffeinated 
black tea compared with basal levels
•k'k'k p ^  0.008 Decreased levels of GLI in saliva following consumption of black tea 
compared with basal levels
6.3.2.2 Salivary GIP-like immunoreactivity following consumption o f test drinks by 
volunteers 60 minutes postprandially
The change over time in salivary GIP-like immunoreactivity (GLI) following 
consumption of water (125 and 200 ml), citric acid, vodka, red wine, decaffeinated 
black tea and whole black tea 60 minutes following a mixed meal is shown in figure 
6.5. Levels of GLI in saliva levels decreased following the meals (p < 0.0001). Basal 
samples taken at 45 and 60 minutes following consumption of the meal (60 minutes and 
75 minutes following consumption of the first test drink, corresponding to -15 and 0 in 
figure 6.5) were increasing. Mean basal values of GLI in saliva averaging all treatments
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were 85 ± 30 pmol/1 at 45 minutes following consumption of the meal and 104 ± 31 
pmol/1 at 60 minutes following the meal.
Repeated measures ANOVA revealed no significant differences between levels of GLI 
in saliva following consumption of water (125 ml and 200 ml), citric acid, vodka, red 
wine, decaffeinated black tea and whole black tea 60 minutes postprandially with 
respect to time x treatment (p = 0.118).
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Figure 6.5 The concentration as GIF of the salivary GIP-like immunoreactivity (pmol/1) in 
volunteers following consumption of water (125 and 200 ml), citric acid, red wine, 
decaffeinated black tea and whole black tea 60 minutes after a test meal {n= 11, mean ± 
SEM)
6.3.3 SALIVARY TOTAL PROTEIN
6.3.3.1 Salivary total protein concentration following consumption o f test drinks by 
volunteers after an overnight fast
The change with time in salivary total protein concentration following consumption of 
water (125 and 200 ml), citric acid, vodka, red wine, decaffeinated black tea and whole 
black tea after an overnight fast is shown in figure 6.6. Mean basal concentrations, 
averaging all treatments, of salivary total protein did not vary (0.62 ± 0.11 g/1). Students
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/-test were used to compare between individual time points. Salivary total protein 
concentration increased significantly from basal levels following consumption of citric 
acid (from 0.70 + 0.1 to 1.05 ± 0.1 g/1,/? = 0.038), red wine (from 0.60 ±0.1 to 1.75 ± 
0.1 g/1,/? = 0.018) and black tea (from 0.52 ± 0.2 to 0.85 ± 0.1 g/1,/? = 0.017). Salivary 
total protein concentration did not change significantly from basal levels following 
consumption of any other test drinks.
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Figure 6.6 The change with time in salivary total protein concentration (g/1) in volunteers
following consumption of water (125 and 200 ml), citric acid, red wine, decaffeinated
black tea and whole black tea after an overnight fast { n^ W,  mean ± SEM)
+ /? = 0.038 Increased levels of salivary total protein following consumption of citric 
acid compared with basal levels
++/? = 0.018 Increased levels of salivary total protein following consumption of red 
wine compared with basal levels
+++ p = 0.017 Increased levels of salivary total protein following consumption of black 
tea compared with basal levels
* /? = 0.038 and 0.002 Increased levels of salivary total protein following consumption 
of red wine compared with water (125 and 200 ml respectively)
** /? = 0.037 and 0.032 Increased levels of salivary total protein following consumption 
of citric acid and vodka compared with water (200 ml)
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Repeated measures ANOVA showed significant differences between salivary total 
protein concentration following consumption of water (125 ml and 200 ml), citric acid, 
vodka, red wine, decaffeinated black tea and whole black tea after an overnight fast {p = 
0.024). Subsequent comparison of variance (using Duncan's multiple range test) 
between individual treatments showed significantly higher amounts of salivary total 
protein following; red wine compared with water (125 and 200 ml) {p = 0.038 and 0.002 
respectively), citric acid and vodka compared with water (200 ml) {p = 0.037 and 0.032 
respectively).
6.3.3.2 Salivary total protein concentration following consumption o f test drinks by 
volunteers 60 minutes postprandially
The change over time in salivary total protein concentration following consumption of 
water (125 and 200 ml), citric acid, vodka, red wine, decaffeinated black tea and whole 
black tea 60 minutes following a mixed meal is shown in figure 6.7. Basal samples 
taken at 45 and 60 minutes following consumption of the meal (60 minutes and 75 
minutes following consumption of the first test drink, corresponding t o -15 and 0 in 
figure 6.7) were not significantly different. Mean basal values, averaging all treatments, 
were 0.88 ±0.17 g/1 at 45 minutes following consumption of the meal and 0.86 ±0.16 
g/1 at 60 minutes following the meal. Salivary total protein concentration did not change 
significantly from basal levels following consumption of any test drink.
Repeated measures ANOVA revealed no significant differences between salivary total 
protein concentration following consumption of water (125 ml and 200 ml), citric acid, 
vodka, red wine, decaffeinated black tea and whole black tea 60 minutes postprandially 
with respect to time x treatment {p = 0.65).
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Figure 6.7 The change with time in salivary total protein concentration (g/1) in volunteers 
following consumption of water (125 and 200 ml), citric acid, red wine, decaffeinated 
black tea and whole black tea 60 minutes after a test meal ( n^  II, mean ± SEM)
6.3.4 SALIVARY a-AMYLASE ACTIVITY
6.3.4.1 Salivary a-amylase activity following consumption o f test drinks by volunteers 
after an overnight fast
The change with time in salivary a-amylase activity following consumption of water 
(125 and 200 ml), citric acid, vodka, red wine, decaffeinated black tea and whole black 
tea after an overnight fast is shown in figure 6.8. Mean basal levels, averaging all 
treatments, of salivary a-amylase activity did not change, mean basal salivary a- 
amylase activity were 26.8 ± 3.7 KU/1. Students /-test were used to compare between 
individual time points. Salivary a-amylase activity increased significantly from basal 
levels following consumption of citric acid (from 28.6 ± 3.6 to 52.0 ± 8.1 KU/1, p = 
0.03) and red wine (from 29.6 ± 5.5 to 66.2 ± 13 KU/1, p = 0.003). Salivary a-amylase 
activity did not change significantly from basal levels in following consumption of any 
other test drinks.
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Repeated measures ANOVA revealed significant differences between salivary a- 
amylase activity following consumption of water (125 ml and 200 ml), citric acid, 
vodka, red wine, decaffeinated black tea and whole black tea after an overnight fast with 
respect to time x treatment (p = 0.002). Subsequent comparison between treatments 
showed significantly higher a-amylase activity following citric acid compared with 
water (125 and 200 m\,p = 0.014 and 0.039 respectively) and following consumption of 
red wine compared with water (125 and 200 ml, p = 0.000078 and 0.000097 
respectively). There was a trend towards higher levels of a-amylase activity following 
vodka compared with 125 ml water {p = 0.062). There were no other significant 
differences in a-amylase activity between individual treatments in fasted volunteers.
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Figure 6.8 The change with time in salivary a-amylase activity (KU/1) in volunteers 
following consumption of water (125 and 200 ml), citric acid, red wine, decaffeinated 
black tea and whole black tea after an overnight fast {n=\ \ ,  mean ± SEM)
+ p = 0.03 Increased levels of salivary a-amylase activity following consumption of 
citric acid compared with basal levels
++ p = 0.003 Increased levels of salivary a-amylase activity following consumption of 
red wine compared with basal levels
* /? = 0.014 and 0.039 Increased levels of salivary a-amylase activity following 
consumption of citric acid compared with water (125 and 200 ml respectively)
** /? < 0.0001 Increased levels of salivary a-amylase activity following consumption of 
red wine compared with water (125 and 200 ml respectively)
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6.3.3.2 Salivary a-amylase activity following consumption o f test drinks by volunteers 
60 minutes postprandially
The change over time in salivary a-amylase activity following consumption of water 
(125 and 200 ml), citric acid, vodka, red wine, decaffeinated black tea and whole black 
tea 60 minutes following a mixed meal is shown in figure 6.9. Salivary a-amylase 
activity increased following the meals {p < 0.0001). Basal samples taken at 45 and 60 
minutes following consumption of the meal (60 minutes and 75 minutes following 
consumption of the first test drink, corresponding to -15 and 0 in figure 6.9) were not 
significantly different. Mean basal values, averaging all treatments, were 67.6 ± 8.6 
KU/1 at 45 minutes following consumption of the meal and 57.3 ± 6.8 KU/1 at 60 
minutes following the meal. Salivary a-amylase activity did not change significantly 
from basal levels following consumption of any test drink.
Repeated measures ANOVA revealed no significant differences in salivary a-amylase 
activity following consumption of water (125 ml and 200 ml), citric acid, vodka, red 
wine, decaffeinated black tea and whole black tea 60 minutes postprandially with 
respect to time x treatment {p = 0.41).
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Figure 6.9 The change with time in salivary a-amylase activity (KU/1) in volunteers 
following consumption of water (125 and 200 ml), citric acid, red wine, decaffeinated 
black tea and whole black tea 60 minutes after a test meal (« = 11, mean ± SEM)
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6.4 DISCUSSION
Basal levels of ILI in saliva following an overnight fast were close to the sensitivity of the 
RIA used (20 pmol/l). From the results of chapter 5 (section 5.3.3.1) and previously in the 
literature (Fekete et al, 1993) it was known that levels of ILI in saliva increased following 
the consumption of food. As volunteers were only given relatively small amounts of each 
test drink, it was therefore expected that any effects seen on ILI in saliva following 
consumption of the test drinks would be small. To achieve basal concentrations of ILI in 
saliva that were consistently higher than 20 pmol/l volunteers were given the test drinks 60 
minutes following a mixed meal as well as following an overnight fast. This was designed 
to take advantage of the greater sensitivity afforded by taking samples from volunteers 
postprandially when concentrations of ILI in saliva were highest.
None of the test drinks containing complex phenols and tannins, namely red wine and 
black tea, modulated the secretion of ILI in saliva. This experiment was designed to 
investigate the acute effects of the beverages given immediately following their 
consumption. From the results presented in chapter 5 it is apparent that the increase in 
concentration of ILI in saliva, following the consumption of food, reaches mean peak 
values that occur later than and are of smaller magnitude than those of plasma insulin. 
These data from chapter 5 indicate that the stimulus for secretion of ILI in saliva occurs 
following food reaching the stomach and that ILI in saliva is possibly derived from 
circulating insulin. It is therefore possible that any effects of dietary complex phenols and 
tannins may take place over a longer time period than the 90 minutes sampling time used 
for the experiment presented in this chapter.
Only one of the test drinks given to the volunteers had any effect on ILI in saliva. ILI in 
saliva levels increased significantly from basal levels immediately following consumption 
of citric acid (from 31.4 ± 5.7 to 45.5 ± 7.5 pmol/I). This apparent increase in ILI in saliva 
following consumption of citric acid was not statistically different from ILI in saliva 
following consumption of water. One must assume that the increase in ILI in saliva 
following consumption of citric acid was due to the astringent nature of the test drink. 
Organic acids such as citric acid are known to stimulate saliva flow (Dawidson et al.
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1998; Ship & Fischer, 1999), to date no reports have been made regarding whether this is 
only the volume flow rate or the mass flow rate of the solutes in the saliva.
There was a statistically significant decrease in levels of GIP-like immunoreactivity (GLI) 
in saliva from basal levels immediately following consumption of citric acid, decaffeinated 
and whole black tea, with no corresponding decrease following the consumption of water. 
From the results presented in chapter 5 it was postulated that GLI in saliva might be 
involved in the inhibition of gastric acid secretion, via inhibition of pentagastrin-stimulated 
gastric acid secretion. Consumption of caffeinated beverages increased levels of GLI in 
rat SSG, but non-caffeine constituents of black tea did not modulate GLI levels in rat 
SSG (section 4.3.3.2). Caffeinated drinks and caffeine are known to stimulate 
pentagastrin-stimulated gastric acid secretion (Cohan et a l, 1971; McArthur et al, 
1982). It is possible that the apparent modulation of GLI in saliva following 
consumption of these test drinks is caused by both the caffeine constituent of black tea 
and the astringent nature of the test drink.
From the results reported in chapter 5, it was evident that GLI in saliva concentrations 
were highest in fasted volunteers. As volunteers were only given relatively small amounts 
of each test drink, it was therefore expected that any effects seen on GLI in saliva 
following consumption of the test drinks would be small. Therefore, the experiment 
presented in this chapter was designed to take advantage of the greater sensitivity afforded 
by collecting samples from volunteers, following a 12-hour fast when levels of GLI in 
saliva would be highest, as well as 60 minutes postprandially.
Salivary a-amylase activity was not altered following the consumption of decaffeinated or 
caffeinated black tea. Other workers have reported that black tea and tannic acid inhibit 
the activity of salivary a-amylase in vitro. Tannic acid when preincubated with a- 
amylase was found to increase the time taken for the total degradation of starch (Gin et 
al, 1999) and black tea and green tea have been shown to inhibit the actions of a  
amylase (Zhang & Kashket, 1998). It was therefore thought possible that salivary a- 
amylase activity might be reduced following black tea consumption. The apparent non- 
effect of black tea consumption on salivary a-amylase activity may be due to an 
increased secretion of a-amylase from the salivary glands in vivo, which would have
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masked any inhibitory effects of the black tea on the a-amylase activity. In the in vitro 
experiments only a finite amount of a-amylase was available and therefore any 
inhibitory effects of the black tea could be more clearly defined, this is not the case in in 
vivo experiments. If it is possible that consumption of black tea polyphenols leads to 
increased production of salivary proline-rich proteins, then it is also possible that 
consumption of black tea polyphenols could lead to increased secretion of a-amylase 
into saliva.
It is also possible that the interactions of black tea polyphenols with salivary proline- 
rich proteins (PR?) (Charlton et al, 1996; Clifford et al, 1996; Mehansho et a l, 1983; 
Mehansho et a l, 1996) forms a complex, such that the bound polyphenols do not inhibit 
salivary a-amylase activity. It is possible that the binding of dietary tannins to salivary 
PR? which are secreted in saliva, negate the inhibitory effect of tannins on salivary a- 
amylase activity in the saliva collected.
When food is consumed it is first chewed and swallowed. This mechanical breakdown 
of food in the mouth allows the food to come into contact with saliva, and therefore a- 
amylase. When the food is swallowed, it reaches the stomach in a bolus. Within this 
bolus salivary a-amylase continues to hydrolyse starch in the stomach until the pH 
reduces to a level where the a-amylase is denatured. Within the centre of a food bolus 
this can be up to an hour after the time that the food was swallowed. As much as 50 % 
of dietary starch is broken down by a-amylase in the stomach. It is therefore quite 
possible that black tea polyphenols within food boluses, which are not bound to PRP or 
HRP, inhibit the actions of salivary a-amylase in the stomach.
The consumption of red wine and citric acid lead to an increase in salivary a-amylase 
activity compared with the water control, and there was a trend towards higher amylase 
activity following consumption of vodka compared with the water control. These data 
contrast with the a-amylase inhibition seen with tannic acid and black tea polyphenols 
(Gin et a l, 1999; Zhang & Kashket, 1998). Salivary a-amylase activity was increased 
following consumption of both citric acid and vodka, but a-amylase activity was not 
affected following consumption of black tea. It is therefore probable that the apparent 
increase in salivary a-amylase activity following consumption of the red wine was
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caused by the acidity and the alcohol content rather than the polyphenol content of red 
wine. The mechanism by which citric acid and alcohol stimulate salivary a-amylase 
activity and/or its secretion is not clear.
There was an increase in total protein concentration following consumption of red wine. 
It would appear that the increased secretion of protein was not able to offset the 
decreased lubrication associated with red wine consumption and attributed to 
precipitation of salivary PRP by tannins. Increased total protein concentration was seen 
following consumption of the citric acid and vodka test drinks (the astringent and 
alcohol controls for red wine). Astringency is described as the mouth drying or puckering 
sensation produced when dietary tannins interact with salivary proteins (Lea & Arnold, 
1978). Dietary tannins are known to bind to salivary proline-rich proteins (Baxter et al, 
1997). Consumption of astringent solutions leads to a change in the protein profile of 
saliva, which can be attributed to the formation of soluble protein-phenol complexes 
(Kallithraka et al, 1998). Increased acidity in red wine has been suggested to increase 
astringency for a given level of astringent polyphenols of the wine (Guinard et al, 
1986). It is therefore possible that increased salivary total protein following 
consumption of red wine was due to the increased astringency the combined effect of 
the acidity and the polyphenol content of the wine.
There was no increase in salivary total protein concentration following consumption of 
black tea. Black tea polyphenols bind to salivary proline-rich and histidine-rich proteins 
(PRP and HRP) (Charlton et al, 1996; Mehansho et a l, 1983; Mehansho et al, 1996; 
Yan & Bennick, 1995). Dietary tannins have been shown to modulate the secretion of 
PRP in saliva in rodents (Mehansho et al, 1983; Mehansho et a l, 1996). Volunteers 
were given five minutes to consume each test beverage, after which they provided a 
saliva sample. In order to see the effects of black tea consumption on salivary total 
protein levels it would be necessary to use a closed system of saliva collection, such as 
cannulation of the ducts within the mouth. This would ensure that all saliva produced 
following and during consumption of the test drink was collected. This was not possible 
for this experiment; therefore it is possible that were alterations in salivary total protein 
levels which were missed due to the experimental protocol.
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There was a significant increase in salivary total protein concentration following 
consumption of the citric acid. Citric acid is used to stimulate saliva flow in volunteer 
studies (Anderesson et al, 1998; Ship & Fischer, 1999). It has been demonstrated that 
different methods of saliva flow stimulation cause different effects on proteins secreted 
into saliva. For instance, the mechanical stimulation of saliva flow (chewing) lead to a 
greater release of certain neuropeptides into saliva than sensory stimulation (acupuncture) 
or unstimulated saliva (Dawidson et al, 1998). It is possible that stimulation of saliva flow 
by citric acid leads to a change in composition in salivary proteins, which accounts for the 
increase in total protein. In order to truly see the effects of citric acid consumption on 
salivary total protein levels it would be necessary to use a closed system of saliva 
collection as discussed in the previous paragraph.
On separate occasions the volunteers consumed 125 and 200 ml of water. These 
volumes were selected to act as a control for the red wine and black tea experiments 
respectively. The opportunity was taken also to investigate statistically whether any 
volume-related effect of drink consumption could be detected. The volume of water 
consumed did not affect salivary insulin-like or GIP-like immunoreactivity, total protein 
or a-amylase activity.
6.4.1 SUMMARY AND CONCLUSIONS
The consumption of the polyphenol-containing test drinks, red wine and black tea, did 
not modulate the levels of ILI in saliva. Levels of ILI were similarly unaffected by the 
consumption of caffeine-containing beverages or by the consumption of different 
volumes of water. There was no statistically significant difference in GLI in saliva 
following consumption of the test beverages in comparison with the consumption of 
water. Levels of GLI were unaffected by the consumption of different volumes of water.
Salivary a-amylase activity was increased following consumption of red wine, citric 
acid and vodka. The consumption of black tea and different volumes of water did not 
modulate salivary a-amylase activity. Salivary total protein was significantly higher 
following consumption of red wine, citric acid and vodka in comparison with the
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consumption of water. The consumption of black tea and different volumes of water did 
not affect the total protein content of water.
In conclusion, the consumption of red wine and black tea does not modulate the levels 
of ILI or GLI in saliva when compared with the consumption of water. The increase in 
salivary a-amylase activity and total protein that occurred following consumption of red 
wine would appear to be due to the acidity and the alcohol content of the wine rather 
than the polyphenolic content alone.
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CHAPTER SEVEN 
INVESTIGATION OF THE EFFECTS OF BLACK TEA 
CONSUMPTION ON SALIVARY HORMONE 
SECRETION AND THE METABOLIC RESPONSE TO A
MEAL
CHAPTER?
7.1 INTRODUCTION
The gut hormones insulin and glucose-dependent insulinotropic polypeptide (GIF) have 
been shown to be present in human saliva (section 2.3.1). Complex phenols and tannins 
are widely distributed and present in our diets. One of the main sources of complex 
phenols in the UK is from drinking black tea. Previous studies (chapter 4) have 
demonstrated that the consumption of whole black tea in rats had some systemic effects 
on plasma glucose, and GIP in the small intestine. It is possible that the dietary tannins 
present in black tea may modulate the endocrine activity of the salivary glands and 
gastrointestinal tract, and have systemic postprandial metabolic effects as a 
consequence.
Approximately 84 % of the total antioxidant activity of tea is solubilised within a five- 
minute brew (Prior & Gao, 1999); it has been estimated that the average domestic brew 
time for a mug of tea is 30 seconds. In order to transfer the maximal amount of tea 
polyphenols into solution and to keep the volume of tea consumed low a two-minute 
brew into 200 ml of water was used in this experiment.
Previous studies have shown some effects of caffeine in tea on plasma glucose levels in 
rats (Chapter 4) (Zeyuan et al, 1998). In humans, however, there is less conclusive 
evidence of an effect on plasma glucose levels by caffeine consumption. Some workers 
have shown that a 330 mg load of caffeine was without effect on plasma TAG or 
glucose levels in fasted volunteers over a period of 30 minutes (Costill et a l, 1978). 
This is in contrast to findings from (Young & Wolever, 1998) where the pattern of 
blood glucose response to a test meal was modulated by consumption of tea with a meal 
compared with the same volume of water. These workers however, did not use a 
caffeine control, and therefore the effect seen on plasma glucose cannot be either related 
to the caffeine content or other constituents of tea.
Coffee consumption has been positively associated with increased plasma TAG levels
(Thelle et a l, 1983). Other workers have demonstrated an association between
increased coffee consumption and increased levels of total cholesterol in both men and
women, and increased LDL cholesterol in men, but tea consumption gave no such
correlations (Haffner et al, 1985). The effect of coffee on blood lipids is due to
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kahweol, a diterpene which is not found else where in the diet. It is therefore not 
expected in this experiment to duplicate the effects seen following coffee consumption 
on plasma lipids.
In this investigation the hormone and metabolic responses were compared in saliva and 
blood following three mixed meals supplemented with either water, decaffeinated black 
tea or whole black tea. GIF and insulin were measured in both blood and saliva samples 
taken at identical time points before and after these meals. Postprandial carbohydrate 
and lipid tolerance were monitored by measuring circulating glucose, TAG and NET A 
levels. The study was of a random within subject 3-way crossover design.
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7.2 METHODS
7.2.1 STUDY DESIGN
This was a random within subject 3-way crossover comparison of hormone and 
metabolic response to a mixed meal consumed with either two 200 ml cups of strong 
whole black tea, decaffeinated black tea or water. One cup was drunk before the meal 
and one cup with the meal. The washout period was seven days.
7.2.2 SUBJECTS
Ten healthy men and women aged between 20 and 30 were recruited from within the 
university by advertisements and ‘word of mouth’. Subjects were excluded if they had a 
body mass index that was not between 20 and 26 kg/m^, had significant current or 
previous medical history, were receiving regular medication (apart from oral 
contraceptives), which may affect gastrointestinal or central nervous systems, consumed 
more than twenty units of alcohol a week, or had given blood within the three months 
prior to the study. Subjects were provided with an information sheet and gave written 
consent to participate in this study. They were interviewed and a venous blood sample 
was taken for haematological screening (Full Blood Count). Their GP was informed of 
the study. The University of Surrey Ethics Committee approved the study protocol.
7.2.3 STUDY PROTOCOL
Three test meals, separated by at least seven days, were given to the subjects in a 
randomised study. Subjects were provided with all food to be consumed during the two 
days prior to the study day. The meals that the subjects were given were very low in 
dietary complex phenols and tannins. During this time subjects refrained from drinking 
tea, coffee, alcohol, caffeine-containing drinks and all tannin-rich drinks. At times other 
than the two days prior to and during the study days subjects were permitted to consume 
their normal diet, with no constraints. Subjects fasted overnight from 2000 h prior to 
each study day.
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On arrival at the Clinical Investigation Unit at the University of Surrey at 0800 h on 
each study day, a cannula was placed into an antecubital vein, under local anaesthetic if 
preferred by the volunteer, by a qualified doctor or nurse. Basal venous blood and saliva 
samples (12 ml and 2 ml respectively) were then taken simultaneously. This was 
repeated after 15 min, immediately before the test drink and meal were given.
After the second basal samples had been taken each subject was asked to eat their meal. 
On one occasion, in random order, the meal was eaten with either two 200 ml cups of 
strong tea (a 2 min brew from a Tesco's green label tea bag, with milk and no sugar), 
two 200 ml cups of strong decaffeinated tea (a 2 min brew from a Tesco's green label 
tea bag, with milk and no sugar) or it was eaten with two 200 ml glasses of water. One 
cup was drunk before the meal and one cup with the meal. The meal was cheese 
sandwiches and a muesli bar (2008 kJ, containing 40 % total energy as carbohydrate, 
40% as fat and 20% as protein). A period of 5 min was allowed to consume the drink, 
and 10 min to consume the meal. After the drink the first samples of blood and saliva 
were collected, and then immediately following the meal. Samples were taken every 15 
min up to 1 h, after which time samples were collected every half hour up to 2 h, and 
hourly up to 9 h. The total amount of blood collected was approximately 576 ml and the 
total amount of saliva was approximately 96 ml.
7.2.4 SAMPLE ANALYSIS
Plasma was separated immediately by centrifugation at 1825 x g for 10 minutes with 
suitable preservatives (see section 2.2.14) and stored at -20 °C until analysis. Plasma 
samples were analysed by RIA for the measurement of GIF, GLP-1 and insulin (see 
sections 2.2.2, 2.2.4 and 2.2.7) and by automated enzymatic methods for TAG, NET A 
and glucose (see sections 2.2.11, 2.2.12 and 2.2.13).
Saliva was centrifuged (10 minutes at 1825 x g) to remove all particulate matter and 
stored at -20 °C. Saliva samples were analysed by RIA for the measurement of GIF and 
insulin (see sections 2.2.3 and 2.2.8). Saliva total protein concentration and amylase 
activity were analysed by automated enzymatic methods (see sections 2.2.9 and 2.2.10).
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7.2.5 STATISTICAL ANALYSIS
Data are expressed in the text as mean ± standard error of the mean. Statistical analysis 
was achieved using the Statistica for Windows statistical software package (StatSoft Inc, 
2300 East 14* St, Tulsa OK 74104, USA). Data were compared with the Kolmogorov- 
Smimov test and transformed if necessary. Comparison between the meals with black tea 
or water was performed by repeated measures analysis of variance (RM-ANOVA) with 
time X treatment as within-subject factors. Significant differences were located using 
Duncan's multiple range test and critical ranges for multiple corrections. Total and 
incremental areas under the curve were calculated by the trapezoidal rule. One way- 
analysis of variance with treatment as the within-subject factor was used to determine 
significant differences between the total and incremental area under the curve following 
the meals with black tea or water. Values ofp< 0.05 were considered significant.
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7.3 RESULTS
The results for all plasma analysis are presented with the exclusion of one subject. Due 
to typically and variably high fasting plasma TAG levels the subject was believed to be 
hyperlipidaemic, and as the experiment was designed to investigate the effects of acute 
black tea consumption on lipid metabolism this data set was removed. The plasma TAG 
results for this subject are presented separately in section 1 3 2 2 ,
7.3.1 PLASMA PEPTIDE HORMONE RESPONSE
7.3.1.1 Circulating insulin response to a mixed meal with black tea or water
The circulating insulin response to a mixed meal consumed with black tea or water can 
be seen in figure 7.1. Basal circulating insulin levels were 67.6 ± 15.5 pmol/1. 
Circulating insulin levels increased following the meals {p < 0.0001). Peak circulating 
insulin levels occurred at 120 minutes following the meal with water (508 ±120  
pmol/1), at 90 minutes following the meal with decaffeinated black tea (451 ± 91 
pmol/1) and at 60 minutes following the meal with whole black tea (687 ± 230 pmol/1).
Repeated measures ANOVA of circulating insulin levels revealed no significant 
variation with respect to time x treatment following meals consumed with water, 
decaffeinated black tea or whole black tea over the nine hours of the experiment 
{p < 0.46), or in the first 90 minutes of the experiment {p = 0.62).
The total response (total area under the curve, TAUC) for plasma insulin over nine 
hours following the meal consumed with water was 1530 ± 220 pmol/l/h, with 
decaffeinated black tea 1750 ± 300 pmol/l/h and with whole black tea 1950 ± 390 
pmol/l/h. One way-ANOVA showed no significant differences between the TAUC 
following the three meals over nine hours {p = 0.35).
The TAUC for plasma insulin over 90 minutes following the meal consumed with water 
was 558 ±110 pmol/l/h, with decaffeinated black tea 537 ± 99 pmol/l/h, and with whole 
black tea 791 ± 200 pmol/l/h. One way-ANOVA showed no significant differences 
between the TAUC following the three meals over nine hours {p = 0.25).
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Figure 7.1 Plasma insulin concentration (pmol/1) in volunteers following consumption 
of a mixed meal with black tea, decaffeinated black tea or water (n = 9, mean ± SEM)
7.3.1.2 Circulating GIF response to a mixed meal with black tea or water 
The circulating GIF response to a mixed meal consumed with black tea or water can be 
seen in figure 7.2. Basal circulating GIF levels were 91.8 ± 20 pmol/1. Circulating GIF 
levels increased following the meals (p < 0.0001). Peak circulating GIF levels occurred 
at 45 minutes following the meal with water (352 ± 63 pmol/1), at 90 minutes following 
the meal with decaffeinated black tea (409 ±110 pmol/1) and at 180 minutes following 
the meal with whole black tea (459 ±230 pmol/1).
Repeated measures ANOVA of circulating GIF levels revealed no significant variation 
with respect to time x treatment following meals consumed with water, decaffeinated 
black tea or whole black tea over the nine hours of the experiment 
ip = 0.46), or in the first 90 minutes of the experiment {p = 0.59).
The TAUC for plasma GIF over nine hours following the meal consumed with water
was 1640 ± 170 pmol/l/h, with decaffeinated black tea 1970 ± 400 pmol/l/h and with
whole black tea 2560 ± 800 pmol/l/h. One way-ANOVA showed no significant
differences between the TAUC following the three meals over nine hours {p = 0.70).
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The TAUC for plasma GIF from 90 minutes to 360 minutes following the meal 
consumed with water was 1100 ± 140 pmol/l/h, with decaffeinated black tea 1420 ±310 
pmol/l/h and with whole black tea 1900 ± 720 pmol/l/h. One way-ANOVA showed no 
significant differences between the TAUC following the three meals over this time 
period {p = 0.25).
The TAUC for plasma GIF over the first 90 minutes following the meal consumed with 
water was 423 ± 61 pmol/l/h, with decaffeinated black tea 432 ± 88 pmol/l/h and with 
whole black tea 472 ± 83 pmol/l/h. One way-ANOVA showed no significant 
differences between the TAUC following the three meals over the first 90 minutes 
following the meals {p = 0.22).
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Figure 7.2 Flasma GIF concentration (pmol/1) in volunteers following consumption of a 
mixed meal with black tea, decaffeinated black tea or water {n = 9, mean ± SEM)
7.3.1.3 Circulating GLP-1 response to a mixed meal with black tea or water
The circulating GLF-1 response to a mixed meal consumed with black tea or water can 
be seen in figure 7.3. Basal circulating GLF-1 levels were 12.3 ± 2.7 pmol/1. Circulating 
GLF-1 levels increased following the meals (n < 0=0001). Feak circulating GLF-1 levels 
occurred at 30 minutes following the meal. GLF-1 levels rose to 23.0 ±3.9  pmol/1 
following the meal with water, to 27.7 ± 4.9 pmol/1 with decaffeinated black tea and to
31.3 ± 6.5 pmol/1 with whole black tea.
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Repeated measures ANOVA of circulating GLP-1 levels revealed significant variation 
with respect to time x treatment following meals consumed with water, decaffeinated 
black tea or whole black tea {p < 0.0001). Consequent comparisons between groups 
showed significantly higher amounts of circulating GLP-1 following the meal 
consumed with black tea compared with the meal consumed with water over nine hours 
ip = 0.03). There was a trend towards higher amounts of circulating GLP-1 following 
the meal consumed with decaffeinated black tea compared with the meal consumed 
with water over nine hours {p = 0.06). There was no significant difference between the 
meals consumed with decaffeinated black tea and whole black tea over the nine hours of 
the experiment {p = 0.7). Repeated measures ANOVA showed no significant 
differences in circulating GLP-1 levels between the meals consumed with black tea or 
water in the first 90 minutes of the experiment {p = 0.44).
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Figure 7.3 Plasma GLP-1 concentration (pmol/1) in volunteers following consumption 
of a mixed meal with black tea, decaffeinated black tea or water {n = 8, mean ± SEM)
The TAUC for plasma GLP-1 over nine hours following the meal consumed with water 
was 126 ± 22 pmol/l/h, with decaffeinated black tea 160 ± 30 pmol/l/h, and with whole 
black tea 173 ±43 pmol/l/h. There were no significant differences between the TAUC 
following the three meals {p = 0.22).
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The TAUC for plasma GLP-1 over the first 90 minutes following the meal consumed 
with water was 30.6 ± 5.6 pmol/l/h, with decaffeinated black tea 33.3 ± 5.1 pmol/l/h and 
with whole black tea 36.2 ± 6.8 pmol/l/h. There were no significant differences in the 
TAUC over the first 90 minutes following the three meals {p = 0.49).
7.3.2 PLASMA METABOLITE RESPONSE TO A MIXED MEAL WITH 
BLACK TEA OR WATER
7.3.2.1 Plasma TAG levels following consumption o f a mixed meal with black tea or 
water
The circulating TAG response to a mixed meal consumed with black tea can be seen in 
figure 7.4. Basal circulating TAG levels were 0.93 ±0.14 mmol/1. Circulating TAG 
levels increased following the meals {p < 0.0001). Peak circulating TAG levels occurred 
at 90 minutes following the meal consumed with water (1.20 ± 0.19 mmol/1), at 120 
minutes following the meal consumed with decaffeinated black tea (1.18 ± 0.18 mmol/1) 
and at 180 minutes following the meal consumed with whole black tea (1.43 ± 0.24 
mmol/1).
Repeated measures ANOVA of plasma TAG levels revealed no significant variation 
with respect to time x treatment following meals consumed with water, decaffeinated 
black tea or whole black tea over nine hours {p = 0.93), but there was a significant 
difference with respect to treatment over nine hours (p = 0.03). Consequent between 
group comparisons showed significantly higher plasma TAG levels following the meal 
consumed with whole black tea compared with the meals consumed with water or 
decaffeinated black tea over nine hours {p = 0.03 and 0.02 respectively). There were no 
significant differences in plasma TAG levels following the meals consumed with water 
or decaffeinated black tea {p = 0.79).
Repeated measures ANOVA of plasma TAG levels revealed no significant variation 
with respect to time x treatment following meals consumed with water, decaffeinated 
black tea or whole black tea over the first 90 minutes {p = 0.28).
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The TAUC for plasma TAG over nine hours following the meal consumed with water 
was 10.3 ± 1.2 mmol/l/h, with decaffeinated black tea 10.2 ± 0.15 mmol/l/h and with 
whole black tea 12.7 ± 1.6 mmol/l/h. One way-ANOVA showed a trend towards 
differences between the TAUC following the three meals {p = 0.057). Subsequent 
between group comparisons revealed significantly higher TAUC following the meal 
consumed with whole black tea compared with the meals consumed with water and 
decaffeinated black tea {p = 0.04 and 0.04 respectively). There was no significant 
difference in the TAUC over nine hours following the meals consumed with water and 
decaffeinated black tea {p = 0.94)
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Figure 7.4 Plasma TAG levels (mmol/1) in volunteers following consumption of a mixed 
meal with black tea, decaffeinated black tea or water {n = 9, mean ± SEM)
The TAUC for plasma TAG over 90 minutes following the meal consumed with water 
was 1.69 ± 0.22 mmol/l/h, with decaffeinated black tea 1.59 ± 0.23 mmol/l/h and with 
whole black tea 1.92 ± 0.27 pmol/l/h. One way-ANOVA showed no significant 
differences in the TAUC over the first 90 minutes following the three meals {p = 0.12).
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7.3.2.2 Plasma TAG levels from volunteer with suspected hyperlipidaemia
Basal plasma TAG levels from an individual volunteer were outside of normal values. 
The circulating TAG response to a meal consumed with black tea for this volunteer can 
be seen in figure 7.5. The fasting plasma samples from different days had variable TAG 
levels at 2.02, 2.75 and 3.33 mmol/1. Peak circulating TAG levels occurred at 180 
minutes following the meal consumed with water (3.53 mmol/1), at 180 minutes 
following the meal consumed with decaffeinated black tea (4.78 mmol/1) and at 240 
minutes following the meal consumed with whole black tea (4.47 mmol/1). After nine 
hours, plasma TAG levels were 2.89, 2.65, 2.73 mmol/1 following the meals consumed 
with water, decaffeinated black tea and whole black tea respectively.
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Figure 7.5 Increase in plasma TAG levels (mmol/1) from basal in an individual volunteer 
with suspected hyperlipidaemia following consumption of a mixed meal with black tea, 
decaffeinated black tea or water (%=1)
Differences in the increase in plasma TAG following meals consumed with water, 
decaffeinated black tea and whole black tea were compared using a students /-test. 
Plasma TAG were significantly lower in this volunteer following decaffeinated black 
tea compared with water and whole black tea (p = 0.01 and 0.04 respectively). There
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was a trend towards lower TAG following consumption of the meal with whole black 
tea compared with water {p = 0.05).
7.3.2.3 Plasma glucose levels following consumption o f a mixed meal with black tea or 
water
The circulating glucose response to a mixed meal consumed with black tea can be seen 
in figure 7.6. Basal circulating glucose levels were 4.27 ± 0.27 mmol/1. Circulating 
glucose levels increased following the meals (p < 0.0001). Peak circulating glucose 
levels occurred at 30 minutes following the meal consumed with water (5.71 ± 0.28 
mmol/1), at 45 minutes following the meal consumed with decaffeinated black tea (5.72 
± 0.22 mmol/1) and 30 minutes following the meal consumed with whole black tea (5.25 
± 0.31 mmol/1).
Repeated measures ANOVA of plasma glucose levels revealed no significant variation 
with respect to time x treatment following meals consumed with water, decaffeinated 
black tea or whole black tea over nine hours (p = 0.92). Repeated measures ANOVA of 
plasma glucose levels revealed no significant differences between meals consumed with 
water, decaffeinated black tea and whole black tea in the first 90 minutes of the 
experiment with respect to time x treatment (p = 0.86).
The TAUC for plasma glucose over nine hours following the meal consumed with water 
was 42.8 ±1.7 mmol/l/h, with decaffeinated black tea 41.7 ± 1.5 mmol/l/h and with 
whole black tea 42.7 ± 1.1 mmol/l/h. One-way ANOVA revealed no significant 
differences between the TAUC following the three meals (p = 0.65). The TAUC for 
plasma glucose over the first 90 minutes following the meal consumed with water was
8.5 ± 0.4 mmol/l/h, with decaffeinated black tea 8.5 ± 0.3 mmol/l/h and with whole 
black tea 8.2 ± 0.3 mmol/l/h. One-way ANOVA revealed no significant differences in 
the TAUC over the first 90 minutes following the three meals (p = 0.60).
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Figure 7.6 Plasma glucose levels (mmol/1) in volunteers following consumption of a 
mixed meal with black tea, decaffeinated black tea or water {n = 9, mean ± SEM)
7.3.2.4 Plasma NEFA levels following consumption o f a mixed meal with black tea or 
water
The circulating NEFA response to a mixed meal consumed with black tea can be seen in 
figure 7.7. Basal circulating NEFA levels were 0.48 + 0.1 mmol/1. Circulating NEFA 
levels decreased following the meals {p < 0.0001). The lowest circulating NEFA levels 
(mmol/1) occurred 90 minutes following the meal consumed with water (0.13 ± 0.15), at 
120 minutes following the meal consumed with decaffeinated black tea (0.16 ± 0.02) 
and 60 minutes following the meal consumed with whole black tea (0.16 ± 0.01).
Repeated measures ANOVA of plasma NEFA levels revealed no significant variation 
with respect to time x treatment following meals consumed with water, decaffeinated 
black tea or whole black tea over the nine hour test period (p = 0.98). Repeated measures 
ANOVA of plasma NEFA levels revealed no significant variation with respect to time x 
treatment following meals consumed with water, decaffeinated black tea or whole black 
tea during the first 90 minutes of the experiment {p = 0.73).
The total response TAUC for plasma NEFA over nine hours following the meal 
consumed with water was 2.16 ± 0.25 mmol/l/h, with decaffeinated black tea 2.21 ±
192
CHAPTER 7
0.14 mmol/l/h and with whole black tea 2.34 ± 0.22 mmol/l/h. One way-ANOVA 
showed no significant differences between the TAUC following the three meals {p = 
0 .66).
The TAUC for plasma NEFA over 90 minutes following the meal consumed with water 
was 0.41 ± 0.07 mmol/l/h, with decaffeinated black tea 0.48 ± 0.09 mmol/l/h and with 
whole black tea 0.44 ± 0.07 mmol/l/h. One way-ANOVA showed no significant 
differences in the TAUC over the first 90 minutes following the three meals {p = 0.75).
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Figure 7.7 Plasma NEFA levels (mmol/1) in volunteers following consumption of a 
mixed meal with black tea, decaffeinated black tea or water {n = 9, mean ± SEM)
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7.3.3 SALIVARY PEPTIDE HORMONE IMMUNOREACTIVITY
7.3.3.1 Salivary insulin-like immunoreactivity response to a mixed meal with black tea 
or water
The salivary insulin-like immunoreactivity (ILI) response to a mixed meal consumed 
with black tea can be seen in figure 7.8. Basal salivary ILI levels were 43.7 ±16 pmol/1. 
Salivary ILI levels increased following the meals (p = 0.002). Peak circulating insulin 
levels occurred at 90 minutes following the meal with water (279 ±81 pmol/1), and at 
120 minutes following the meal with decaffeinated black tea (280 ± 74 pmol/1) and the 
meal with whole black tea (291 ± 74 pmol/1).
Repeated measures ANOVA of salivary ILI levels revealed no significant variation with 
respect to time x treatment following meals consumed with water, decaffeinated black 
tea or whole black tea over the nine hour test period (p = 0.97) and in the first 90 minutes 
of the experiment (p = 0.89).
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Figure 7.8 Salivary insulin-like immunoreactivity (pmol/1) in volunteers following 
consumption of a mixed meal with black tea, decaffeinated black tea or water (n = 10, 
mean ± SEM)
The TAUC for salivary ILI over nine hours following the meal consumed with water
was 1270 ± 220 pmol/l/h, with decaffeinated black tea 1110 ± 240 pmol/l/h and with
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whole black tea 886 ± 200 pmol/l/h. One way-ANOVA showed no significant 
differences between the TAUC following the three meals {p = 0.24).
The TAUC for salivary ILI over 90 minutes following the meal consumed with water 
was 208 ± 52 pmol/l/h, with decaffeinated black tea 189 ± 53 pmol/l/h and with whole 
black tea 156 ± 27 pmol/l/h. One way-ANOVA showed no significant differences in the 
TAUC over the first 90 minutes following the three meals {p = 0.91).
73.3.2 Salivary GIP-like immunoreactivity response to a mixed meal with black tea or 
water
The salivary GIP-like immunoreactivity (GLI) response to a mixed meal consumed with 
black tea can be seen in figure 7.9. Basal circulating GIP levels were 256 ± 79 pmol/1. 
Salivary GLI levels decreased following the meals (p = 0.0001). Salivary GLI levels at 
15 minutes following the meal with water were 123 ± 34 pmol/I, following the meal 
with decaffeinated 113 ±48 pmoI/1 and following the meal with whole black tea were 
121 ± 41 pmol/1.
Repeated measures ANOVA of salivary GLI levels revealed significant variation with 
respect to time x treatment following meals consumed with water, decaffeinated black 
tea or whole black tea over the nine hour test period (p = 0.021). Consequent 
comparisons between groups showed a trend towards higher amounts of salivary GIP 
following the meal consumed with water compared with the meal consumed with black 
tea over nine hours (p = 0.098). Repeated measures ANOVA of salivary GLI levels 
revealed significant variation with respect to time x treatment following meals 
consumed with water, decaffeinated black tea or whole black tea over the first 90 
minutes of the experiment (p = 0.003). Consequent comparisons between groups 
showed no significant differences in salivary GLI following the three meals.
The TAUC for salivary GLI over nine hours following the meal consumed with water 
was 1350 ± 420 pmol/l/h, with decaffeinated black tea 1150 ± 380 pmol/l/h and with 
whole black tea 941 ± 230 pmol/l/h. There were no significant differences between the 
TAUC following the three meals (p = 0.21).
195
CHAPTER 7
The TAUC for salivary GLI over the first 90 minutes following the meal consumed 
with water was 178 ± 72 pmol/l/h, with decaffeinated black tea 179 ± 64 pmol/l/h and 
with whole black tea 170 ± 60 pmol/l/h. There were no significant differences in the 
TAUC over the first 90 minutes following the three meals (p = 0.91).
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Figure 7.9 Salivary GLI-like immunoreactivity (pmol/1) in volunteers following 
consumption of a mixed meal with black tea, decaffeinated black tea or water (n = 10, 
mean ± SEM)
7.3.4 SALIVARY TOTAL PROTEIN AND a-AMYLASE ACTIVITY
7.3.4.9 Salivary total protein concentration following consumption o f a mixed meal with 
black tea or water
The salivary total protein following consumption of a mixed meal consumed with black 
tea can be seen in figure 7.10. Basal total protein levels were 0.97 ± 0.28 g/1. Salivary 
total protein increased immediately following food (p = 0.018). Peak total protein levels 
occurred at 15 minutes following the meals. Salivary total protein levels rose to 1.97 ± 
0.45 g/1 following the meal consumed with water, 1.74 ± 0.34 g/1 following the meal 
consumed with decaffeinated black tea and 2.39 ± 0.56 g/1 following the meal 
consumed with whole black tea.
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Repeated measures ANOVA of salivary total protein levels revealed no signifleant 
variation with respeet to time x treatment following meals consumed with water, 
decaffeinated black tea or whole black tea over the nine hour test period {p = 0.34). 
Repeated measures ANOVA of salivary total protein levels revealed no significant 
variation with respeet to time x treatment following meals consumed with water, 
decaffeinated black tea or whole black tea over the first 30 minutes of the experiment {p 
-  0.49).
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Figure 7.10 Salivary total protein (g/1) in volunteers following consumption of a mixed 
meal with black tea, decaffeinated black tea or water {n= 10, mean ± SEM)
The TAUC for salivary total protein over nine hours following the meal consumed with 
water was 11.7 ± 1.9 g/l/h, with decaffeinated black tea 11.5 ± 1.6 g/l/h and with whole 
black tea 12.0 ± 2.5 g/l/h. One way-ANOVA showed no significant differences between 
the TAUC following the three meals (p = 0.65).
The TAUC for salivary total protein over 30 minutes following the meal consumed with 
water was 0.71 ± 0.2 g/l/h, with decaffeinated black tea 0.66 ± 0.1 g/l/h and with whole 
black tea 0.79 ± 0.2 g/l/h. One way-ANOVA showed no significant differences in the 
TAUC over the first 30 minutes following the three meals (p = 0.77).
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7.3.4.10 Salivary a-amylase activity following consumption o f a mixed meal with black 
tea or water
The salivary a-amylase activity following consumption of a mixed meal consumed with 
black tea can be seen in figure 7.11. Basal salivary a-amylase levels were 32.9 ± 4.5 
KU/1. Salivary a-amylase activity increased following the meals {p < 0.0001). Peak 
salivary a-amylase activity occurred at 15 minutes following the meal with water (90.9 
±15.9 KU/1), following the meal with decaffeinated black tea (79.6 ±15.8 KU/1) and 
the meal with whole black tea (78.3 ± 15.4 KU/1).
Repeated measures ANOVA of salivary a-amylase activity revealed no significant 
variation with respect to time x treatment following meals consumed with water, 
decaffeinated black tea or whole black tea over the nine hour test period {p = 0.74). 
Repeated measures ANOVA of salivary a-amylase activity revealed no significant 
variation with respect to time x treatment following meals consumed with water, 
decaffeinated black tea or whole black tea over the first 90 minutes of the experiment {p 
= 0.15).
The TAUC for salivary a-amylase activity over nine hours following the meal 
consumed with water was 736 ±110 KU/l/h, with decaffeinated black tea 787 ±130 
KU/l/h and with whole black tea 832 ±130 KU/l/h. One way-ANOVA showed no 
significant differences between the TAUC following the three meals (p = 0.46).
The TAUC for salivary a-amylase activity over 90 minutes following the meal 
consumed with water was 114 ± 21 KU/l/h, with decaffeinated black tea 112 ± 19 
KU/l/h and with whole black tea 126 ± 19 KU/l/h. One way-ANOVA showed no 
significant differences in the TAUC over the first 90 minutes following the three meals 
{p = 0.37).
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Figure 7.11 Salivary amylase activity (KU/1) in volunteers following consumption of a 
mixed meal with black tea, decaffeinated black tea or water (« = 10, mean ± SEM)
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7.4 DISCUSSION
Plasma insulin levels increase following the absorption of nutrients. The plasma insulin 
responses to a mixed meal consumed with water, decaffeinated black tea or whole black 
tea were not significantly different. There was a non-significant increase in the total 
area under the curve (TAUC) in the first 90 minutes following the meal consumed with 
whole black tea compared with decaffeinated black tea and water. The increase in total 
amount of insulin in plasma over the nine-hour test period occurred following the 
caffeinated black tea. This apparent increase in TAUC would therefore appear to be an 
effect of the caffeine present within the tea and not due solely to the tea polyphenols or 
other tea constituents.
Caffeine acts as an antagonist to central adenosine receptors, which may account for its 
reported stimulant properties. Competitive antagonism of adenosine receptors leads to 
an increase in synaptic activity and consequently stimulates the release of 
neurotransmitters. This in turn causes a net increase in the brain's glucose requirements 
(Nehlig et a l, 1991), it should be noted that the uptake of glucose by the brain is not 
insulin dependent. The main function of insulin is to stimulate glucose uptake from 
plasma. If the consumption of caffeine has led to a greater requirement for glucose then 
greater amounts of insulin would be necessary to augment the glucose uptake.
At various times other hypotheses have been advanced for the actions of caffeine, these 
include the weak inhibition of the activity of phosphodiesterases. This produces a 
stimulant effect on cardiac function and increased blood flow in coronary arteries. 
Caffeine has been shown to increase the resting metabolic rate by 16 % in normal 
subjects without any influence on either plasma insulin or glucose levels over 180 
minutes (Acheson et ah, 1980). It is therefore possible that in the present study the 
consumption of caffeine increased the resting metabolic rate of volunteers which in turn 
lead to a greater requirement for glucose by tissues and hence insulin.
Circulating GIP levels were not significantly different following the meals with whole
black tea, decaffeinated black tea or water. Circulating GIF did not decrease from peak
levels as rapidly following the meal consumed with whole black tea compared with
water and decaffeinated black tea, and levels remained elevated over five hours
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following the meal. Circulating GIP levels were also elevated following the 
decaffeinated black tea. It would appear that the elevated levels (not statistically 
significant) of GIP from 90 minutes to 360 minutes were a response not only to caffeine 
but also to other constituents of black tea, for example polyphenols.
GIP secretion is stimulated by the absorption of nutrients. From the animal studies 
described in chapters 3 and 4 it has been postulated that consumption of black tea 
polyphenols and caffeine led to an increase in gut transit time. This would allow the 
absorption of nutrients to occur over a longer period of time and therefore lead to 
stimulation of GIP secretion over a prolonged period of time with respect to a water 
control.
Circulating GLP-1 levels were significantly higher following the meal consumed with 
black tea compared with the meal consumed with water. There was a trend towards 
increased levels of GLP-1 following the meal with decaffeinated black tea compared 
with water. From these data it is apparent that elevated circulating GLP-1 levels were 
found following the whole black tea and the decaffeinated black tea compared with 
water. These data are consistent with the suggestion that black tea polyphenols and 
caffeine increase gut transit time and therefore absorption of nutrients occurs over a 
longer period of time and elevated levels of GLP-1 occur.
There were non-significantly lower levels of plasma glucose immediately following the 
meal consumed with whole black tea compared with water and decaffeinated black tea. 
If black tea polyphenols and caffeine lead to an increased gut transit time this indicates 
a longer period of contact of nutrients with absorptive surfaces, thus allowing a greater 
uptake of nutrients over the whole transit period. If glucose absorption occurred over a 
longer period of time then one would expect plasma insulin levels to be elevated over 
this same period of time. Plasma insulin levels were higher immediately following the 
meal with whole black tea; plasma glucose levels were lower following the meal 
consumed with whole black tea. It is possible that the caffeine present in tea stimulated 
insulin secretion and therefore led to an increased rate of glucose uptake from the 
plasma.
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The effects of black tea and caffeine on blood glucose levels have been examined by 
other workers in both overnight fasted volunteers and postprandially. Blood glucose 
levels were increased in volunteers, 45 minutes following a test meal consumed with tea 
compared with the same volume of water (Young & Wolever, 1998). Other workers 
have reported increased plasma glucose two to four hours following ingestion of 
caffeine and an oral glucose load (Pizziol et a l, 1998). These findings are potentially in 
disagreement with the results of this investigation where plasma glucose levels were 
lower following the meal consumed with black tea compared with water, although these 
differences were not statistically significant. There are also reports of no effect of 
caffeine (8 mg/kg body weight) on plasma glucose levels in fasted volunteers compared 
with glucose control (Acheson et al, 1980), and these data would appear to more 
closely support the findings of this investigation.
There were no significant differences in plasma TAG levels following the meals 
consumed with whole black tea, decaffeinated black tea or water. From the shape of the 
curve (figure 7.4) it would appear that plasma TAG clearance was delayed following 
the meal consumed with whole black tea compared with water or decaffeinated black 
tea. This indicates that the caffeine consumed from the whole black tea may have 
decreased TAG clearance following the meal.
Data from chronic studies, where hamsters were given whole black tea in place of 
drinking water, suggest plasma TAG levels were reduced in overnight fasted animals 
following chronic black tea consumption compared with control animals (Vinson & 
Dabbagh, 1998). Other workers have reported that green tea supplements, equivalent to 
two cups of green tea, had no effect on basal levels of plasma TAG in volunteers 
(Nakagawa et al, 1999). It would therefore appear that although elevated postprandial 
levels of plasma TAG were seen following caffeinated black tea consumption with a 
meal, indicating delayed clearance from plasma, this habitual tea consumption would 
not lead to altered lipid profiles. It would be necessary to carry out an intervention trial 
where diets were supplemented with controlled levels of black tea to see the effects of 
black tea and caffeine consumption on plasma lipid profiles.
Elevated levels of circulating GIP and GLP-1 were seen following the meal consumed
with whole black tea and decaffeinated black tea compared with water. Plasma TAG
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clearance was delayed following the meal consumed with whole black tea compared 
with water and decaffeinated black tea. Dietary fat is a known secretagogue for GIF, but 
circulating levels of TAG do not stimulate GIP secretion. It therefore seems unlikely 
that elevated hormone levels are related to the delayed TAG clearance from plasma 
following the meal consumed with whole black tea, but rather that these events are 
independent of one another.
Plasma TAG levels from the volunteer with suspected hyperlipidaemia were lower 
following the meal consumed with decaffeinated black tea compared with water and 
whole black tea. It would appear from these data that the consumption of decaffeinated 
black tea with the meal aided the clearance of plasma TAG following the meal 
compared with water. It would not be possible to draw conclusions about the effects of 
the non-caffeine constituents of black tea on postprandial TAG clearance in patients 
with hyperlipidaemia based on the data from one volunteer, but these data may justify 
further work in this area.
There were no significant differences in plasma NEFA concentration following the 
mixed meal with whole black tea decaffeinated black tea or water. Plasma NEFA levels 
decreased following food in accordance with values quoted in the literature (Elliott et 
al, 1993). Caffeine ingestion has been associated with increased NEFA in blood in both 
volunteer studies and animal studies (Cowan et al, 1977; Hetzler et a l, 1990; Leblanc 
et al, 1995; Powers et al, 1983). The data presented here did not find any affect of 
caffeine consumption with a meal on postprandial NEFA levels. It is possible that the 
caffeine levels present in the tea consumed by the volunteers were not high enough to 
exert an effect on postprandial plasma NEFA levels.
Salivary ILI concentration rose following meals, mean peak levels of ILI in saliva were 
lower then circulating insulin levels (279 ± 81 and 508 ± 120 pmol/1 respectively) and 
peak values were obtained in saliva later than those of plasma (120 minutes in saliva 
compared with 90 minutes in plasma). These data are consistent with those seen 
following consumption of the swallowed meal in chapter 5 (section 5.3.3.1), and those 
reported in the literature (Fekete et al, 1993). Further discussion of salivary ILI can be 
found in section 5.4.
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One hypothesis proposed to explain the presence of ILI in saliva is that salivary ILI is 
the product of ultrfiltration of insulin from blood into saliva. For this to be possible one 
would expect levels of ILI in saliva to be consistently lower than those of plasma. 
Although postprandial peak values of ILI in saliva have been consistently lower than 
and observed later than those of plasma insulin, levels of salivary ILI 240 minutes 
following the meal were higher than those of plasma (167 ± 28 and 127 ± 21 
respectively) although this was not statistically significant. The mean concentration of 
ILI in saliva remained higher than that of plasma until 540 minutes following the meal 
with water. These data therefore do not support the theory that salivary ILI is solely an 
ultrafiltrate from blood.
Salivary ILI was not significantly different following the meals consumed with whole 
black tea, decaffeinated black tea or water. The consumption of whole black tea and 
decaffeinated black tea with a meal led to a quicker decrease in salivary ILI compared 
with water (see figure 7.8). This decrease would appear to be in part due to the 
consumption of tea constituents other than caffeine.
Salivary GLI concentrations dropped immediately following food as demonstrated in 
chapter 5 (section 5.3.3). There was a trend towards higher levels of GLI in saliva 
following the meal consumed with water compared with the meal consumed with whole 
black tea. One proposed function of GLI in saliva is inhibition of the pentagastrin- 
stimulated gastric acid secretion in the fasted state (see section 5.4). Caffeinated drinks 
and caffeine are known to stimulate pentagastrin-stimulated gastric acid secretion 
(Cohan et a l, 1971; McArthur et al, 1982). It is possible that the apparent modulation 
of salivary GLI following consumption of the caffeinated tea may be involved in the 
action of caffeine to stimulate gastric acid secretion. It is also possible that the proposed 
increase in gut transit time following consumption of black tea, may also require less 
inhibition of gastric acid and therefore lower levels of salivary GLI.
Levels of salivary a-amylase activity were not significantly lower following the meal 
with black tea. It has been demonstrated that black tea and tannic acid inhibit the 
activity of salivary a-amylase in vitro (Zhang & Kashket, 1998; Gin et a l, 1999). It was
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therefore expected to see a reduction in salivary a-amylase activity following the meals 
with black tea. However, black tea polyphenols bind to salivary proline-rich and 
histadine-rich proteins (PR?) (HRP) (Charlton et a l, 1996; Mehansho et a l, 1983; 
Mehansho et al, 1996; Yan & Bennick, 1995), and habituai tea drinking leads to 
increased amounts of these PRP produced in saliva (Mehansho et a l, 1992). It is 
therefore possible that the binding of dietary tannins to PRP and HRP which are 
observed in the buccal cavity neutralise their inhibitory effects on salivary a-amylase 
activity in vitro.
Saliva total protein was not significantly different following the meals consumed with 
water or black tea. Dietary tannins have been shown to modulate the secretion of PRP in 
saliva (Mehansho et al, 1983; Mehansho et a l, 1996). It was therefore expected that 
salivary total protein would be higher following the meals with black tea, as increased 
levels of PRP would be present in saliva. It is possible that the expected salivary total 
protein increase was not seen as the tannin-PRP complexes were swallowed 
immediately they were formed. It would appear from these data that the signal for 
salivary PRP release from the salivary parotid glands is triggered from within the oral 
cavity and is sensitive to the presence of dietary tannins within the mouth.
A two-day wash out period for dietary tannins and caffeine was included within the 
study protocol. This was designed to minimise the effect of habitual tea and wine 
drinking amongst volunteers and to provide a reliable base line that was equal for all 
volunteers with regard to dietary tannin and polyphenol consumption. In rodents, acute 
exposure to various types of tannin causes an increased secretion of PRP and HRP, the 
effects of chronic exposure over a long period of time on PRP and HRP secretion are 
less certain. As the volunteers were not characterised as to status with regard to habitual 
or non-habitual tea consumption, it was not possible to determine any differences in 
total protein secretion following black tea consumption between habitual and non- 
habitual tea drinkers.
In this investigation subjects were given two cups of tea to consume with their meal. A 
two-minute brew was used to make the tea. It has been reported in the literature that 84 
% of the total antioxidant activity of black tea polyphenols is released into the tea liquor
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after a five-minute brew (Prior & Gao, 1999). It was decided to use a two-minute brew 
to maximise the amount of tea polyphenols present in the tea within a convenient 
volume but without elevating the dose to a volume unlikely to be consumed by regular 
drinkers of several cups of more rapidly brewed tea. It is quite possible that a stronger 
brew may have led to stronger differences between the decaffeinated black tea and 
water but as this would not relate to what is consumed on average then this would not 
reflect the real effects as taken by the average population.
7.4.1 SUMMARY AND CONCLUSIONS
The non-caffeine constituents and caffeine within black tea may cause an increase in gut 
transit time when consumed with a meal. This proposed action of black tea constituents 
on gut transit time was supported by the elevated levels of the peptide hormones GIP 
and GLP-1 following the meals consumed with black tea compared with water. 
Consumption of caffeinated black tea may also delay plasma TAG clearance following 
a meal.
Within this experiment neither black tea polyphenols nor caffeine had any statistically 
significant effects on the postprandial pattern of plasma glucose and NEFA, salivary 
total protein, a-amylase activity or salivary ILI.
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CHAPTER 8
8.1 DISCUSSION
GIF-like immunoreactivity (GLI) was found in both rat salivary submandibular gland 
(SSG) extracts and human saliva. This is the first known report of GLI in human saliva. 
The RIA results for fractions collected from HPLC analysis (section 2.3.3.5) suggest 
that GLI present in extracts of rat SSG have a different molecular form to that of 
intestinal GIF. The pattern of GLI concentrations in extracts of rat SSG and human 
saliva was consistent with GLI in saliva coming from local synthesis within the SSG. 
Levels of GLI in saliva were higher in saliva from volunteers after an overnight fast, 
which corresponded with lower levels of GLI in extracts from rat SSG following an 
overnight fast. Levels of GLI in both human saliva and extracts of rat SSG were 
reversed postprandially. If GLI were synthesised within the salivary glands and secreted 
into saliva in the fasted state one would expect GLI to be synthesised and stored 
postprandially in order to be secreted into saliva in the absence of food.
The GLI in human saliva and extracts of rat SSG did not respond to the presence of 
nutrients in the same manner as GIF secreted from the intestine into the circulation. GLI 
in extracts from rat SSG was increased in fed rats compared with fasted rats, and GIF 
levels from extracts of rat small intestine were higher from fasted rats compared with 
fed rats. GLI in human saliva decreased immediately following both food ingestion and 
sham feeding, whereas plasma GIF levels increased following food ingestion but did not 
alter following sham feeding. This pattern of GLI synthesis and secretion is not 
consistent with a role for salivary gland GLI in postprandial nutrient metabolism.
Due to the high levels of GLI in saliva from volunteers following an overnight fast, and 
the presence of somatostatin in extracts of rat SSG (Deville de Ferrier et a l, 1989), it is 
possible that salivary gland GLI is involved in the inhibition of gastric acid secretion 
(section 5.4). Levels of GLI in human saliva decreased immediately following food, 
which is consistent with the hypothesised role of GLI in saliva in gastric acid inhibition. 
GIF was originally characterised by its ability to inhibit gastric acid secretion, but 
circulating levels of GIF are lower than that necessary for GIF to be a physiological 
inhibitor of gastric acid secretion (Nauck et a l, 1992). In contrast levels of GLI in 
human saliva following an overnight fast are at a level consistent with that necessary for 
GLI in saliva to be involved in the inhibition gastric acid secretion.
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As GLI in saliva decreases following sham feeding as well as swallowed food it is 
possible that GLI in saliva contributes to the control of gastric acid secretion seen in the 
cephalic phase response to the sight, taste and smell of food. Further work is required to 
verify the involvement of salivary gland GLI in regulation of gastric acid secretion and 
to characterise the GLI found in salivary gland extracts.
In contrast to the GLI in extracts of rat SSG and human saliva, ILI in extracts of rat 
salivary glands and human saliva did not exhibit a similar pattern. ILI values in extracts 
from rat salivary glands were higher in SSG and SPG from fed animals compared with 
those of fasted animals, suggesting that ILI in extracts of rat salivary glands would be 
secreted in the fasted state. ILI in human saliva also increased following nutrient 
ingestion. The pattern of ILI concentrations in extracts of rat SSG and SPG and human 
saliva were therefore not consistent with ILI in saliva coming from local synthesis 
within the SSG and SPG.
ILI in human saliva increased following nutrient ingestion without a corresponding 
increase in levels of C-peptide in saliva and ILI in saliva did not increase following the 
sham fed meal. It would appear from this that although ILI in extracts of rat SSG may 
come from local synthesis, ILI in saliva is an ultrafiltrate from blood. There is other 
evidence available to substantiate this hypothesis; for example, salivary gland ILI 
concentration is not dependent on serum insulin levels (Carter et a l, 1995). This 
hypothesis is further supported by (i) an increase in ILI in saliva following an 
intravenous injection of insulin without a corresponding increase in salivary C-peptide 
(Vallejo et al, 1984), (ii) the lower levels and delayed time of peak ILI in saliva 
compared with plasma insulin, and (iii) a positive correlation between ILI in saliva and 
plasma insulin levels (Fekete et al, 1993; Marchetti et a l, 1986). It can therefore be 
concluded that the ILI in human saliva is an ultrafiltrate from blood.
A possible role for insulin in saliva is not obvious. If ILI in saliva were an ultrafiltrate 
from blood then it would require an active transport mechanism to pass from the blood 
into saliva as insulin does not diffuse across the cell membrane. It is possible that ILI in 
saliva has a role in glucose sensing or in secretion of digestive hormones, and enzymes
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such as salivary a-amylase. Another possibility is that ILI in saliva may be a quirk of 
evolution without a function.
Similarly, the role of insulin within the salivary glands is also unknown. It would appear 
that the ILI found in the salivary glands has paracrine effects within the glands, possibly 
involved with protein synthesis. Pancreatic insulin potentiates the release of 
somatostatin in the pancreas (Kadowaki et a l, 1980); somatostatin has also been found 
in extracts of rat SSG (Deville de Perrier et a l, 1989). It is possible therefore that 
salivary gland ILI has a similar role in the salivary glands on the hormone somatostatin 
and other proteins.
GLP-1 (7-36) amide was not found in either rat salivary gland extracts or human saliva. 
Although this glucagon-like peptide was not detected in these studies it does not 
necessarily mean that other glucagon-like peptides are not present. In the literature the 
results of investigations using different antisera have argued for both the presence and 
absence of glucagon-like peptides (Bhathena et al, 1977; Lawrence et a l, 1977; Smith 
et a l, 1979; Tahara et al, 1983). These antisera were all supposedly specific to 
glucagon, but it is possible that one or more of the antisera used crossreacted with other 
glucagon-like peptides, which result from posttranslational processing of proglucagon 
(figure 1.3). The crossreactivities of the antisera were not specified and therefore there 
is still the possibility that, for instance, GLP-2 is present in the salivary glands and 
human saliva despite the failure to detect GLP-1. Due to the unavailability of the 
necessary antiserum this work could not be investigated further.
It was thought that as dietary tannins have been shown to induce hypertrophy of the 
salivary parotid gland and stimulate a change in gene expression within the parotid 
gland of rodents (Mehansho et al, 1992) dietary CPT may modulate the peptide 
hormone content of the salivary glands. The chronic studies on rats and the acute studies 
on volunteers reported in this thesis have shown that red wine, red wine polyphenols 
and black tea polyphenols have little effect on the ILI and GLI of the salivary glands 
and saliva. Also, there was no evidence of hypertrophy of the SSG or SPG. The 
concentrations of dietary tannins used in the human studies were at relative dietary 
physiological doses (two glasses of red wine or black tea) rather than at larger
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pharmacological doses that may have been used in some previous studies on rodents. A 
larger dose of dietary CPT may have induced greater effects on the endocrine activity of 
the salivary glands. The doses used within this thesis were designed to reflect those that 
might reasonably be consumed by the average black tea or red wine drinker, in order to 
determine the effects that would be seen in the average consumer.
Consumption of red wine and decaffeinated black tea increased the total protein content 
of human saliva. In contrast to the inhibition of pure a-amylase by dietary tarmins 
demonstrated by in vitro studies (Gin et a l, 1999), consumption of red wine in vivo 
increases the total a-amylase activity in saliva. The in vitro study used a finite amount 
of a-amylase in a closed system, which cannot be compared with the increase in 
secretion of a-amylase from the in vivo experiment. This aspect has been discussed 
more hilly in chapter 6.
Neither red wine polyphenols nor black tea polyphenols modulated intestinal GIP 
concentrations. Consumption of red wine polyphenols increased the total GLP-1 content 
of the small intestine and consumption of black tea increased GLP-1 levels in plasma. 
Black tea polyphenols increased the total insulin response to a meal. We did not 
measure the circulating insulin response following consumption of red wine. However, 
levels of ILI in saliva reflect those of plasma insulin and there is a positive correlation 
between plasma and ILI in saliva (Fekete et a l, 1993). Red wine did not modulate ILI 
in saliva and it is therefore unlikely that red wine has no effect on plasma insulin levels.
Within all the black tea feeding experiments caffeine controls were used to differentiate 
between the effects of caffeine and those of black tea polyphenols. Caffeine 
consumption led to a non-significant increase in GLI in extracts of rat SSG from fasted 
animals and a reduction in GLI in human saliva, two to six hours following a meal. It 
would therefore appear that the consumption of caffeine modulated the secretion of GLI 
from the salivary glands and into saliva. Caffeinated drinks are known to stimulate 
pentagastrin-stimulated gastric acid secretion. We have hypothesised that GLI in saliva 
is involved with inhibition of gastric acid secretion via suppression of the pentagastrin- 
stimulated gastric acid secretion. It is possible that the reduced levels of GLI in saliva
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following consumption of caffeinated drinks contribute to the stimulation of gastric acid 
secretion by caffeine. The mechanism by which this may occur is not clear.
Although this thesis has found relatively weak effects of dietary polyphenols from red 
wine and black tea in comparison with those reported in the literature, it should be noted 
that physiological doses were used in all experiments as described previously. There are 
also differences due to the use of in vivo and in vitro experiments. One of the major 
reasons for differences between the in vitro and in vivo experiments is that within in 
vivo experiments the dietary polyphenols will be exposed to various digestive processes 
following consumption, whereas in vitro experiments provide a closed system with 
greater experimental control. For instance salivary PR? in the mouth which bind to 
dietary polyphenols and possible metabolism by gut microflora prior to absorption, 
events that would not occur in vitro.
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8.2 CONCLUDING REMARKS
In summary, studies of rat salivary glands have shown salivary gland ILI comes from 
local synthesis and our studies indicate that it is structurally similar to pancreatic 
insulin. Salivary gland ILI is not involved with glucose homeostasis, but may have 
paracrine functions within the salivary glands, possibly involved with protein synthesis. 
Salivary gland GLI comes from local synthesis and our studies indicate that it is 
structurally different from intestinal GIP. GLP-1 (7-36) amide is not present in rat 
salivary glands.
Studies of human saliva have shown ILl in saliva does not come from local synthesis, 
but is an ultrafiltrate from blood. GLI in saliva comes from local synthesis in the 
salivary glands and is secreted into saliva. The function of GLI within the salivary 
glands and saliva is possibly involved with the inhibition of gastric acid secretion via 
the somatstatin-gastrin pathway and is involved in the control of cephalic phase gastric 
acid secretion. GLP-1 (7-36) amide is not present in human saliva.
Chronic rat feeding studies indicated that whole black tea consumption in rats increased 
GIP levels in the duodenum and reduced plasma glucose levels, these effects were 
primarily attributable to caffeine rather than the polyphenol content of black tea. 
However red wine polyphenols appeared to be responsible for increased duodenal GLP- 
1 concentrations in rats.
Acute studies in humans indicated that red wine consumption increased salivary a- 
amylase in activity in volunteers and whole black tea consumption modulated 
circulating GIP and GLP-1 levels. Red wine and black tea polyphenols and caffeine at 
relative dietary physiological doses do not modulate salivary gland insulin-like and 
GlP-like immunoreactivity.
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8.3 FUTURE WORK
Based on the findings of this research there are a numbers of areas, which require
further investigation to give further understanding of the peptide hormones present in
the salivary glands and saliva and also the possible health effects of dietary phenols.
1. The role of ILl in human saliva needs further clarification. By use of insulin- 
dependent diabetic patients the levels of ILl in saliva relative to those of plasma can 
be ascertained.
2. The role of GLI in the inhibition of gastric acid secretion needs verification by use 
of specific GIF receptor antagonists such as GIP (1-30). Also the GLI in the salivary 
glands and saliva needs further chemical characterisation.
3. The possible presence of glucagon-like peptides other than GLP-1 in the salivary 
glands and saliva requires investigation using specific antisera for these peptides.
4. Further investigations are required into the effects of dietary phenols on:
• The intestinal metabolism of nutrients such as dietary lipids
• Secretion of other peptide hormones from the intestine such as GLP-2
• Gut motility
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